UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________
FORM 10-K
☒
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For the fiscal year ended September 30, 2021
or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the transition period from _______________ to _______________
Commission File Number 001-15401
EDGEWELL PERSONAL CARE COMPANY
(Exact name of registrant as specified in its charter)
Missouri
(State or other jurisdiction of incorporation or organization)
6 Research Drive
Shelton, CT 06484
(Address of principal executive offices and zip code)
43-1863181
(I. R. S. Employer Identification No.)
(203) 944-5500
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Common Stock, par value $0.01 per share
Stock symbol
EPC
Name of each exchange on which registered
New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None.
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not
contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller
reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
Non-accelerated filer
☐ (Do not check if a smaller reporting company)
Smaller reporting company
Emerging growth company
☐
☐
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. ☒
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of March 31, 2021,
the last day of the registrant’s most recently completed second fiscal quarter, was $2,150,843,429.
The number of shares of the registrant’s common stock outstanding as of October 31, 2021 was 54,371,878.
Certain portions of the registrant’s definitive proxy statement for its 2021 annual meeting of shareholders, to be filed with the
Securities and Exchange Commission within 120 days after September 30, 2021, are incorporated by reference into Part III of this
report.
DOCUMENTS INCORPORATED BY REFERENCE
EDGEWELL PERSONAL CARE COMPANY
INDEX TO FORM 10-K
PART I
Item 1.
Business.
Item 1A.
Risk Factors.
Item 1B.
Unresolved Staff Comments.
Item 2.
Item 3.
Item 4.
Properties.
Legal Proceedings.
Mine Safety Disclosures.
PART II
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities.
Selected Financial Data.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Item 5.
Item 6.
Item 7.
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk.
Item 8.
Item 9.
Financial Statements and Supplementary Data.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.
Item 9A.
Controls and Procedures.
Item 9B.
Other Information.
Item 10.
Item 11.
Item 12.
Item 13.
Item 14.
Directors, Executive Officers and Corporate Governance.
Executive Compensation.
PART III
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Certain Relationships and Related Transactions, and Director Independence.
Principal Accounting Fees and Services.
Item 15.
Exhibits, Financial Statement Schedules.
Part IV
Signatures
Exhibit Index
3
11
19
19
20
20
21
23
24
42
43
87
87
87
88
88
88
88
88
89
90
91
Presentation of Information
Unless the context requires otherwise, references to “Edgewell Personal Care Company,” “Edgewell,” “we,” “us,” “our” and
“the Company” refer to Edgewell Personal Care Company, and its consolidated subsidiaries.
Trademarks and Trade Names
We own or have rights to use trademarks and trade names that we use in conjunction with the operation of our business, which
appear throughout this Annual Report on Form 10-K. Solely for convenience, we only use the ™ or ® symbols the first time
any trademark or trade name is mentioned. We may also refer to brand names, trademarks, service marks and trade names of
other companies and organizations, and these brand names, trademarks, service marks and trade names are the property of their
respective owners.
Industry and Market Data
Unless we indicate otherwise, we base the information concerning our industry contained or incorporated by reference herein
on our general knowledge of and expectations concerning the industry. Our market position, market share and industry market
size are based on our estimates using internal data and data from various industry analyses, our internal research and
adjustments and assumptions that we believe to be reasonable. We have not independently verified data from industry analyses
and cannot guarantee its accuracy or completeness. In addition, we believe that data regarding the industry, market size and our
market position and market share within such industry provide general guidance but are inherently imprecise. Further, our
estimates and assumptions involve risks and uncertainties and are subject to change based on various factors, including those
discussed in the “Risk Factors” section of this document. These and other factors could cause results to differ materially from
those expressed in the estimates and assumptions.
Retail sales for purposes of market size, market position and market share information are based on retail sales in United States
dollars.
Forward-Looking Statements
This Annual Report on Form 10-K contains “forward-looking statements” within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995
provides a safe harbor for forward-looking statements made by or on behalf of Edgewell Personal Care Company or any of our
businesses. Forward-looking statements generally can be identified by the use of words or phrases such as “believe,” “expect,”
“expectation,” “anticipate,” “may,” “could,” “intend,” “estimate,” “plan,” “target,” “predict,” “likely,” “will,” “should,”
“forecast,” “outlook,” or other similar words or phrases. These statements are not based on historical facts, but instead reflect
our expectations, estimates or projections concerning future results or events, including, without limitation, the future earnings
and performance of Edgewell Personal Care Company or any of our businesses. These statements are not guarantees of
performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict
and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any
of our expectations, estimates or projections will be achieved. The forward-looking statements included in this report are only
made as of the date of this report, and we disclaim any obligation to publicly update any forward-looking statement to reflect
subsequent events or circumstances, except as required by law. You should not place undue reliance on these statements.
Factors that could cause fluctuations in our actual results include, but are not limited to, the following:
•
•
•
•
•
•
•
•
•
the ongoing novel coronavirus 2019 (COVID-19) pandemic;
our ability to compete in products and prices in an intensely competitive industry;
the loss of any of our principal customers;
our inability to execute a successful e-commerce strategy;
fluctuations in the price and supply of raw materials;
our failure to maintain our brands’ reputation;
our failure to achieve projected gross cost savings under our various initiatives;
legislative or regulatory changes impacting or limiting our business; and
product quality and safety issues, including recalls and product liability.
1
In addition, other risks and uncertainties not presently known to us or that we presently consider immaterial could significantly
affect the forward-looking statements. The list of factors above is illustrative, but not exhaustive. All forward-looking
statements should be evaluated with the understanding of their inherent uncertainty. Additional risks and uncertainties include
those detailed from time to time in our publicly filed documents, including in Item 1A. Risk Factors of Part I of this Annual
Report on Form 10-K.
2
PART I
Item 1. Business.
Overview
Edgewell Personal Care Company, and its subsidiaries, is one of the world’s largest manufacturers and marketers of personal
care products in the wet shave, sun and skin care, and feminine care categories. We operate in more than 20 countries and have
a global footprint in more than 50 countries.
History and Development
We were incorporated in the state of Missouri on September 23, 1999 and, prior to April 2000, were a wholly-owned subsidiary
of Ralston Purina Company. On April 1, 2000, all of the outstanding shares of our common stock were distributed to
shareholders of Ralston Purina Company and we became an independent publicly-owned company. During the years that
followed, we implemented a strategy of acquiring several personal care brands, which created the foundation for the company
we are today.
In 2003, we completed the acquisition of the Schick-Wilkinson Sword business (“SWS”) from Pfizer, Inc., which was the
second largest manufacturer and marketer of men’s and women’s wet shave products in the world. Our portfolio of wet shave
products includes: Hydro® and Quattro® men’s shaving systems; Hydro Silk®, Quattro for Women®, Intuition® and Silk
Effects® Plus women’s shaving systems; and the Hydro, Quattro, Xtreme 3®, Slim Twin®, Slim Triple®, Skintimate and
Extra3™ disposables. SWS has over 100 years of history in the shaving products industry with a reputation for high quality and
innovation in shaving technology. SWS products are sold throughout the world.
In 2007, we acquired Playtex Products, Inc. (“Playtex”), a leading manufacturer and marketer of well-recognized brands such
as Playtex® feminine care products, Wet Ones® pre-moistened wipes, and Banana Boat® and Hawaiian Tropic® sun care
products, thereby expanding our branded consumer products portfolio.
In 2009, we completed the acquisition of the Edge® and Skintimate® shave preparation brands from S.C. Johnson & Son, Inc.,
adding market leading United States (“U.S.”) shave preparation brands to our existing wet shave product portfolio. In 2010, we
completed the acquisition of American Safety Razor, LLC (“ASR”), a leading global manufacturer of private label and value
wet shaving razors and blades and specialty blades.
Strengthening our company’s feminine care product portfolio, in 2013 we acquired the Stayfree® pad, Carefree® liner and
o.b.® tampon feminine hygiene brands in the U.S., Canada and the Caribbean from Johnson & Johnson.
In 2015, we completed the separation of our Household Products business, which manufactures and markets batteries and
portable lighting, into a separate publicly-traded company (the “Spin” or the “Separation”). We completed the tax-free
Separation by distributing 100% of the outstanding shares of common stock of Energizer SpinCo, Inc. to our shareholders. The
newly formed company assumed the name Energizer Holdings, Inc. (“New Energizer”) and began trading under the symbol
“ENR” on the New York Stock Exchange (“NYSE”). Edgewell retained the Personal Care business and trades on the NYSE
under the symbol “EPC.” Following the Separation, we do not beneficially own any shares of New Energizer. In connection
with the Separation, we changed our name to Edgewell Personal Care Company on June 30, 2015.
In recent years, we have entered the men’s grooming and skin care markets through several acquisitions. On October 31, 2016,
we completed the acquisition of Bulldog Skincare Holdings Limited (“Bulldog”), a men’s grooming and skincare company
based in the United Kingdom (“U.K.”). On March 1, 2018, we completed the acquisition of Jack Black, L.L.C. (“Jack Black”),
a men’s luxury skincare company based in the U.S. Finally, on September 2, 2020, we completed the acquisition of Cremo
Holding Company, LLC (“Cremo”), one of the strongest and fastest growing masstige brands in men’s grooming, offering a
complete line of beard, hair, body wash, shave prep and skin care products. These more recent acquisitions have created
opportunities to expand our personal care portfolio into the growing, global grooming category, and have allowed us to leverage
our international geographic footprint.
3
Our Business Segments and Product Strategies
We manage our business in three operating segments: Wet Shave, Sun and Skin Care, and Feminine Care. The Company
previously had an All Other segment that consisted primarily of our infant and pet care products business that was sold in
December 2019. Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-
based compensation costs, costs associated with restructuring initiatives and other items that are not representative of
management’s view on how segment performance is evaluated. Information regarding the product portfolios of these segments
is included within the following discussion. Financial information regarding each of our reportable segments, as well as other
geographical information, is included in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of
Operations and in Note 18 of Notes to Consolidated Financial Statements included within Item 8. Financial Statements and
Supplementary Data of this Annual Report on Form 10-K.
Wet Shave
Wet Shave products are sold under the Schick®, Wilkinson Sword®, Edge, Skintimate, Shave Guard and Personna® brand
names. We manufacture and distribute Schick and Wilkinson Sword razor systems, composed of razor handles and refillable
blades, and disposable shave products for men and women. While we market our wet shave products throughout the world, our
primary markets are the U.S., Canada, Japan, Germany, France and the U.K. We believe we hold the number two global market
share position in wet shaving. The category is highly competitive, with manufacturers vying for consumer loyalty and retail
shelf space.
During 2017, we launched our first direct-to-consumer site in the U.S. and see continued growth opportunities across direct-to-
consumer platforms across markets in North America, Europe, and Asia.
In 2021, we relaunched Schick Hydro Skin Comfort™ with innovation led by the Stubble Eraser™ and includes four new
razors including a Sensitive Razor, Dry Skin Razor, Slim Head Sensitive Razor, and a 4-in-1 Groomer.
In the U.S., Canada and Japan, we sell market-leading shave preparation products, including shaving gels and creams under the
Edge, Skintimate and Shave Guard brands.
We also manufacture, distribute and sell a complete line of private label and value-priced wet shaving disposable razors,
shaving systems and replacement blades. These wet shave products are sold primarily under a retailer’s store name or under our
value brand names such as Personna.
Sun and Skin Care
Sun and Skin Care products are sold under the Banana Boat, Hawaiian Tropic, Bulldog®, Jack Black®, Cremo® and Wet Ones
brand names. We market Sun Care products under the Banana Boat and Hawaiian Tropic brands and believe these brands, on a
combined basis, hold a leading market share position in the U.S. sun care category. We compete across the full spectrum of Sun
Care categories: general protection, sport, kids, baby, tanning and after sun. Outside of the U.S., we believe we are also the
leading Sun Care manufacturer in Australia and Mexico. We expect to continue to drive our worldwide business through
product innovation, increased distribution and geographic expansion.
We offer Wet Ones antibacterial hand wipes, the leader in the U.S. portable hand wipes category. We have grown our portfolio
of hygiene products to include Wet Ones plus alcohol sanitizing wipes and Wet Ones hand sanitizer gel.
We have acquired a portfolio of men’s grooming skin care products that have grown under our direction. Our Bulldog skincare
products are purpose-built for men and were created to work simply and efficiently while dealing with issues specific to men’s
skin. Since acquiring Bulldog, we have expanded sales geographically and are committed to further growth and distribution for
the brand. We acquired the Jack Black brand to obtain a footprint in the luxury men’s skincare market and we will use
resources at our disposal to grow the Jack Black brand globally. Finally, we further expanded our portfolio of men’s skincare
and grooming brands with the acquisition of Cremo, a masstige brand in men’s grooming that offers a complete line of “barber
quality” beard, hair and skin care products.
4
Feminine Care
In Feminine Care, we market products under the Playtex, Stayfree, Carefree and o.b. brands. We offer tampons under the
Playtex Gentle Glide® 360°®, Playtex Sport®, Playtex and o.b. brands, including the Playtex Sport compact tampon launched
in 2017. We also market pads and liners under the Stayfree and Carefree brands. We believe we are one of the top two
manufacturers of feminine care products in North America, with unique, competitive product technologies and well-known
brands that address complementary consumer needs. We intend to continue to invest in innovation in our feminine care brands.
Competition
The personal care product categories are highly competitive, both in the U.S. and globally, as large manufacturers with global
operations and new entrants attempting to disrupt the market compete for consumer acceptance and increasingly limited retail
shelf space. Competition is based upon several factors, including brand perception, product performance, customer service and
price and promotion. The continued growth in online sales also puts additional competitive pressure on our Company.
Wet Shave
The global shaving products category is comprised of wet shave blades and razors, electric shavers and shaving gels and
creams. With our established brands and product lines and global presence, we believe we compete effectively in this market.
Our principal competitors in the global wet shave business are: The Procter & Gamble Company, which owns the Gillette brand
and is the leading company in the global wet shave segment; Bic Group, which is expanding beyond its historical strength in the
disposable segment; and Dorco, which competes primarily in the private label segment. We also compete with newer entrants to
the Wet Shave market for both direct-to-consumer online and traditional retail shelf space including Unilever (Dollar Shave
Club brand), Harry's, Perio (Barbasol and PureSilk brands), Beiersdorf (Nivea branded women’s wet shave product in
Germany) and numerous other online start-ups.
Sun and Skin Care
The markets for sun and skin care are also highly competitive, characterized by the frequent introduction of new products
accompanied by major advertising and promotional programs. Our competitors in these markets consist of a large number of
domestic and foreign companies, including Bayer AG and Johnson & Johnson.
The market for sun care products is also characterized historically by global growth and is impacted by trends in skin care. With
our balanced sun care portfolio, depth of sun care formulation expertise and global presence, we believe we compete effectively
and have more than doubled our international sun care business since acquiring the Banana Boat and Hawaiian Tropic brands in
2008. We intend to continue to compete by driving product innovation, building differentiated brand equity and focusing on in-
store visibility.
The global men’s skin care market is expected to continue to grow, with increased demand for men’s personal care products.
Our competitors in this market include large companies such as Johnson & Johnson, L’Oréal S.A., The Estee Lauder
Companies, Inc. and Unilever, as well as smaller companies. We compete in the market by creating simple and effective skin
care products with natural ingredients at multiple price points through our Bulldog and Cremo skin care products and in the
luxury men’s skin care market with Jack Black.
Feminine Care
The markets for feminine care and other personal products is characterized by large manufacturers with global presence, as well
as new market entrants, and is likewise very competitive, with a large number of domestic and foreign competitors, including
The Procter & Gamble Company and Kimberly Clark Corp. With our acquisition of the Stayfree, Carefree and o.b. brands, we
expanded our presence within the feminine care product category and became one of the top two manufacturers in North
America. We compete by having a portfolio of well-known brands that address complementary consumer needs.
5
Sales and Distribution
Our products are marketed primarily through a direct sales force and supplemented by strategic exclusive and non-exclusive
distributors and wholesalers. In the U.S., Japan and larger markets in Western Europe and Latin America, we have dedicated
commercial organizations, reflecting the scale and importance of these businesses to our Company. In several countries where
we do not have dedicated commercial organizations, we utilize third-party distributors and wholesalers. As a result of increased
competition through the expansion of online markets, we have established e-commerce operations across several business lines,
including global Schick.com websites providing men’s and women’s shaving products, Bulldog direct to consumer sites, Jack
Black direct to consumer sites, and an acceleration of e-commerce sales in China through our partnership with T-Mall. We
distribute our products to consumers through numerous retail locations worldwide, including mass merchandisers and
warehouse clubs, food, drug and convenience stores, and military stores.
Although a large percentage of our sales are attributable to a relatively small number of retail customers, only Walmart Inc. and
its subsidiaries (“Walmart”), as a group, account for more than 10% of our consolidated annual net sales. Walmart accounted
for approximately 21% of our net sales in fiscal 2021. Purchases by Walmart included products from all of our segments.
Target Corporation represented approximately 11% of net sales for our Sun and Skin Care segment and 10% for our Feminine
Care segment, respectively.
Generally, orders are shipped within a month of their order date. Because of the short period of time between order and
shipment dates, the dollar amount of current backlog is not material and is not considered to be a reliable indicator of future
sales volume.
Government contracts do not represent a material portion of our net sales.
Seasonality
Customer orders for sun care products within our Sun and Skin Care segment are highly seasonal, which has historically
resulted in higher sun care sales to retailers during the late winter through mid-summer months. Within our Wet Shave segment,
sales of women’s products are moderately seasonal, with increased consumer demand in the spring and summer months. See
“Our business is subject to seasonal volatility” in Item 1A. Risk Factors.
Sources and Availability of Raw Materials
The principal raw materials used in our products include steel, various plastic resins, plastic based components, textile fibers
and non-woven fabrics, organic and inorganic chemicals, soap-based lubricants and plastic-pulp based packaging. These
materials are sourced on a regional or global basis, as applicable, and are generally available from multiple sources. Price and
availability of our raw materials fluctuate over time. While we have confidence our supply assurance plans adequately support
our current operational needs, we cannot predict the future with certainty. Both price and supply are subject to risk from global
socio- and macroeconomic influences such as, but not limited to, force majeure, loss or impairment to key manufacturing sites,
transportation, government regulation, currency or other unforeseen circumstances. In the past, we have avoided significant
interruption in the availability of our input materials and believe our extensive experience in procurement allows us to manage
these risks effectively.
Patents, Technology and Trademarks
We own a number of U.S. and international trademarks, which we consider of substantial importance and which are used
individually or in conjunction with our other trademarks. These include, but are not limited to: Edgewell™, Schick, Schick
Hydro, Schick Hydro Silk, Hydro Connect™, Wilkinson Sword, Intuition, Quattro, Xtreme 3, Protector™, Silk Effects, Slim
Twin, Edge, Skintimate, Personna, Banana Boat, Hawaiian Tropic, Bulldog, Jack Black, Cremo, Gentle Glide, Sport, Sport
Level Protection™, Wet Ones, Stayfree, Carefree and o.b. As a result of the Playtex acquisition, we also own royalty-free
licenses in perpetuity to the Playtex trademark in the U.S. and in many international jurisdictions related to certain feminine
hygiene and other products but excluding certain baby care and apparel-related products. We consider the protection of our
trademarks to be important to our business.
Our ability to compete effectively in the Wet Shave, Sun and Skin Care, and Feminine Care personal care categories depends,
in part, on our ability to maintain the proprietary nature of technology and manufacturing processes through a combination of
patent and trade secret protection, non-disclosure agreements and licensing agreements. We own or license a considerable
number of patents, patent applications and other technology from third parties, which we believe are important to our business.
These relate primarily to shaving product improvements and additional features, feminine care hygiene products including
digital and applicator tampons, pads and liners, sunscreen formulations and manufacturing processes.
6
As of September 30, 2021, we owned, either directly or beneficially, approximately 460 unexpired U.S. patents, which have a
range of expiration dates from October 2021 to January 2, 2039, and we had approximately 54 pending U.S. patent applications.
We routinely prepare additional patent applications for filing in the U.S. and actively pursue foreign patent protection in various
countries. As of September 30, 2021, we owned, either directly or beneficially, approximately 1,313 foreign patents, having a
range of expiration dates from October 2021 to August 2045, and we had approximately 103 pending patent applications in
foreign countries.
We rely on trademark, trade secret, patent and copyright laws to protect our intellectual property rights. We cannot be sure that
these intellectual property rights will be effectively utilized or, if necessary, successfully asserted. There is a risk that we will
not be able to obtain and perfect our own intellectual property rights, or, where appropriate, license intellectual property rights
from others.
Governmental Regulation and Environmental Matters
We are subject to various federal, state, local and foreign laws and regulations by governmental agencies intended to protect the
public health and environment, including those governing the manufacture, use, discharge and disposal of hazardous materials,
labeling and notice requirements related to consumer exposure to certain chemicals, and requirements for the recycling of our
products and their packaging. These agencies include, but are not limited to (i) the U.S. Food and Drug Administration (the
“FDA”) and equivalent international agencies that regulate ingredients in consumer products; (ii) the U.S. Environmental
Protection Agency (“EPA”) and equivalent international agencies that regulate our manufacturing facilities; and (iii) the
Chemical Registration/Notification authorities that regulate chemicals that we use in, or transport to, the various countries in
which we manufacture and/or market our products. We have seen an increase in registration and reporting requirements
concerning the use of certain chemicals in a number of countries, such as the Registration, Evaluation, Authorization and
Restriction of Chemicals (“REACH”) regulations in the European Union (the “E.U.”).
Contamination has been identified at certain of our current and former facilities, as well as third-party waste disposal sites, and
we are conducting investigation and remediation activities in relation to such properties. In connection with certain sites, we
have received notices from the EPA, state agencies and private parties seeking contribution that we have been identified as a
potentially responsible party (“PRP”) under the Comprehensive Environmental Response, Compensation and Liability Act of
1980 (“CERCLA”) and, as a result, we may be required to share in the cost of cleanup with respect to a number of federal
“Superfund” sites. In addition to potential costs to clean up our own properties, we may also be required to share in the cost of
cleanup with respect to state-designated sites and certain international locations.
The amount of our ultimate liability in connection with those sites may depend on many factors, including the volume and
toxicity of material contributed to the site, the number of other PRPs and their financial viability and the remediation methods
and technology to be used. Total environmental capital expenditures and operating expenses are not expected to have a material
adverse effect on our total capital and operating expenditures, cash flows, earnings or competitive position. Current
environmental spending estimates could be modified as a result of changes in our plans or our understanding of the underlying
facts, changes in legal requirements, including any requirements related to global climate change or other factors.
The U.S. Toxic Substances Control Act of 1976 (“TSCA”) and similar laws in other jurisdictions are intended to ensure that
chemicals do not pose unreasonable risks to human health or the environment. TSCA requires the EPA to maintain the TSCA
registry listing chemicals manufactured or processed in the United States. Chemicals not listed on the TSCA registry cannot be
imported into or sold in the U.S. until registered with the EPA. TSCA also sets forth specific reporting, recordkeeping and
testing rules for chemicals, including requirements for the import and export of certain chemicals, as well as other restrictions
relevant to our business. Pursuant to these laws, the EPA from time to time issues Significant New Use Rules, or SNURs, when
it identifies new uses of chemicals that could pose risks to human health or the environment and also requires pre-manufacture
notification of new chemical substances that do not appear on the TSCA registry. When we import chemicals into the U.S., we
must ensure that chemicals appear on the TSCA registry prior to import, participate in the SNUR process when a chemical we
import requires testing data and report to the EPA information relating to quantities, identities and uses of imported chemicals.
Many European countries, as well as the E.U, have been very active in adopting and enforcing environmental regulations. As
such, it is possible that new regulations may increase the risk and expense of doing business in such countries.
7
REACH requires manufacturers and importers of chemical substances to register such substances with the European Chemicals
Agency, or the ECHA, and enables European and national authorities to track such substances. Depending on the amount of
chemical substances to be manufactured or imported, and the specific risks of each substance, REACH requires different sets of
data to be included in the registration submitted to the ECHA. Registration of substances with the ECHA imposes significant
recordkeeping requirements that can result in significant financial obligations for companies such as ours to import products
into Europe. REACH is accompanied by legislation regulating the classification, labeling and packaging of chemical substances
and mixtures.
We believe that our facilities and products are in substantial compliance with current laws and regulations.
Human Capital
Employee Profile
At Edgewell, we are committed first and foremost to people: our employees, the consumers who use our products, the suppliers
and retailers who partner with us, and the communities in which we operate. As of September 30, 2021, we had approximately
6,900 employees, with 2,100 based in the U.S. Certain of our employees are represented by unions or works councils. We have
cultivated a culture that is centered around our guiding purpose of Making Useful Things Joyful, supported by a set of values
and behaviors that guide organizational actions and decisions, such as a focus on diversity, equity and inclusion through our
sustainability program.
Our foundational values of “People first,” “Move forward,” “Listen up and speak up” and “Own it together” support a culture
of celebration, agility, authenticity and collaboration. This culture promotes trust and teamwork, which results in bold and
aggressive goals, smart risks and an environment where innovation and ideation thrives. During the past year, we reinforced our
foundational values through several key initiatives:
• We revamped our performance management process with increased accountability to live by our values by
incorporating a new ‘360-degree Values Assessment’ to ensure we evaluate each teammate’s performance not only on
the results achieve, but on how they achieve them;
• We launched an internal recognition platform, InspireJOY, to recognize those exhibiting our values through
•
recognition awards from managers and peers; and
To strengthen our “Listen up and speak up” value, we incorporated open, live Q&As in our All Hands meetings to
promote transparency between employees and executive leaders.
Employee Wellness
The COVID-19 pandemic presented an opportunity to demonstrate our “People first” value through the institution of paid
pandemic leave for our US manufacturing teams. This policy covers lost wages due to taking time off for childcare or to self-
quarantine, or for team members with underlying conditions, and has been utilized by approximately 80% of our US
manufacturing team members through September 2021. For our office-based employees, we scheduled numerous “Take a
Break” days throughout the past year to augment the existing holiday schedule and provide additional time away from the
office for focus on personal well-being without having to take personal time off.
The wellness of our people remains a primary focus and we believe that the most productive people are those who are at their
best, both physically and mentally. Our employees have access to several programs related to employee wellness including:
onsite wellness testing and education; mental and emotional health awareness and support; and work-life balance through flex-
time, remote working arrangements and parental leave, among others.
Ensuring a positive, purposeful working experience for our employees that is reflective of our purpose and values is central to
our business operations. We continually monitor employee retention rates and believe our progressive human resources
policies, learning and development, talent acquisition, workplace health and safety, and community engagement and support
activities enable us to attract and retain key personnel.
8
Diversity, Equity and Inclusion
We are committed to our continued efforts to increase diversity and foster an inclusive work environment that supports the
global workforce, consumers and the communities we serve. We recruit the best people for the job regardless of gender,
ethnicity or other protected traits and it is our policy to comply fully with all domestic, foreign and local laws relating to
discrimination in the workplace. Our diversity, equity and inclusion (DEI) principles are also reflected in our employee training,
and in particular with respect to our policies against harassment, bullying and the elimination of bias in the workplace. We
continue to enhance our DEI policies which are guided by our executive leadership team.
During 2021, we advanced our focus on DEI through many specific actions including:
•
Our CEO joined the CEO Action for Diversity & Inclusion™, pledging Edgewell to take additional actions to continue
cultivating a workplace where diverse perspectives and experiences are welcomed and respected and where employees
feel encouraged to discuss DEI;
• We joined the Board Diversity Action Alliance, an organization taking action to increase the representation of racially
and ethnically diverse directors on corporate boards;
• We appointed a Director of DEI who is leading and advancing our global DEI strategy aimed at building an inclusive
culture;
• We launched Teammate Resource Groups focused on increasing representation of and building an inclusive culture for
women and multicultural employees; and
•
Over 90% of our employees that are Directors and above attended training in mitigating bias in hiring and performance
evaluations.
Edgewell’s Sustainable Care 2030 is our ambitious strategy that will enable us to sustain and grow our business while inspiring
a world where the joy of caring for yourself is balanced with caring for our shared planet and society. Unveiled in 2020,
Sustainable Care 2030 includes key commitments and targets across our brands, operations and supply chain, as well as our
workforce and communities. Overall, DEI is an important part of our sustainability strategy with a focus on sustaining the
safety and well-being of our employees, the people who use our products, the partners with whom we work and the
communities we serve. We will build upon the commitments outlined in our Sustainable Care 2030 strategy to promote an open
and inclusive culture where everyone is treated fairly and with respect so that we can retain and attract the best talent.
Employee Recognition and Talent Development
We understand that to attract and retain great people, we must listen to and engage them regularly. Each year, we conduct an
anonymous employee engagement survey to gauge our progress and identify the areas in the employee experience where we
excel and areas for improvement. For the survey conducted in Summer 2021, our overall positivity score was 71% with 3,800
employees interacting with the survey.
We continue to build robust new learning and career development programs, which in fiscal year 2021 included the roll-out of
our Spark Growth program. Every People Manager across our company has now graduated from the program – a total of nearly
900 employees. The program has better equipped our People Managers to develop employees, engage in career discussions, and
maximize employee performance and potential. This will not only support the learning and growth of People Managers, but
also ensure that our leaders effectively enable our employees to do their best work and to support career aspirations and
mobility within the organization.
In addition to global themes, our employee experience results identified diverse priorities at the functional, country and team
levels. Our goal is to support our People Managers in taking accountability for their results and to empower them to make
changes at a local level to improve the employee experience.
9
Executive Officers
Set forth below are the names and ages as of September 30, 2021, and current positions of our executive officers.
Name
Rod R. Little
Daniel J. Sullivan
Paul R. Hibbert
John N. Hill
Marisa B. Iasenza
Eric O’Toole
Nick Powell
Age Title
52 Chief Executive Officer
52 Chief Financial Officer
52 Chief Supply Chain Officer
58 Chief Human Resources Officer
52 Chief Legal Officer and Corporate Secretary
54
54
President, North America
President, International
Set forth below is a brief description of the position and business experience of each of our executive officers.
Rod R. Little has served as Chief Executive Officer since March 1, 2019. Mr. Little previously served as our Chief Financial
Officer beginning in March 2018. Prior to joining Edgewell, Mr. Little served as Chief Financial Officer of HSNi from January
2017 to December 2017, and as Executive Vice President and Chief Financial Officer of Elizabeth Arden, Inc. from April 2014
to November 2016. Prior to joining Elizabeth Arden, Mr. Little spent 17 years with Procter & Gamble where he held numerous
positions of increasing responsibility in Procter & Gamble’s divisional and corporate finance organization, ultimately serving as
the chief finance officer of their global salon professional division from 2009 until 2014. Mr. Little also served for five years in
the United States Air Force prior to joining Procter & Gamble in 1997.
Daniel J. Sullivan has served as Chief Financial Officer since April 1, 2019. Prior to joining Edgewell, Mr. Sullivan served as
Executive Vice President and Chief Financial Officer of Party City Holdco Inc. Previously, Mr. Sullivan spent six years, from
2010 to 2016, with Ahold USA Inc., where he held positions of increasing responsibility within their control and finance
divisions, ultimately serving as Executive Vice President and Chief Financial Officer from 2013 to 2016. Prior to that, Mr.
Sullivan spent 13 years at Heineken N.V, most recently as the Chief Financial and Operating Officer of Heineken USA. Mr.
Sullivan is a certified public accountant.
Paul R. Hibbert has served as Chief Supply Chain Officer since June 1, 2020. Prior to his current role, Mr. Hibbert was Vice
President Global Supply Chain & Operations from February 2018 through May 2020. Before joining Edgewell in 2018, Mr.
Hibbert served as the Executive Vice President of Supply Chain for Safety-Kleen Systems, Inc. from 2015 through 2018, and
he held various roles of increasing responsibility such as Senior Vice President Supply Chain at Central Garden and Pet
Company, Supply Chain Consultant at Chemtura BioLab, Inc., and Supply Chain Vice President Home and Garden Division at
Spectrum Brands, Inc.
John N. Hill has served as Chief Human Resources Officer since April 4, 2017. Mr. Hill had previously led the North America
commercial organization as our company’s Vice President, North America since July 1, 2015, and as the VP, North America
Commercial of Energizer’s Personal Care division from 2007 to 2015. Mr. Hill joined our company in 2003 as General
Manager Schick Canada following the acquisition of Schick-Wilkinson Sword from Pfizer, Inc.
Marisa B. Iasenza has served as Chief Legal Officer and Corporate Secretary since June 4, 2018. From 2008 to 2018, Ms.
Iasenza served in roles of increasing responsibility at Harman International Industries, Incorporated, most recently as Senior
Vice President, General Counsel & Secretary. Prior to joining Harman, Ms. Iasenza served as Assistant General Counsel at
UAP Holdings, Inc. from 2007-2008, and prior thereto she worked in private practice in Southern California.
Eric O’Toole has served as President, North America since May 26, 2020. Prior to joining Edgewell, Mr. O’Toole was General
Manager of Walmart’s Sporting Goods e-commerce division. Mr. O’Toole had joined e-commerce startup Jet.com in early
2016 prior to Jet.com’s acquisition by Walmart. Earlier in his career, he held various positions at the Groupe Danone from 2003
to 2016 including President Danone Waters of America, SVP Sales and VP Business Development, The Dannon Company.
Nick Powell has served as President, International since June 1, 2020. Mr. Powell had previously served as VP Europe and
Latin America from April 2018 through May 2020; VP Europe, Middle East and Africa from 2017 through 2018; and VP North
Europe from 2015 to 2017. Prior to this experience, he was also Area Business Director and Managing Director for Energizer
Holdings and Schick-Wilkinson Sword.
10
Available Information
Our website address is www.edgewell.com. We are not including the information contained on our website as part of, or
incorporating it by reference into, this filing. We make available to the public on our website, free of charge, our Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed
or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as soon as reasonably practicable after
such material is electronically filed with, or furnished to, the U.S. Securities and Exchange Commission (“SEC”).
Item 1A. Risk Factors.
The following risks and uncertainties could materially adversely affect our business, results of operations, financial condition
and cash flows. We may amend or supplement the risk factors described below from time to time in other reports we file with
the SEC.
Macroeconomic Conditions and Related Risk Factors
The COVID-19 pandemic has affected how we are operating our respective businesses, and the duration and extent to which
this will impact our future results of operations remains uncertain.
The Novel Coronavirus 2019 (“COVID-19”) pandemic and efforts to control its spread have materially affected how we and
our partners and suppliers are operating our businesses. Specifically, we could continue to experience disruptions in our
manufacturing and supply chain operations, commodity volatility (cost and availability), and the availability, retention, and cost
of the labor force. Outside of these potential cost impacts, there continues to be a risk of changing consumer behavior and
category demands driven by COVID-19 uncertainty, that could impact our net sales. It is not clear what long-term effects the
COVID-19 pandemic will have on our business, including the effects on our customers. If we are not able to respond to and
manage the impact of the COVID-19 pandemic effectively we may continue to experience unfavorable impacts on our
operations. The COVID-19 pandemic may also heighten other risks described in this Risk Factors section.
Changes in production costs, including raw material prices and tariffs, could erode our profit margins and negatively impact
operating results.
Pricing and availability of raw materials, energy, shipping and other services needed for our business can be volatile due to
general economic conditions, labor costs, production levels, import duties and tariffs and other factors beyond our control.
There is no certainty that we will be able to offset future cost increases. This volatility can significantly affect our production
costs and may, therefore, have a material adverse effect on our business, results of operations and financial condition.
Competition in our industries may hinder our ability to execute our business strategy, achieve profitability, or maintain
relationships with existing customers.
The categories in which we operate are largely mature and highly competitive, both in the U.S. and globally, as a number of
companies compete for consumer acceptance, limited retail shelf space and e-commerce opportunities. Because of the highly
competitive environment in which we operate, as well as increasing retailer concentration, our retailer customers, including
online retailers, frequently seek to obtain pricing concessions or better trade terms, resulting in either reduction of our margins
or losses of distribution to lower cost competitors. Competition is based upon brand perceptions, product performance and
innovation, customer service and price. Our ability to compete effectively may be affected by a number of factors, including:
•
•
•
•
several of our competitors, including The Procter & Gamble Company, Unilever, Johnson & Johnson and others, may
have substantially greater financial, marketing, research and development and other resources and greater market share
in certain segments than we do, which could provide them with greater scale and negotiating leverage with retailers
and suppliers, and other competitors are newer companies backed by private-equity investors with the goal of
expanding revenue instead of profitability;
our competitors may have lower production, sales and distribution costs, and higher profit margins, which may enable
them to offer aggressive retail discounts and other promotional incentives;
our competitors may be able to obtain exclusive distribution rights at particular retailers or favorable in-store
placement;
our retailers could reduce inventories, shift to different products, or require us to lower our prices to retain shelf
placement of our products; and
11
•
we may lose market share to private label brands sold by retail chains, or to price brands sold by local and regional
competitors, which, in each case, are typically sold at lower prices than our products.
Legal, Regulatory, Tax and Other Risks
Our business is subject to increasing global regulation, including product related regulations and environmental
regulations, that may expose us to significant liabilities.
The manufacturing, packaging, labeling, storage, distribution, advertising and sale of our products are subject to extensive
regulation. For example, a number of our products are regulated by health authorities both in the U.S. and in the E.U. (such as
the U.S. Food and Drug Administration), and by consumer protection organizations (such as the U.S. Consumer Product Safety
Commission). These regulatory frameworks focus on our ingredients as well as the safety and efficacy of our products.
Similarly, the advertising and marketing of our products is regulated by agencies such as the U.S. Federal Trade Commission.
All of these regulatory frameworks exist at the federal, state and local level in the U.S. as well as in foreign countries where we
sell our products. New or more restrictive regulations or more restrictive interpretations of existing regulations are likely and
could lead to additional compliance costs and could have an adverse impact on our business. Additionally, a finding that we are
in violation of, or not in compliance with, applicable laws or regulations could subject us to material civil remedies, including
fines, damages, injunctions or product recalls, or criminal sanctions. Even if a claim is unsuccessful, is not merited or is not
fully pursued, the negative publicity surrounding such assertions could jeopardize our reputation and brand image and have a
material adverse effect on our businesses, as well as require resources to rebuild our reputation.
We must comply with various environmental laws and regulations in the jurisdictions in which we operate, including those
relating to the handling and disposal of solid and hazardous wastes and the remediation of contamination associated with the
use and disposal of hazardous substances. A release of such substances due to an accident or intentional act could result in
substantial liability to governmental authorities or to third parties. Pursuant to certain environmental laws, we could be subject
to joint and several strict liability for contamination relating to our or our predecessors’ current or former properties or any of
their respective third-party waste disposal sites. In addition to potentially significant investigation and remediation costs, any
such contamination can give rise to claims from governmental authorities or other third parties for natural resource damage,
personal injury, property damage or other liabilities. We have incurred, and will continue to incur, capital and operating
expenses and other costs in complying with environmental laws and regulations, including remediation costs relating to our
current and former properties and third-party waste disposal sites. As new laws and regulations are introduced, we could
become subject to additional environmental liabilities in the future that could cause a material adverse effect on our results of
operations or financial condition.
Our Company may be named a party to legal proceedings that can result in significant expenses, fines and reputational
damage.
In the ordinary course of business, the Company and its subsidiaries are subject to numerous claims and lawsuits involving
various issues such as patent disputes, product liability claims and claims that our product manufacturing, sales, and marketing
practices violate various consumer protection laws both in the United States and internationally. Litigation, in general, and class
action and multi-district litigation, in particular, can be expensive and disruptive. Some of these matters may include large
numbers of plaintiffs, may involve parties seeking large or indeterminate amounts, including punitive or exemplary damages,
and may remain unresolved for several years. While the Company believes it has substantial defenses in these matters, it is not
feasible to predict the ultimate outcome of litigation. The Company could in the future be required to pay significant amounts as
a result of settlements or judgments in these matters, including matters where the Company could be held jointly and severally
liable among other defendants.
Our business involves the potential for product liability and other claims against us, which could affect our results of
operations and financial condition and result in product recalls or withdrawals.
We face exposure to claims arising out of alleged defects in our products, including for property damage, bodily injury or other
adverse effects. We maintain product liability insurance, but this insurance does not cover all types of claims, particularly
claims other than those involving personal injury or property damage or claims that exceed the amount of insurance coverage.
Further, we may not be able to maintain such insurance in sufficient amounts, on desirable terms, or at all, in the future. In
addition to the risk of monetary judgments not covered by insurance, product liability claims could result in negative publicity
that could harm our products’ reputation and in certain cases require a product recall. Product recalls or product liability claims,
and any subsequent remedial actions, could have a material adverse effect on our business, reputation, brand value, results of
operations and financial condition.
12
Our business could be negatively impacted by corporate citizenship and sustainability matters.
There is an increased focus from certain investors, customers, consumers, employees, and other stakeholders concerning
corporate citizenship and sustainability matters. From time to time, we announce certain initiatives, including goals, regarding
our focus areas, which include environmental matters, packaging, responsible sourcing, social investments and diversity, equity
and inclusion. We could fail, or be perceived to have failed, in our achievement of such initiatives or goals, or we could fail in
accurately reporting our progress on such initiatives and goals. Such failures could be due to changes in our business (e.g.,
shifts in business among distribution channels or acquisitions). Moreover, the standards by which citizenship and sustainability
efforts and related matters are measured are developing and evolving, and certain areas are subject to assumptions, which
standards and assumptions could change over time. In addition, we could be criticized for the scope of such initiatives or goals
or perceived as not acting responsibly in connection with these matters. Adverse incidents related to corporate citizenship or
sustainability matters could impact the value of our brands, the cost of our operations, and our relationships with existing and
future investors, which could have a material adverse effect on our business.
If we fail to adequately protect our intellectual property rights, competitors may manufacture and market similar products,
which could adversely affect our market share and results of operations.
The vast majority of our total net sales are from products bearing proprietary trademarks and brand names. In addition, we own
or license from third parties a considerable number of patents, patent applications and other technology. We rely on trademark,
trade secret, patent and copyright laws to protect our intellectual property rights. There is a risk that we will not be able to
obtain and perfect or maintain our own intellectual property rights or, where appropriate, license intellectual property rights
necessary to support new product introductions. In addition, even if such rights are protected in the U.S., the laws of some other
countries in which our products are or may be sold do not protect intellectual property rights to the same extent as the laws of
the U.S. Our intellectual property rights could be invalidated, circumvented or challenged in the future, and we could incur
significant costs in connection with legal actions relating to such rights. As patents expire, we could face increased competition
or decreased royalties, either of which could negatively impact our operating results. If other parties infringe our intellectual
property rights, they may dilute the value of our brands in the marketplace, which could diminish the value that consumers
associate with our brands which may harm our sales.
Legislative changes in applicable tax laws, policies and regulations or unfavorable resolution of tax matters may result in
additional tax liabilities, which could adversely impact our cash flows and results of operations.
Our businesses are subject to taxation in the U.S. and multiple foreign jurisdictions. The impact of any legislative tax law,
policy or regulation changes by federal, state, local and foreign authorities may result in additional tax liabilities which could
adversely impact our cash flows and results of operations. Significant estimation and judgment are required in determining our
provisions for taxes in the U.S. and jurisdictions outside the U.S. In the ordinary course of our business, there are transactions
and calculations in which the ultimate tax determination is uncertain. We are regularly under audit by tax authorities, and
although we believe our tax positions are defensible and our tax provision estimates are reasonable, the final outcome of tax
audits and related litigation could be materially different than that reflected in our income tax provisions and accruals. The
unfavorable resolution of any audits or litigation could have an adverse impact on future operating results and our financial
condition. More aggressive and assertive tax collection policies, particularly in jurisdictions outside the U.S., may increase the
costs of resolving tax issues and enhance the likelihood that we will have increased tax liabilities going forward. In addition,
international tax reform remains a priority with the Organization for Economic Cooperation and Development’s Action Plan on
Base Erosion & Profit Shifting and other proposed foreign jurisdictional tax law changes. Given the uncertainty of the possible
changes and their potential interdependency, we are unable to determine the net consolidated impact of changes in global tax
legislation, if any.
13
Our financial results could be adversely impacted by the U.K.’s departure from the E.U.
On June 23, 2016, the U.K. held a referendum in which voters approved an exit from the E.U., commonly referred to as
“Brexit.” The U.K. officially exited the E.U. on January 31, 2020, however, negotiations between the U.K. and E.U. regarding
the separation remain ongoing. On December 24, 2020, the E.U. and the U.K. agreed on the final terms of a trade and
cooperation agreement relating to their relationship following Brexit. This trade and cooperation agreement covers, among
other things, tariffs and quotas on goods, labor and social standards, environmental protection matters, tax transparency and
customs provisions. The trade agreements are being continually reviewed and updated and any changes to the trading
relationship between the U.K. and the E.U. may result in increased cost of goods imported into and exported from the U.K.
which may decrease the profitability of our operations in the U.K. and elsewhere. For fiscal 2021, net sales of our U.K.
operations were 4% of our consolidated net sales. These and other potential implications of Brexit could adversely affect our
business and financial results.
Information Technology and Systems
A failure of a key information technology system or a breach of our information security could adversely impact our ability
to conduct business.
We rely extensively on information technology systems in order to conduct business, including some that are managed by third-
party service providers. These systems include, but are not limited to, programs and processes relating to internal and external
communications, ordering and managing materials from suppliers, converting materials to finished products, shipping products
to customers, processing transactions, summarizing and reporting results of operations, and complying with regulatory, legal or
tax requirements. These information technology systems could be damaged or cease to function properly due to the poor
performance or failure of third-party service providers, catastrophic events, power outages, network outages, failed upgrades or
other similar events. If our business continuity plans do not effectively resolve such issues on a timely basis, we may suffer
interruptions in conducting our business which may adversely impact our operating results.
Periodically, we also need to upgrade our information technology systems or adopt new technologies. If such a new system or
technology does not function properly or otherwise exposes us to increased cybersecurity breaches and failures, it could affect
our ability to order materials, make and ship orders, and process payments in addition to other operational and information
integrity and loss issues. Further, if the information technology systems, networks or service providers we rely upon fail to
function properly or cause operational outages or aberrations, or if we or one of our third-party providers suffer significant
unavailability of key operations, or inadvertent disclosure of, lack of integrity of, or loss of our sensitive business or stakeholder
information, due to any number of causes, ranging from catastrophic events or power outages to improper data handling,
security incidents or employee error or malfeasance, and our business continuity plans do not effectively address these failures
on a timely basis, we may be exposed to reputational, competitive, operational, financial and business harm as well as litigation
and regulatory action. The costs and operational consequences of responding to the above items and implementing remediation
measures could be significant and could adversely impact our results.
An information security incident, including a cybersecurity breach, could have a negative impact to the Company’s business
or reputation.
Our systems and networks, as well as those of our retailer customers, suppliers, service providers, and banks, may become the
target of advanced cyber-attacks or information security breaches which will pose a risk to the security of our services, systems,
networks and supply chain, as well as to the confidentiality, availability and integrity of data of our Company, employees,
customers or consumers, and disrupt our operations or damage our facilities or those of third parties. As cybersecurity threats
rapidly evolve in sophistication and become more prevalent across the industry globally, we are continually increasing our
attention to these threats. We assess potential threats and vulnerabilities and make investments seeking to address them,
including ongoing monitoring and updating of networks and systems, increasing specialized information security skills,
deploying employee security training, and updating security policies for our Company and our third-party providers. However,
because the techniques, tools and tactics used in cyber-attacks frequently change and may be difficult to detect for periods of
time, we may face difficulties in anticipating and implementing adequate preventative measures or fully mitigating harms after
such an attack. As a result, a cyber-attack could negatively impact our net sales and increase our operating and capital costs. In
addition, our employees frequently access our suppliers’ and customers’ systems and we may be liable if our employees are the
source of any breaches in these third-party systems. It could also damage our reputation with retailer customers and consumers
and diminish the strength and reputation of our brands or require us to pay monetary penalties.
14
Business and Operational Risk Factors
Loss of any of our principal customers could significantly decrease our sales and profitability.
Walmart, together with its subsidiaries, is our largest customer, accounting for approximately 21% of our net sales in fiscal
2021. Generally, sales to our top customers are made pursuant to purchase orders and we do not have supply agreements or
guarantees of minimum purchases from them. As a result, these customers may decrease their level of purchases from us at any
time. The loss or a substantial decrease in the volume of purchases by any of our top customers would harm our sales and
profitability. Increasing retailer customer concentration could result in reduced sales outlets for our products, as well as greater
negotiating pressures and pricing requirements.
Changes in the policies of our retailer customers and increasing dependence on key retailer customers in developed markets
may adversely affect our business.
In recent years, retailer consolidation both in the U.S. and internationally has increased. This trend has resulted in the increased
size and influence of large consolidated retail customers, including internet-based retailers, who may demand lower pricing,
special packaging or impose other requirements on us. These business demands may relate to inventory practices, logistics or
other aspects of the customer-supplier relationship. Some of our customers, particularly our high-volume retail customers, have
sought to obtain pricing and other concessions and better trade terms. To the extent we provide concessions or better trade
terms to those customers, our margins are reduced. Further, if we are unable to effectively respond to the demands of our
customers, these customers could reduce their purchases of our products and increase their purchases of products from
competitors, which would harm our sales and profitability. In addition, reductions in inventory by our customers, including as a
result of consolidations in the retail industry, or our customers managing their working capital requirements, could result in
reduced orders for our products and adversely affect our results of operations for the financial periods affected by such
reductions.
Protracted unfavorable market conditions have caused many of our customers to more critically analyze the number of brands
they sell, which could lead to the retailer reducing or discontinuing certain of our product lines, particularly those products that
were not number one or two in their category.
Our inability to execute a successful e-commerce strategy could have a significant negative impact on our business.
Sales of consumer products via e-commerce has gained increasing importance among market participants as more end user
customers purchase consumer goods through e-commerce. We are engaged in e-commerce sales channels with respect to many
of our products; however, if e-commerce and other sales channels were to take significant market share away from traditional
brick and mortar retailers, and if we are not successful in achieving sales growth in these sales channels, our business, financial
condition and results of operations may be negatively impacted. While we are establishing an e-commerce footprint, there can
be no assurances that these initiatives will be successful.
We face risks arising from our ongoing efforts to achieve cost savings.
In the normal course of business, we may initiate projects which change our manufacturing footprint or our operations in order
to gain production efficiencies and reduce costs. The execution of cost savings initiatives may present a number of significant
risks, including:
•
•
•
•
•
•
actual or perceived disruption of service or reduction in service standards to customers;
the failure to preserve adequate internal controls as we restructure our general and administrative functions, including
our information technology and financial reporting infrastructure;
the failure to preserve supplier relationships and distribution, sales and other important relationships and to resolve
conflicts that may arise;
loss of sales as we reduce or eliminate staffing on non-core product lines;
diversion of management attention from ongoing business activities; and
the failure to maintain employee morale and retain key employees while implementing benefit changes and reductions
in the workforce.
Because of these and other factors, we cannot predict whether we will realize the purpose and anticipated benefits of these
initiatives and, if we do not, our business and results of operations may be adversely affected.
15
We are currently dependent on third party manufacturers to manufacture many products for our business. Our business
could suffer as a result of a third-party manufacturer’s inability to produce our products for us on time or to our
specifications.
The inability of a third-party manufacturer to ship orders in a timely manner, in desirable quantities or to meet our safety,
quality and social compliance standards or regulatory requirements could have a material adverse impact on our business.
While certain of our relationships with these third parties are subject to minimum volume commitments, whereby the third-
party manufacturer has committed to produce and we have committed to purchase a minimum quantity of product, we may
nonetheless experience situations where such manufacturers are unable to fulfill their obligations under our agreements.
Our manufacturing facilities, supply channels or other business operations may be subject to disruption from events beyond
our control.
Operations of our manufacturing and packaging facilities worldwide, and of our corporate offices, and the methods we use to
obtain supplies and to distribute our products, may be subject to disruption for a variety of reasons, including availability of raw
materials, work stoppages, industrial accidents, disruptions in logistics, loss or impairment of key manufacturing sites, product
quality or safety issues, licensing requirements and other regulatory issues, trade disputes between countries in which we have
operations, and acts of war, terrorism, pandemics, fire, earthquake, hurricanes, flooding or other natural disasters. The supply of
our raw materials may be similarly disrupted. There is also a possibility that third-party manufacturers, which produce a
significant portion of certain of our products, could discontinue production with little or no advance notice, or experience
financial problems or problems with product quality or timeliness of product delivery, resulting in manufacturing delays or
disruptions, regulatory sanctions, product liability claims or consumer complaints. If a major disruption were to occur, it could
result in delays in shipments of products to customers or suspension of operations. We maintain business interruption insurance
to potentially mitigate the impact of business interruption, but such coverage may not be sufficient to offset the financial or
reputational impact of an interruption.
Loss of reputation of our leading brands or failure of our marketing plans could have an adverse effect on our business.
We depend on the continuing reputation and success of our brands, particularly the Schick, Wilkinson Sword, Edge, Skintimate,
Playtex, Wet Ones, Banana Boat, Hawaiian Tropic, Bulldog, Cremo, Jack Black, Stayfree, Carefree and o.b. brands. Our
operating results could be adversely affected if one of our leading brands suffers damage to its reputation due to real or
perceived quality issues. Further, the success of our brands can suffer if our marketing plans or new product offerings do not
improve or have a negative impact on our brands’ image or ability to attract and retain consumers. Additionally, if claims made
in our marketing campaigns become subject to litigation alleging false advertising, it could damage our brand, cause us to alter
our marketing plans in ways that may materially and adversely affect sales, or result in the imposition of significant damages
against us. Further, a boycott or other campaign critical of us, through social media or otherwise, could negatively impact our
brands’ reputation and, consequently, our products’ sales.
Our business is subject to seasonal volatility.
Customer orders for sun care products within our Sun and Skin Care segment are highly seasonal, which has historically
resulted in higher sun care sales to retailers during the late winter through mid-summer months. Accordingly, our sales,
financial performance, working capital requirements and cash flow may experience volatility during these periods. Further,
purchases of our sun care products can be significantly impacted by unfavorable weather conditions during the summer period,
and as a result we may suffer decreases in net sales if conditions are not favorable for use of our products, which could in turn
have a material adverse effect on our financial condition, results of operation and cash flows. Within our Wet Shave segment,
sales of women’s products are moderately seasonal, with increased consumer demand in the spring and summer months.
16
Our financial performance depends on our ability to anticipate and respond to consumer trends and changes in consumer
preferences. New product introductions may not be as successful as we anticipate, which could have a material adverse
effect on our business, prospects, results of operations, financial condition and/or cash flows.
We have a rigorous process for the continuous development and evaluation of new product concepts, led by executives in
marketing, sales, research and development, product development, operations, legal and finance. However, consumer
preference and spending patterns change rapidly and cannot be predicted with certainty. There can be no assurance that we will
anticipate and respond to trends for consumer products effectively. Each new product launch, including those resulting from our
product development process, carries risks, as well as the possibility of unexpected consequences, including:
•
•
•
•
•
•
the acceptance of our new product launches and sales of such new products may not be as high as we anticipate;
our marketing, promotional, advertising and/or pricing strategies for our new products may be less effective than
planned and may fail to effectively reach the targeted consumer base or engender the desired consumption of the
products by consumers;
we may incur costs exceeding our expectations as a result of the continued development and launch of new products,
including, for example, unanticipated levels of research and development costs, advertising, promotional and/or
marketing expenses, sales return expenses or other costs related to launching new products;
we may experience a decrease in sales of certain of our existing products as a result of newly-launched products, the
impact of which could be exacerbated by shelf space limitations and/or any shelf space loss;
our product pricing strategies for new product launches may not be accepted by customers and/or consumers, which
may result in sales being less than we anticipate; and/or
we may experience a decrease in sales of certain of our products as a result of counterfeit products and/or products
sold outside of their intended territories.
Each of the risks referred to above could delay or impede our ability to achieve our sales objectives, which could have a
material adverse effect on our business, prospects, results of operations, financial condition and/or cash flows.
Impairment of our goodwill and other intangible assets would result in a reduction in net income.
We have a material amount of goodwill, trademarks and other intangible assets, as well as other long-lived assets, which are
periodically evaluated for impairment in accordance with current accounting standards. Declines in our profitability and
estimated cash flows related to specific intangible assets, as well as potential changes in market valuations for similar assets and
market discount rates, may result in an impairment charge, which could have an adverse impact on our operating results.
Our access to capital markets and borrowing capacity could be limited.
Our access to capital markets to raise funds through the sale of debt or equity securities is subject to various factors, including
general economic and financial market conditions. Significant reduction in market liquidity conditions could impact access to
funding and increase associated funding costs, which could reduce our earnings and cash flows. Additionally, disruptions in
financial markets could reduce our access to debt and equity capital markets, negatively affecting our ability to implement our
business plan and strategy.
Our access to debt financing at competitive risk-based interest rates is partly a function of our credit ratings. The major credit
rating agencies periodically evaluate our creditworthiness and have assigned us credit ratings. These ratings are based on a
number of factors, which include our financial strength and financial policies as well as our strategies, operations and execution.
A downgrade to our credit ratings could increase our interest rates, limit our access to public debt markets, limit the institutions
willing to provide us credit facilities, result in more restrictive credit arrangements and make any future credit facilities or credit
facility amendments more costly and difficult to obtain.
We have a substantial level of indebtedness and are subject to various covenants relating to such indebtedness, which could
limit our discretion to operate and grow our business.
As of September 30, 2021, our debt level was approximately $1.3 billion. We may be required to dedicate a substantial portion
of our cash to debt service, thereby reducing funds available to fund working capital, capital expenditures, acquisitions and
investments and other general corporate purposes. Our failure to make scheduled interest payments or to repay or refinance the
indebtedness at maturity or obtain additional financing as needed could have a material adverse effect on our business.
17
Additionally, certain of our debt instruments are subject to certain financial and other covenants, including debt ratio tests. We
may be in breach of such covenants in the event of future declines in our operating cash flows or earnings performance, foreign
currency movements or other events. In the event of such breach, our lenders may be entitled to accelerate the related debt as
well as any other debt to which a cross-default provision applies, and we could be required to seek amendments or waivers
under the debt instruments or to refinance the debt. There is no assurance that we would obtain such amendments or waivers or
effect such refinancing, or that we would be able to do so on terms similar to those of our current debt instruments. The
covenants and financial ratio requirements contained in our debt instruments could also:
•
•
•
•
•
increase our vulnerability to general adverse economic and industry conditions;
require a substantial portion of our cash flow from operations to make payments on our indebtedness;
reduce the cash flow available or limit our ability to borrow additional funds, to pay dividends, to fund capital
expenditures and other corporate purposes and to pursue our business strategies;
limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we operate; and
place us at a competitive disadvantage relative to our competitors that have greater financial flexibility or limit, among
other things, our ability to borrow additional funds as needed or take advantage of business opportunities as they arise.
Our Revolving Credit Facility (See Liquidity and Capital Resources for details) contains customary representations and
warranties, and affirmative and negative covenants, including limitations on additional indebtedness, dividends, and other
distributions, entry into new lines of business, use of loan proceeds, restrictions on liens on the assets of the Company and our
subsidiaries, transactions with affiliates and dispositions. The breach of any of these covenants could result in a default under
the Revolving Credit Facility. In addition, the Revolving Credit Facility contains customary events of default that include,
among others, non-payment of principal, interest or fees, violation of covenants, inaccuracy of representations and warranties,
failure to make payment on, or defaults with respect to, certain other material indebtedness, bankruptcy and insolvency events,
material judgments and change of control provisions. Upon the occurrence of an event of default, and after the expiration of any
applicable grace period, payment of any outstanding loans under the Revolving Credit Facility could be accelerated and the
lenders thereunder could foreclose on their security interests in the assets of the Company and certain of our subsidiaries.
We are subject to risks related to our international operations, including currency fluctuations, which could adversely affect
our results of operations.
Our businesses are conducted on a worldwide basis, with nearly 43% of our sales in fiscal 2021 arising outside the U.S., and a
significant portion of our production capacity and cash are located overseas. Consequently, we are subject to a number of risks
associated with doing business in foreign countries, including:
•
•
•
•
•
•
•
•
•
•
the possibility of expropriation, confiscatory taxation or price controls;
the ability to repatriate foreign-based cash effectively for strategic needs in the U.S., as well as the heightened
counterparty, internal control and country-specific risks associated with holding cash overseas;
the effect of foreign income taxes, value-added taxes and withholding taxes, including the inability to recover amounts
owed to us by a government authority without extended proceedings or at all;
the effect of the U.S. tax treatment of foreign source income and losses, and other restrictions on the flow of capital
between countries;
adverse changes in local investment or exchange control regulations;
restrictions on and taxation of international imports and exports;
legal and regulatory constraints, including tariffs and other trade barriers;
currency fluctuations, including the impact of hyper-inflationary conditions, particularly where exchange controls limit
or eliminate our ability to convert from local currency;
political or economic instability, government nationalization of business or industries, government corruption and civil
unrest, including political or economic instability; and
difficulty in enforcing contractual and intellectual property rights.
One or more of these factors could harm our international operations or investments and our operating results.
18
We may not be able to attract, retain and develop key personnel.
Our future performance depends in significant part upon the continued service of our executive officers and other key
personnel. The loss of the services of one or more of our executive officers or other key employees could have a material
adverse effect on our business, prospects, financial condition and results of operations. Our success also depends on our
continuing ability to attract, retain and develop highly qualified personnel. Competition for such personnel is intense, and there
can be no assurance that we can retain and motivate our key employees or attract and retain other highly qualified personnel in
the future.
We may not be able to continue to identify and complete strategic acquisitions and effectively integrate acquired companies
to achieve desired financial benefits.
We have completed a number of acquisitions, and we expect to continue making acquisitions if appropriate opportunities arise.
Acquisitions could be a key use of our cash and a potential driver of future growth. However, we may not be able to identify
and successfully negotiate suitable strategic acquisitions at attractive valuations, obtain financing for future acquisitions on
satisfactory terms or otherwise complete future acquisitions. Our reduced size relative to other companies in our industry may
make completing desirable acquisitions more challenging.
If we can complete future acquisitions, we may face significant challenges in consolidating functions and effectively integrating
procedures, personnel, product lines, and operations in a timely and efficient manner. The integration process can be complex
and time consuming, may be disruptive to our existing and acquired business and may cause an interruption of, or a loss of
momentum in, the business. Even if we can successfully complete the integration of acquired businesses into our operations,
there is no assurance that anticipated cost savings, synergies, or revenue enhancements will be realized within the expected time
frame, or at all. Such acquisitions may result in potentially dilutive issuances of our equity securities, the incurrence of
additional debt, restructuring charges, impairment charges, contingent liabilities, amortization expenses related to intangible
assets, and increased operating expenses, which could adversely affect our results of operations and financial condition.
We may experience losses or be subject to increased funding and expenses related to our pension plans.
The funding obligations for our pension plans are impacted by the performance of the financial markets, interest rates and
governmental regulations. While the pension benefit earned to date by active participants under our legacy U.S. pension plan
was frozen effective January 1, 2014, and retirement service benefits no longer accrue under this retirement program, our
pension obligations are expected to remain significant. If the investment of plan assets does not provide the expected long-term
returns, if interest rates or other assumptions change, or if governmental regulations change the timing or amounts of required
contributions to the plans, we could be required to make additional pension contributions which may have an adverse impact on
our liquidity, our ability to comply with debt covenants and may require recognition of increased expense within our financial
statements.
Item 1B. Unresolved Staff Comments.
None.
Item 2. Properties.
As of September 30, 2021, we owned or leased 57 properties, 27 in the U.S. and 30 globally. Ten of these properties are used as
production plants consisting of 1.8 million square feet that is owned and 0.9 million square feet that is leased. Five of these
plants are located in the U.S., and five are in other countries. Six of these plants are used exclusively by our Wet Shave
segment, one by our Feminine Care segment, two by our Sun and Skin Care segment and one is shared by our Wet Shave and
Sun and Skin Care segments. We also have 12 warehouses consisting of 1.4 million square feet that is owned and 1.3 million
square feet that is leased. We operate from 35 different offices throughout the world, totaling 0.4 million square feet, all of
which are leased, and includes our corporate headquarters in Shelton, Connecticut. We believe all of our facilities are well-
maintained and suitable for the operations conducted in them.
19
Item 3. Legal Proceedings.
We, and our affiliates, are subject to a number of legal proceedings in various jurisdictions arising out of our operations during
the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and
fact, and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be
determined with certainty. We review our legal proceedings and claims, regulatory reviews and inspections on an ongoing basis
and follow appropriate accounting guidance when making accrual and disclosure decisions. We establish accruals for those
contingencies when the incurrence of a loss is probable and can be reasonably estimated, and disclose the amount accrued and
the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for our financial
statements to not be misleading. We do not record liabilities when the likelihood that the liability has been incurred is probable,
but the amount cannot be reasonably estimated. Based upon present information, we believe that our liability, if any, arising
from such pending legal proceedings, asserted legal claims and known potential legal claims, which are likely to be asserted, is
not reasonably likely to be material to our financial position, results of operations or cash flows, taking into account established
accruals for estimated liabilities.
See also the discussion captioned “Governmental Regulation and Environmental Matters” and “Legal, Regulatory, Tax and
Other Risks” included within Item 1. Business of this Annual Report on Form 10-K.
Item 4. Mine Safety Disclosures.
Not applicable.
20
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities.
Market Information
Edgewell common stock is listed and traded on the New York Stock Exchange (“NYSE”) under the symbol “EPC.”
There were approximately 5,507 shareholders of record of our common stock as of October 31, 2021.
Issuer Purchases of Equity Securities
In January 2018, our Board of Directors approved an authorization to repurchase up to 10.0 million shares of our common
stock. This authorization replaced a prior share repurchase authorization from May 2015. The following table sets forth the
purchases of our Company’s securities by our Company and any affiliated purchasers within the meaning of Rule 10b-18(a)(3)
(17 CFR 240.10b-18(a)(3)) during the fourth quarter of fiscal 2021:
Period
July 1, 2021 to July 31, 2021
August 1, 2021 to August 31, 2021
September 1, 2021 to September 30, 2021
Total Number of
Shares
Purchased (1)
Average Price
Paid per Share (2)
Total Number of
Shares Purchased
as Part of
Publicly
Announced Plans
or Programs
Maximum
Number that May
Yet Be Purchased
Under the Plans
or Programs
2,391
—
3,405
$
$
$
43.56
—
42.78
—
—
—
9,750,000
9,750,000
9,750,000
(1)
5,796 shares purchased during the quarter relate to the surrender of shares of common stock to our Company to satisfy tax withholding obligations
in connection with the vesting of restricted stock equivalents.
(2)
Includes $0.02 per share of brokerage fee commissions.
During fiscal 2021, we repurchased 250,000 shares of common stock under the share repurchase authorization from January
2018 for $9.2 million. Future share repurchases, if any, would be made in the open market, privately negotiated transactions or
otherwise, in such amounts and at such times as we deem appropriate based upon prevailing market conditions, business needs
and other factors.
During fiscal 2021, we repurchased 116,247 shares related to the surrender of shares of common stock to satisfy tax
withholding obligations in connection with the vesting of restricted stock equivalent awards.
21
Performance Graph
The following graph compares the cumulative five-year total return provided to shareholders of Edgewell Personal Care
Company’s common stock relative to the cumulative total returns of the S&P Midcap 400 index and the S&P Household
Products index. An investment of $100 (with reinvestment of all dividends and other distributions) is assumed to have been
made in our common stock and in each of the indices on September 30, 2016 and its relative performance is tracked through
September 30, 2021. These indices are included only for comparative purposes as required by SEC rules and do not necessarily
reflect management’s opinion that such indices are an appropriate measure of the relative performance of our common stock.
They are not intended to forecast possible future performance of our common stock, nor is our historical common stock price
performance necessarily indicative of our future common stock price performance.
* $100 invested on September 30, 2016 in stock or index, with reinvestment of all dividends. Fiscal year ending September 30.
Copyright© 2021 Standard & Poor’s, a division of S&P Global. All rights reserved.
Edgewell Personal Care Company
S&P Midcap 400
S&P Household Products
9/16
9/17
9/18
9/21
$ 100.00 $ 91.51 $ 58.14 $ 40.86 $ 35.06 $ 45.65
$ 100.00 $ 115.70 $ 130.10 $ 124.69 $ 119.91 $ 170.11
$ 100.00 $ 100.24 $ 96.52 $ 130.74 $ 145.03 $ 146.45
9/19
9/20
22
COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*Among Edgewell Personal Care Company, the S&P Midcap 400 Index, and the S&PHousehold Products IndexEdgewellS&P Midcap 400S&P Household Products9/169/179/189/199/209/21$0$20$40$60$80$100$120$140$160$180$200$220
Item 6. Selected Financial Data.
The selected historical financial data presented below should be read in conjunction with Item 7. Management’s Discussion and
Analysis of Financial Condition and Results of Operations and our consolidated financial statements and accompanying notes
included in Item 8. Financial Statements and Supplementary Data.
(in millions, except per share data)
Statements of Earnings Data
Fiscal Year
Net sales
Depreciation and amortization
Earnings (loss) before income taxes (2)
Net earnings (loss)
Basic earnings (loss) per share
Diluted earnings (loss) per share
2021
2020
2019
2018
2017
$
2,087.3
$
1,949.7
$
2,141.0
$
2,234.4
$
2,298.4
87.1
146.0
88.8
87.3
93.8
(390.3)
97.6
163.8
$
117.0
$
67.6
$
(372.2) $
103.3
$
2.15
2.12
1.25
1.24
(6.88)
(6.88)
1.90
1.90
96.2
(52.9)
5.7
0.10
0.10
Balance Sheet Data
As of September 30,
Working capital (1)
Property, plant and equipment, net
Total assets
Long-term debt
2021
2020
2019
2018
2017
$
598.9
$
473.1
$
384.8
$
234.2
$
362.6
3,674.6
1,234.2
370.9
3,540.9
1,237.9
396.0
3,420.9
1,097.8
424.1
3,953.3
1,103.8
661.8
453.4
4,188.8
1,525.4
(1) Working capital represents current assets less current liabilities.
(2) Earnings (loss) before income taxes were impacted by the following items:
Restructuring and related costs
$
(30.1) $
(38.1) $
(55.6) $
(39.9) $
(30.3)
2021
2020
2019
2018
2017
Fiscal Year
Cost of early retirement of long-term debt
Acquisition and integration costs
Sun Care reformulation costs
COVID-19 expenses
Gain on sale of Infant and Pet Care business
Feminine and Infant Care evaluation costs
Impairment charges
Investor settlement expense
Gain on sale of Playtex gloves assets
Pension settlement expense
Total
(26.1)
(8.4)
(1.1)
—
—
—
—
—
—
—
(26.2)
(39.8)
—
(4.3)
4.1
(0.3)
—
—
—
—
—
(6.7)
(2.8)
—
—
(2.1)
(570.0)
(0.9)
—
—
—
(5.2)
(25.3)
—
—
—
—
—
—
—
—
—
(24.4)
(319.0)
—
15.3
(5.4)
—
—
—
$
(65.7) $
(104.6) $
(638.1) $
(84.9) $
(349.3)
23
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
(in millions, except per share data)
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with
our Consolidated Financial Statements and the accompanying notes included in this Annual Report on Form 10-K. The
following discussion may contain forward-looking statements that reflect our plans, estimates and beliefs and involve risks,
uncertainties and assumptions. Our actual results could differ materially from those discussed in these forward-looking
statements. Factors that could cause or contribute to these differences include those discussed in Item 1A. Risk Factors and
“Forward-Looking Statements” included within this Annual Report on Form 10-K.
Non-GAAP Financial Measures
While we report financial results in accordance with GAAP, this discussion also includes non-GAAP measures. These non-
GAAP measures are referred to as “adjusted” or “organic” and exclude items such as restructuring charges, acquisition and
integration costs, cost of early debt retirement, UK tax rate increase, impairment charges, COVID-19 pandemic expenses,
advisory expenses in connection with the evaluation of the Feminine and Infant Care businesses, Sun Care reformulation costs,
investor settlement expenses, the disposition of the Infant and Pet Care business, the related tax effects of these items and the
impact of the Tax Act. Reconciliations of non-GAAP measures are included within this Management’s Discussion and Analysis
of Financial Condition and Results of Operations.
This non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial
performance prepared in accordance with GAAP. We use this non-GAAP information internally to make operating decisions
and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating
results. Given the various significant events, including the Project Fuel restructuring and recent acquisitions and divestitures,
we view the use of non-GAAP measures that take into account the impact of these unique events as particularly valuable in
understanding our underlying operational results and providing insights into future performance. The information can also be
used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by the types of
items that are excluded. This non-GAAP information is also a component in determining management’s incentive
compensation. Finally, we believe this information provides more transparency. The following provides additional detail on our
non-GAAP measures:
• We analyze our net sales and segment profit on an organic basis to better measure the comparability of results between
periods. Organic net sales and organic segment profit exclude the impact of changes in foreign currency, acquisitions,
and divestitures. This information is provided because these types of fluctuations can distort the underlying change in
net sales and segment profit either positively or negatively.
• We utilize “adjusted” non-GAAP measures including gross profit, SG&A, operating income, income taxes, net
earnings, and diluted earnings per share internally to make operating decisions. The following items are excluded
when analyzing non-GAAP measures: restructuring charges, acquisition and integration costs, cost of early debt
retirement, UK tax rate increase, impairment charges, COVID-19 pandemic expenses, advisory expenses in connection
with the evaluation of the Feminine and Infant Care businesses, Sun Care reformulation costs, investor settlement
expenses, the disposition of the Infant and Pet Care business, and the impact of the Tax Act.
All comparisons are with the same period in the prior year, unless otherwise noted.
Impact of COVID-19
On March 11, 2020, the World Health Organization declared the novel coronavirus 2019 (“COVID-19”) a worldwide
pandemic, which has impacted individuals, families, companies and economies around the world. Throughout the pandemic, we
have taken and continue to take significant measures to protect our employees and business, while remaining in compliance
with local guidelines and requirements.
The Company’s top priority during this time continues to be ensuring the health and welfare of our employees and additional
measures have been put in place at all of our manufacturing locations. To date, we have not experienced any material
operational disruptions across our manufacturing or distribution facilities.
The prolonged COVID-19 environment has resulted in increased supply chain challenges across product procurement and
distribution. The continued duration and severity of COVID-19 may cause further disruptions related to our key suppliers,
increase procurement costs and impact our ability to hire and retain employees, which may result in higher labor costs going
forward. However, the impact, timing and severity of potential disruptions cannot be reasonably estimated at this time.
We expect to maintain adequate liquidity during these uncertain times and we will continue to assess the impact that COVID-19
has on our liquidity needs and current economic market conditions. As noted within “Liquidity and Capital Resources” below,
24
COVID-19 has not had a significant impact on our liquidity, cash flows or capital resources, including our ability to enter into
the unsecured indenture agreement for 4.125% Senior Notes in the amount of $500 due April 1, 2029 (“2029 Notes”).
Significant Events
Acquisitions
On September 2, 2020, we completed the acquisition of Cremo, a premier men's grooming company in the U.S, in an all-cash
transaction at a purchase price of $233.9. As a result of the acquisition, Cremo became a wholly owned subsidiary of the
Company. Refer to Note 3 of Notes to Condensed Consolidated Financial Statements for further discussion on the Cremo
acquisition.
Divestiture
On December 17, 2019, we completed the sale of our Infant and Pet Care business included in the All Other segment for $122.5
which included consideration for providing services for up to one year under a transition services agreement. For further
information on the divestiture of the Infant and Pet Care business, refer to Note 3 of Notes to Condensed Consolidated
Financial Statements.
Goodwill and Intangible Asset Impairment
The Company performs an annual test for impairment of goodwill and indefinite-lived intangible assets. The annual test
performed in the fourth quarter of fiscal 2021 and 2020, respectively, did not indicate that the Company’s goodwill and
intangible assets had a fair value below the carrying value.
During the third quarter of fiscal 2019, we determined a triggering event had occurred following a decline in our market
capitalization and share price. We performed an interim impairment analysis on all long-lived assets, including definite-lived
intangibles, goodwill, and indefinite-lived intangible assets, using financial information through June 30, 2019 and forecasts for
cash flows developed using our three-year strategic plan. The interim impairment review was performed. The results of the
impairment review indicated the carrying value of the goodwill of the Wet Shave, Infant Care, and Skin Care reporting units
were greater than their respective fair values, resulting in a non-cash goodwill impairment of $369.0, $37.0, and $2.0,
respectively. Additionally, the carrying value of the Wet Ones and Diaper Genie trade names were greater than the fair values
and resulted in non-cash impairments of the indefinite-lived intangible assets of $87.0 and $75.0, respectively. We performed
an assessment in the fourth quarter of fiscal 2019 to determine if any significant events or changes in circumstances had
occurred that would be considered a potential triggering event. We did not identify any indication of a triggering event that
would indicate the existence of additional impairment of the reporting units, indefinite-lived intangible assets, and definite-lived
intangible assets.
Refer to Notes 2 and 7 of Notes to Consolidated Financial Statements for further discussion on the annual impairment test.
Project Fuel
Project Fuel was an enterprise-wide transformational initiative that was launched in the second fiscal quarter of 2018, to address
all aspects of our business and cost structure, simplifying and transforming the organization, structure and key processes.
Project Fuel facilitated further re-investment in our growth strategy while enabling us to achieve our desired future state
operations.
Fiscal 2021 Project Fuel related gross savings were approximately $68, bringing final cumulative gross savings for the program
to approximately $280. The savings generated during the project are being used to fuel investments and brand building in
strategic growth initiatives, mitigate operational cost headwinds from inflation and other rising input costs and improve the
overall profitability and cash flow of the Company.
Restructuring and related charges were $30.1 for fiscal 2021, bringing final cumulative charges to $163.7 for the project.
Capital expenditures for Project Fuel were $13.6 for fiscal 2021 bringing cumulative capital expenditures to $71.7 for the
project.
For further information on our restructuring projects, refer to Note 4 of Notes to Condensed Consolidated Financial Statements.
25
Executive Summary
Following is a summary of key results for fiscal 2021, 2020 and 2019. Net earnings and diluted earnings per share (“EPS”) for
the time periods presented were impacted by restructuring charges, acquisition and integration costs, cost of early debt
retirement, UK tax rate increase, impairment charges, COVID-19 pandemic expenses, advisory expenses in connection with the
evaluation of the Feminine and Infant Care businesses, Sun Care reformulation costs, investor settlement expenses, the
disposition of the Infant and Pet Care business, the related tax effects of these items and the impact of the Tax Act. The impact
of these items on reported net earnings and EPS are provided below as a reconciliation of net earnings and EPS to adjusted net
earnings and adjusted diluted EPS, which are non-GAAP measures.
Fiscal 2021
•
•
•
Net sales were $2,087.3, an increase of 7.1% from fiscal 2020, inclusive of a 2.9% increase due to the acquisition of
Cremo, a 1.4% decrease due to the sale of the Infant and Pet Care business and a 1.9% increase due to currency
movements. Organic net sales increased 3.7% for fiscal 2021 as compared to the prior year period, as growth in Wet
Shave and Sun and Skin Care were partially offset by slight declines in Feminine Care.
Net earnings for fiscal 2021 was $117.0, as compared to net earnings of $67.6 in the prior fiscal year. On an adjusted
basis, as illustrated in the table below, net earnings for fiscal 2021 increased 12.0% to $166.7. The increase was
primarily driven by higher net sales attributable to a rebound from prior year COVID-19 declines. Increased net sales
were offset by higher Advertising and sales promotion expense (“A&P”) in support of investments in critical
commercial efforts compared to the prior year.
Net earnings per diluted share during fiscal 2021 was $2.12 compared to earnings of $1.24 in the prior fiscal year. On
an adjusted basis, as illustrated in the table below, net earnings per diluted share during fiscal 2021 were $3.02
compared to $2.73 in the prior year.
Year Ended September 30, 2021
Gross
Profit
SG&A
Operating
Income
EBIT
Income
taxes
Net
Earnings
Diluted
EPS
GAAP — Reported
$ 950.1
$ 391.2
$ 238.8
$
146.0 $
29.0 $ 117.0
$
Restructuring and related costs
Acquisition and integration costs
Sun Care reformulation costs
Cost of early retirement of long-term
debt
UK tax rate increase
0.6
1.3
1.1
—
—
8.7
7.1
—
—
—
30.1
8.4
1.1
—
—
30.1
8.4
1.1
26.1
—
7.5
2.1
0.3
6.4
(0.3)
22.6
6.3
0.8
19.7
0.3
Total Adjusted Non-GAAP
$ 953.1
$ 375.4
$ 278.4
$
211.7 $
45.0 $ 166.7
$
2.12
0.41
0.12
0.01
0.36
—
3.02
GAAP as a percent of net sales
Adjusted as a percent of net sales
45.5 %
45.7 %
18.7 %
18.0 %
11.4 %
GAAP effective tax rate
13.3 % Adjusted effective tax rate
19.8 %
21.2 %
26
Year Ended September 30, 2020
Gross
Profit
SG&A
Operating
Income
EBIT
Income
Taxes
Net
Earnings
Diluted
EPS
GAAP — Reported
$ 880.9
$ 408.8
$ 176.0
$
87.3 $
19.7 $
Restructuring and related charges
Acquisition and integration costs
COVID-19 expenses
Feminine and Infant Care evaluation
costs
Cost of early retirement of long-term
debt
Gain on sale of Infant and Pet Care
business
0.2
0.6
4.3
—
—
—
13.3
39.2
—
0.3
—
—
38.1
39.8
4.3
0.3
—
—
38.1
39.8
4.3
0.3
26.2
8.7
9.7
1.1
0.1
6.4
$
67.6
29.4
30.1
3.2
0.2
19.8
1.24
0.54
0.56
0.06
—
0.36
(4.1)
(2.6)
(1.5)
(0.03)
Total Adjusted Non-GAAP
$ 886.0
$ 356.0
$ 258.5
$
191.9 $
43.1 $ 148.8
$
2.73
GAAP as a percent of net sales
Adjusted as a percent of net sales
45.2 %
45.4 %
21.0 %
18.3 %
9.0 %
GAAP effective tax rate
13.3 % Adjusted effective tax rate
22.6 %
22.5 %
Year Ended September 30, 2019
Gross
Profit
SG&A
Operating
Income
EBIT
Income
Taxes
Net
Earnings
Diluted
EPS
$ 966.6
$ 372.0
$ 243.8
$
(390.3) $
(18.1) $ (372.2)
$
(6.88)
GAAP — Reported
Impairment charges
Restructuring and related charges
Acquisition and integration costs
Sun Care reformulation costs
Feminine and Infant Care evaluation
costs
Investor settlement expense
Impact of dilutive shares
Income tax reform
—
0.6
—
2.8
—
—
—
—
—
8.6
6.7
—
2.1
0.9
—
—
—
55.6
6.7
2.8
2.1
0.9
—
—
570.0
55.6
6.7
2.8
2.1
0.9
—
—
65.3
12.4
1.6
0.7
0.5
0.2
—
(3.6)
504.7
43.2
5.1
2.1
1.6
0.7
—
3.6
Total Adjusted Non-GAAP
$ 970.0
$ 353.7
$ 311.9
$
247.8
$
59.0
$ 188.8
$
GAAP as a percent of net sales
Adjusted as a percent of net sales
45.1 %
45.3 %
17.4 %
16.5 %
11.4 %
GAAP effective tax rate
14.6 % Adjusted effective tax rate
4.6 %
23.8 %
9.33
0.80
0.09
0.04
0.03
0.01
(0.01)
0.07
3.48
Operating Results
The following table presents changes in net sales for fiscal 2021 and 2020, as compared to the corresponding prior year period,
and provides a reconciliation of organic net sales to reported amounts.
27
Net Sales
Net Sales - Total Company
For the Years Ended September 30,
Net sales - prior year
Organic
Impact of Infant and Pet Care sale
Impact of Cremo acquisition
Impact of currency
Net sales - current year
2021
%Chg
2020
%Chg
$
1,949.7
$
2,141.0
72.1
(26.8)
56.0
36.3
3.7 %
(1.4) %
2.9 %
1.9 %
(94.9)
(93.4)
4.5
(7.5)
$
2,087.3
7.1 % $
1,949.7
(4.4) %
(4.4) %
0.2 %
(0.3) %
(8.9) %
For fiscal 2021, net sales increased 7.1% on a reported basis. Organic net sales increased 3.7% versus the prior year. The
increase in organic net sales was largely driven by improving consumption across all categories and strong growth in Sun Care,
Women’s Shave and Men’s Grooming. Organic net sales increased in North America by 5.2% while International organic net
sales increased by 1.4%.
For further discussion regarding net sales, including a summary of reported versus organic changes, see “Segment Results.”
Gross Profit
Gross profit was $950.1 in fiscal 2021, as compared to $880.9 in fiscal 2020. Gross margin as a percent of net sales for fiscal
2021 was 45.5%, up 30 basis points as compared to fiscal 2020. Adjusted gross margin as a percent of sales increased by 30
basis points compared to fiscal 2020, driven by Project Fuel related savings and favorable pricing and promotion, partially
offset by increased commodity and labor costs.
Selling, General and Administrative Expense
SG&A was $391.2 in fiscal 2021, or 18.7% of net sales, as compared to $408.8 in fiscal 2020, or 21.0% of net sales. Adjusted
SG&A as a percent of net sales decreased 30 basis points compared to fiscal 2020 as stronger cost control and the benefit of
sales leverage more than offset investments made in increased talent and capabilities and unfavorable foreign currency
fluctuations.
Advertising and Sales Promotion Expense
For fiscal 2021, A&P was $241.5, up $25.3 as compared to fiscal 2020. A&P as a percent of net sales was 11.6% for fiscal
2021, compared with 11.1% in fiscal 2020. The increase in A&P was the result of investments in and focus on critical
commercial efforts supporting the Schick Hydro relaunch, Schick Stubble Eraser® product launch, Skintimate campaign,
Men’s systems development in Japan, increased support for the Sun Care business and the inclusion of Cremo brand
investments. Fiscal 2020 had reduced A&P expense as a result of the COVID-19 pandemic.
Research and Development Expense
Research and development expense (“R&D”) increased to $57.8 in fiscal 2021, compared to $55.3 in fiscal 2020. As a percent
of net sales, R&D was approximately 2.8% in both fiscal 2021 and fiscal 2020.
28
Interest Expense Associated with Debt
Interest expense associated with debt for fiscal 2021 was $67.9, an increase of $6.7 as compared to fiscal 2020. The increase in
interest expense was the result of higher average outstanding debt and a higher weighted interest rate, primarily as a result of
the issuance of the 5.5% $750 Senior Notes due 2028 issued in May 2020 (the “2028 Notes”).
In addition to the interest expense associated with debt, we incurred $26.1 of costs for the early retirement of the $500 Senior
Notes due 2022 in fiscal 2021.
Other (Income) Expense, Net
Other (income) expense, net was income of $1.2 in fiscal 2021 compared to expense of $5.4 in fiscal 2020. The favorable
movement was largely related to foreign currency movements and lower pension benefit expense, partially offset by
unfavorable hedge settlements.
Income Tax Provision (Benefit)
Income taxes, which include federal, state and foreign taxes, were 19.8%, 22.6% and 4.6% of Earnings (loss) before income
taxes in fiscal 2021, 2020 and 2019, respectively.
The effective income tax rate for fiscal 2021 for operations was 19.8% as compared to 22.6% in the prior year. On an adjusted
basis, the effective tax rate for fiscal 2021 was 21.2% compared to 22.5% in the prior year. The fiscal 2021 effective tax rate
reflects a more favorable mix of foreign earnings while fiscal 2020 includes the unfavorable impact of the sale of the Infant and
Pet Care business.
Earnings before income taxes
Income tax provision
Net earnings
Effective tax rate
Earnings before income taxes
Income tax provision
Net earnings
Effective tax rate
(Loss) earnings before income taxes
Income tax (benefit) provision
Net (loss) earnings
2021
Reported
Adjustments
Adjusted
(Non-GAAP)
146.0
29.0
117.0
$
$
65.7
$
16.0
49.7
$
211.7
45.0
166.7
19.8 %
21.2 %
2020
Reported
Adjustments
Adjusted
(Non-GAAP)
87.3
19.7
67.6
$
$
22.6 %
104.6
$
23.4
81.2
$
191.9
43.1
148.8
22.5 %
2019
Reported
Adjustments
Adjusted
(Non-GAAP)
(390.3)
$
638.1
$
(18.1)
77.1
(372.2)
$
561.0
$
247.8
59.0
188.8
$
$
$
$
$
$
Effective tax rate
4.6 %
23.8 %
29
Our effective tax rate is highly sensitive to the mix of countries from which earnings or losses are derived. Declines in earnings
in lower tax rate jurisdictions, earnings increases in higher tax rate jurisdictions, or repatriation of foreign earnings or operating
losses in the future could increase future tax rates. Additionally, adjustments to prior year tax provision estimates could increase
or decrease future tax provisions.
Segment Results
Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation
costs, costs associated with restructuring charges, acquisition and integration costs, cost of early debt retirement, COVID-19
pandemic expenses, impairment charges, advisory expenses in connection with the evaluation of the Feminine and Infant Care
businesses, Sun Care reformulation costs, investor settlement expenses, the disposition of the Infant and Pet Care business and
the amortization and impairment of intangible assets. The exclusion of such changes from segment results reflects
management’s view on how it evaluates segment performance. Financial items, such as interest income and expense, are
managed on a global basis at the corporate level.
Our operating model includes some shared business functions across the segments, including product warehousing and
distribution, transaction processing functions and, in most cases, a combined sales force and management teams. We apply a
fully allocated cost basis, in which shared business functions are allocated between the segments on a percentage of net sales
basis. Such allocations are estimates and do not represent the costs of such services if performed on a stand-alone basis.
The following tables present changes in segment net sales and segment profit for fiscal 2021 and 2020, as compared to the
corresponding prior year periods, and also provide a reconciliation of organic segment net sales and organic segment profit to
reported amounts. For a reconciliation of Segment profit to Earnings (loss) before income taxes, see Note 18 of Notes to
Consolidated Financial Statements.
Wet Shave
Net Sales - Wet Shave
For the Years Ended September 30,
Net sales - prior year
Organic
Impact of currency
Net sales - current year
2021
%Chg
2020
%Chg
$
1,162.3
$
1,250.1
26.6
27.0
2.3 %
2.3 %
(83.2)
(4.6)
$
1,215.9
4.6 % $
1,162.3
(6.7) %
(0.3) %
(7.0) %
Wet Shave net sales for fiscal 2021 increased 4.6%, inclusive of a 2.3% increase due to currency movements. Organic net sales
increased $26.6, or 2.3%, primarily driven by significantly higher volumes and slightly favorable price mix. The increase in
organic net sales was driven by growth in Women’s systems, partially offset by declines in Men’s systems and Shave Preps.
Women’s systems growth included increases in Intuition, Skintimate and Hydro Silk, while Men’s systems saw growth in
Hydro and Bulldog, partially mitigating declines in other brands. By region, North America and International organic net sales
both increased by 2.3%.
Segment Profit - Wet Shave
For the Years Ended September 30,
Segment profit - prior year
Organic
Impact of currency
2021
%Chg
2020
%Chg
$
206.2
8.9
5.9
$
4.3 %
2.9 %
7.2 % $
246.5
(37.9)
(2.4)
206.2
(15.4) %
(0.9) %
(16.3) %
Segment profit - current year
$
221.0
Wet Shave segment profit for fiscal 2021 was $221.0, up $14.8 or 7.2%, inclusive of the impact of currency movements.
Organic segment profit increased $8.9, or 4.3%. The increase in segment profit was driven by higher volumes, particularly in
Women’s systems and disposables, partially offset by higher A&P in support of Men’s Hydro and Women’s Skintimate razors
and unfavorable operating costs driven by higher freight and commodity prices.
30
Sun and Skin Care
Net Sales - Sun and Skin Care
For the Years Ended September 30,
Net sales - prior year
Organic
Impact of Cremo acquisition
Impact of currency
Net sales - current year
2021
%Chg
2020
%Chg
$
462.0
$
463.1
59.0
56.0
8.3
12.8 %
12.1 %
1.8 %
(3.1)
4.5
(2.5)
$
585.3
26.7 % $
462.0
(0.7) %
1.0 %
(0.5) %
(0.2) %
Sun and Skin Care net sales for fiscal 2021 increased 26.7%, inclusive of a 12.1% increase from the Cremo acquisition and a
1.8% increase due to currency movements. Organic net sales increased $59.0, or 12.8%, primarily due to increased Sun Care
sales as Banana Boat and Hawaiian Tropic both had double digit growth, rebounding from declines in the prior year due to the
COVID-19 pandemic, which resulted in travel disruption during the summer vacation season. Organic growth in Men’s
grooming of 14.8% was driven by favorable volumes in Jack Black and Bulldog. Wet Ones sales grew as a result of price, with
volumes flat compared to the prior year.
Segment Profit - Sun and Skin Care
For the Years Ended September 30,
Segment profit - prior year
Organic
Impact of Cremo acquisition
Impact of currency
Segment profit - current year
2021
%Chg
2020
%Chg
$
$
69.1
19.2
8.9
1.5
98.7
$
27.8 %
12.9 %
2.1 %
42.8 % $
80.4
(11.7)
1.1
(0.7)
69.1
(14.6) %
1.4 %
(0.9) %
(14.1) %
Sun and Skin Care segment profit for fiscal 2021 was $98.7, an increase of 42.8% compared to the prior year, inclusive of a
12.9% increase from the Cremo acquisition and a 2.1% increase from currency movements. Organic segment profit increased
$19.2, or 27.8% driven by increased net sales and gross margin from favorable volumes of Sun Care products and pricing for
Sun Care and Wet Ones, partially offset by higher freight and materials costs.
31
Feminine Care
Net Sales - Feminine Care
For the Years Ended September 30,
Net sales - prior year
Organic
Impact of currency
Net sales - current year
2021
%Chg
2020
%Chg
$
$
298.6
(13.5)
1.0
286.1
$
308.1
(4.5) %
0.3 %
(9.1)
(0.4)
(4.2) % $
298.6
(3.0) %
(0.1) %
(3.1) %
Feminine Care net sales for fiscal 2021 decreased $12.5, or 4.2%, inclusive of a 0.3% increase due to currency movements.
Organic segment net sales decreased $13.5, or 4.5%, driven by overall category declines, lost distribution, and the impact of the
prior year pantry loading.
Segment Profit - Feminine Care
For the Years Ended September 30,
Segment profit - prior year
Organic
Impact of currency
Segment profit - current year
2021
%Chg
2020
%Chg
$
$
52.3
(15.7)
0.6
37.2
$
(30.0) %
1.1 %
(28.9) % $
48.3
4.1
(0.1)
52.3
8.5 %
(0.2) %
8.3 %
Feminine Care segment profit for fiscal 2021 was $37.2, a decrease of $15.1, or 28.9%, inclusive of currency impacts. The
decrease is primarily due to unfavorable gross margin from lower sales volumes across all products, unfavorable cost mix due
to higher material costs and higher warehouse and distribution costs.
All Other
The Infant and Pet Care business divestiture, completed in December 2019, disposed of the entirety of the operations of the All
Other segment. The results below represent the impact of the divestiture to segment performance:
Net Sales - All Other
For the Years Ended September 30,
Net sales - prior year
Organic
Impact of Infant and Pet Care business sale
Impact of currency
Net sales - current year
Segment Profit - All Other
For the Years Ended September 30,
Segment profit - prior year
Organic
Impact of Infant and Pet Care business sale
Impact of currency
Segment profit - current year
2021
%Chg
2020
%Chg
26.8
—
$
— %
(26.8)
(100.0) %
—
—
— %
(100.0) % $
119.7
0.5
(93.4)
—
26.8
0.4 %
(78.0) %
— %
(77.6) %
2021
%Chg
2020
%Chg
3.1
—
(3.1)
—
—
$
— %
(100.0) %
— %
(100.0) % $
11.7
0.5
(9.1)
—
3.1
4.3 %
(77.8) %
— %
(73.5) %
$
$
$
$
32
General Corporate and Other Expenses
General corporate and other expenses
Restructuring and related costs
Cost of early retirement of long-term debt
Acquisition and integration planning costs
Sun Care reformulation costs
Feminine and Infant Care evaluation costs
COVID-19 expenses
Gain on sale of Infant and Pet Care business
Impairment charges
Investor settlement expense
General corporate and other expenses
% of net sales
$
Fiscal Year
2021
2020
2019
$
56.5
30.1
26.1
8.4
1.1
—
—
—
—
—
$
54.9
38.1
26.2
39.8
—
0.3
4.3
(4.1)
—
—
57.3
55.6
—
6.7
2.8
2.1
—
—
570.0
0.9
$
122.2
$
159.5
$
695.4
5.9 %
8.2 %
32.5 %
For fiscal 2021, general corporate expenses were $56.5, an increase of $1.6 as compared to fiscal 2020. Fiscal 2020 general
corporate expenses decreased $2.4 when compared to fiscal 2019. The increase in general corporate expenses in fiscal 2021
relates to additional benefit and incentive payments, partially offset by savings from Project Fuel and reduced consulting and
legal fees.
The Company incurred expenses associated with the early retirement of the $500 Senior Notes due 2022 and $600 Senior Notes
due 2021, including the recognition of remaining debt issuance costs and interest expense in the second quarter of fiscal 2021
and third quarter of fiscal 2020, respectively. Acquisition and integration costs incurred in fiscal 2021 and the fourth quarter of
fiscal 2020 were related to the acquisition of Cremo, which was completed in September 2020. Additionally, the Company
incurred expenses, primarily legal, consulting and financing costs, associated with the termination of the Harry’s acquisition in
the first half of fiscal 2020.
Liquidity and Capital Resources
To date, COVID-19 has not had a significant impact on our liquidity or capital resources. However, the ongoing COVID-19
pandemic has led to disruption and volatility in the global capital markets, which, depending on future developments, could
impact our capital resources and liquidity in the future.
At September 30, 2021, a portion of our cash balances were located outside the U.S. Given our extensive international
operations, a significant portion of our cash is denominated in foreign currencies. We manage our worldwide cash requirements
by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with
which those funds can be accessed. We generally repatriate a portion of current year earnings from select non-U.S. subsidiaries
only if the economic cost of the repatriation is not considered material.
Our cash is deposited with multiple counterparties which consist of major financial institutions. We consistently monitor
positions with, and credit ratings of, counterparties both internally and by using outside ratings agencies.
Our total borrowings were $1,276.5 at September 30, 2021, including $26.5 tied to variable interest rates. Our total borrowings
at September 30, 2020 were $1,271.1. We had outstanding international borrowings, recorded within Notes payable, of $26.5
and $21.1 as of September 30, 2021 and September 30, 2020, respectively.
Historically, we have generated and expect to continue to generate positive cash flows from operations. Our cash flows are
affected by the seasonality of our Sun Care products, typically resulting in higher net sales and increased cash generation in the
second and third quarter of each fiscal year. While we cannot reasonably estimate the full impact COVID-19 will have on our
cash flows, we believe our cash on hand, cash flows from operations and borrowing capacity under our U.S. Revolving Credit
Facility due 2025 (the “Revolving Credit Facility”) will be sufficient to satisfy our future working capital requirements, interest
payments, R&D activities, capital expenditures, and other financing requirements for at least the next 12 months. We will
continue to monitor our cash flows, spending, and liquidity needs.
33
Short-term financing needs primarily consist of working capital requirements and principal and interest payments on our long-
term debt. Long-term financing needs will depend largely on potential growth opportunities, including acquisition activity and
repayment or refinancing of our long-term debt obligations. We may, from time-to-time, seek to repurchase shares of our
common stock. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual
restrictions and other factors. Our long-term liquidity may be influenced by our ability to borrow additional funds, renegotiate
existing debt, and raise equity under terms that are favorable to us.
In fiscal 2022, we expect our total capital expenditures to be in the range of $60 to $70 primarily related to both maintenance of
and productivity efforts across manufacturing facilities, new product development and information technology system
enhancements. While we intend to fund these capital expenditures with cash generated from operations, we may also utilize our
borrowing facilities.
During fiscal 2021, we contributed $4.9 to our pension and postretirement plans. Due to the election of certain terms of the
American Rescue Plan Act, we are not required to make any cash contributions to our pension and postretirement plans in fiscal
2022.
Debt Covenants
The Revolving Credit Facility governing our outstanding debt at September 30, 2021 contains certain customary representations
and warranties, financial covenants, covenants restricting our ability to take certain actions, affirmative covenants, and
provisions relating to events of default. Under the terms of the Revolving Credit Facility, the ratio of our indebtedness to our
earnings before interest, taxes, depreciation and amortization (“EBITDA”), as defined in the agreement and detailed below,
cannot be greater than 4.0 to 1.0. In addition, under the Revolving Credit Facility, the ratio of our EBITDA to total interest
expense must exceed 3.0 to 1.0. If we fail to comply with these covenants or with other requirements of the Revolving Credit
Facility, the lenders may have the right to accelerate the maturity of the debt. Acceleration under one of our facilities would
trigger cross-defaults on our other borrowings. Under the Revolving Credit Facility, EBITDA is defined as net earnings, as
adjusted to add-back interest expense, income taxes, depreciation and amortization, all of which are determined in accordance
with GAAP. In addition, the Revolving Credit Facility allows certain non-cash charges such as stock award amortization and
asset write-offs including, but not limited to, impairment and accelerated depreciation, and operating expense reductions or
synergies to be “added-back” in determining EBITDA for purposes of the indebtedness ratio. Total debt and interest expense
are calculated in accordance with GAAP.
As of September 30, 2021, we were in compliance with the provisions and covenants associated with the Revolving Credit
Facility.
Cash Flows
A summary of our cash flow from operating, investing and financing activities is provided in the following table:
Net cash from (used by):
Operating activities
Investing activities
Financing activities
Effect of exchange rate changes on cash
Fiscal Year
2021
2020
2019
$
229.0
$
232.6
$
190.6
(48.7)
(65.4)
(0.4)
(196.4)
(18.7)
5.6
(45.5)
(63.8)
(6.1)
75.2
Net increase (decrease) in cash and cash equivalents
$
114.5
$
23.1
$
Operating Activities
Cash flow from operating activities was $229.0 in fiscal 2021, as compared to $232.6 in fiscal 2020. The slight decrease in
fiscal 2021 was primarily a result of net cash outflow from working capital in the current period compared to an inflow from
working capital changes in the prior year period, partially offset by improved earnings compared to the prior year period.
34
Investing Activities
Cash flow used by investing activities was $48.7 in fiscal 2021 as compared to $196.4 in fiscal 2020. During fiscal 2021, we
collected $7.5 of proceeds from the sale of the Infant and Pet Care business, compared to $95.8 in the prior year. Capital
expenditures were $56.8 and $47.7 during fiscal 2021 and 2020, respectively. Additionally, other investing cash inflows related
to the collection of receivables from our $150 uncommitted master accounts receivable purchase agreement with The Bank of
Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the purchaser (the “Accounts Receivable Facility”) totaled $2.6 and $4.3
during fiscal 2021 and 2020, respectively, as a result of collections on the deferred purchase price of accounts receivables sold.
During fiscal 2020, we completed the acquisition of Cremo for $233.6 and a minority investment of a direct-to-consumer
company totaling $13.8.
Financing Activities
Net cash used by financing activities was $65.4 in fiscal 2021 as compared to $18.7 in fiscal 2020. During fiscal 2021, we
repurchased $9.2 of our common stock under our 2018 Board authorization to repurchase our common stock. The Company
repaid its 2022 Senior Notes with the proceeds received from the issuance of the 2029 Senior Notes, together with cash on
hand. Additional financing cash outflows incurred were related to costs of early debt retirement of the 2022 Senior Notes
totaling $26.1 and debt issuance costs of $6.5. Dividend payments totaled $25.6 in fiscal 2021. Additionally, cash flows
associated with the Accounts Receivable Facility were inflows of $2.4 during fiscal 2021 compared to financing outflows of
$11.2 in the prior year period. In the prior year period, the Company replaced its 2021 Senior Notes in the amount of $600 with
the 2028 Senior Notes in the amount of $750. Early debt retirement costs incurred in connection with the repayment of the 2021
Senior Notes totaled $26.2 and debt issuance costs totaling $11.7. The Company had net repayments of its Revolving Credit
Facility during fiscal 2020 totaling $117.0.
Share Repurchases
In January 2018, our Board approved an authorization to repurchase up to 10.0 shares of our common stock. This authorization
replaced a prior share repurchase authorization from May 2015. During fiscal 2021, we repurchased 0.3 shares of our common
stock for $9.2. We have 9.7 shares remaining available for purchase under the January 2018 Board authorization. As a part of
our capital allocation strategy, we plan to implement a more consistent approach to share repurchases and intend to repurchase
approximately $300 in shares of our common stock over the next three fiscal years. Additionally, we intend to enter into a Rule
10b5-1 trading plan to facilitate the repurchase of our common shares in accordance with this share repurchase program.
During fiscal 2021, 0.1 shares were purchased related to the surrender of shares of common stock to satisfy tax withholding
obligations in connection with the vesting of restricted stock equivalent awards.
Since November 15, 2021, we repurchased 0.2 shares of common stock on the open market for $7.4. We have 9.6 shares
remaining available for purchase under the January 2018 Board authorization.
Dividends
On August 5, 2021, the Company’s Board of Directors (the “Board”) declared a cash dividend of $0.15 per share of common
stock outstanding. The dividend was paid on October 5, 2021 to holders of record as of the close of business on September 9,
2021. Dividends declared during fiscal 2021 totaled $33.7. Payments made for dividends during fiscal 2021 totaled $25.6.
On November 4, 2021, the Board declared a quarterly cash dividend of $0.15 per common stock outstanding for the fourth
fiscal quarter. The dividend is payable January 6, 2022 to stockholders of record as of the close of business on December 3,
2021.
Inflation
Management recognizes that inflationary pressures may have an adverse effect on our company through higher material, labor
and transportation costs, asset replacement costs and related depreciation, healthcare and other costs. In general, we have been
able to offset or minimize inflation effects through a variety of methods including pricing actions, cost reductions and
productivity improvements. We can provide no assurance that such mitigation will be available in the future.
35
Seasonality
Customer orders for sun care products within our Sun and Skin Care segment are highly seasonal. This has historically resulted
in higher sun care sales to retailers during the late winter through mid-summer months. Within our Wet Shave segment, sales of
women’s products are moderately seasonal, with increased consumer demand in the spring and summer months. See “Our
business is subject to seasonal volatility” in Item 1A. Risk Factors.
Foreign Currency
Certain net sales and costs of our international operations are denominated in the local currency of the respective countries. As
such, sales and profits from these subsidiaries may be impacted by fluctuations in the value of these local currencies relative to
the U.S. dollar. We also have significant intercompany financing arrangements that may result in gains and losses in our results
of operations. In an effort to mitigate the impact of currency exchange rate effects, we may hedge certain operational and
intercompany transactions; however, our hedging strategies may not fully offset gains and losses recognized in our results of
operations.
On June 23, 2016, the U.K held a referendum in which voters approved an exit from the E.U., commonly referred to as
“Brexit.” The U.K. officially exited the E.U. on January 31, 2020, however, negotiations between the U.K. and E.U. regarding
the separation remain ongoing. On December 24, 2020, the E.U. and the U.K. agreed on the final terms of a trade and
cooperation agreement related to their relationship following Brexit. Future impacts on our U.K. operations and financial results
will depend, in part, on the outcome of tariff, trade, regulatory and other negotiations.
Generally, a weaker British pound as compared to the U.S. dollar during a reporting period causes the local currency results of
our U.K. operations to be translated into fewer U.S. dollars. Historically, our hedging strategy has included hedging a portion of
our exposure to the British pound, thereby reducing our currency risk. We routinely monitor and evaluate this strategy based on
risk and will adjust as necessary to minimize exposure to fluctuations in exchange rates related to our U.K. operations. For
fiscal 2021, net sales of our U.K. operations were 4% of our consolidated net sales.
Commitments and Contingencies
Contractual Obligations
We have significant contractual obligations to fulfill our business operations including the repayment of short and long term
debt, periodic interest payments, minimum levels of pension funding, and other obligations including payments for various
leases of real estate, vehicles, and equipment, and minimum fixed costs to be paid to third party logistics vendors. We are also
party to various service and supply contracts that generally extend one to three months. These arrangements are primarily
individual, short-term purchase orders for routine goods and services at market prices, which are part of our normal operations
and are reflected in historical operating cash flow trends. These contracts can generally be canceled at our option at any time.
We do not believe such arrangements will adversely affect our liquidity position. In addition, we have various commitments
related to service and supply contracts that contain penalty provisions for early termination. Because of the short period
between order and shipment date (generally less than one month) for most of our orders, the dollar amount of current backlog is
not material and is not considered to be a reliable indicator of future sales volume. Generally, sales to our top customers are
made pursuant to purchase orders and we do not have supply agreements or guarantees of minimum purchases from them. As a
result, these customers may cancel their purchase orders or reschedule or decrease their level of purchases from us at any time.
As of September 30, 2021, we do not believe such purchase arrangements or termination penalties will have a significant effect
on our results of operations, financial position or liquidity position in the future.
Environmental Matters
Our operations, like those of other companies, are subject to various federal, state, local and foreign laws and regulations
intended to protect public health and the environment. These regulations relate primarily to worker safety, air and water quality,
underground fuel storage tanks, and waste handling and disposal. Accrued environmental costs at September 30, 2021 were
$11.8. It is difficult to quantify with reasonable certainty the cost of environmental matters, particularly remediation and future
capital expenditures for environmental control equipment. Total environmental capital expenditures and operating expenses are
not expected to have a material effect on our total capital and operating expenditures, consolidated earnings or competitive
position. However, current environmental spending estimates could be modified as a result of changes in our plans or our
understanding of underlying facts, changes in legal requirements, including any requirements related to global climate change,
or other factors.
36
Critical Accounting Policies
The methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the
results we report in our consolidated financial statements. Specific areas, among others, requiring the application of
management’s estimates and judgment include assumptions pertaining to accruals for consumer and trade promotion programs,
pension and postretirement benefit costs, share-based compensation, future cash flows associated with impairment testing of
goodwill and other long-lived assets, uncertain tax positions, the reinvestment of undistributed foreign earnings and tax
valuation allowances. On an ongoing basis, we evaluate our estimates, but actual results could differ materially from those
estimates.
Our most critical accounting policies are revenue recognition, pension and other postretirement benefits, the valuation of long-
lived assets (including property, plant and equipment), income taxes (including uncertain tax positions) and the carrying value
of intangible assets (and the related impairment testing of goodwill and other indefinite-lived intangible assets). A summary of
our significant accounting policies is contained in Note 2 of Notes to Consolidated Financial Statements. This listing is not
intended to be a comprehensive list of all of our accounting policies.
Revenue Recognition
We derive revenue from the sale of our products. Revenue is recognized when the customer obtains control of the goods, which
occurs when the ability to use and obtain benefits from the goods are passed to the customer, most commonly upon the delivery
of the goods,. Discounts are offered to customers for early payment, and an estimate of the discounts is recorded as a reduction
of Net sales in the same period as the sale. Our standard sales terms are final and returns or exchanges are not permitted with
the exception of end of season returns for Sun Care products, as detailed below. Reserves are established and recorded in cases
where the right of return does exist for a particular sale.
We assess the contractual obligations in customers’ purchase orders and identify performance obligations related to the
transferred goods (or a bundle of goods) that are distinct. To identify the performance obligations, we consider all the goods
promised, whether explicitly stated or implied based on customary business practices. Our purchase orders are short term in
nature, lasting less than one year, and contain a single delivery element. For a purchase order that has more than one
performance obligation, we allocate the total consideration to each distinct performance obligation on a relative stand-alone
selling price basis. We do not exclude variable consideration in determining the remaining value of performance obligations.
We record sales at the time that control of goods passes to the customer. The terms of these sales vary, but, in all instances, the
following conditions are met: (1) the sales arrangement is evidenced by purchase orders submitted by customers; (2) the selling
price is fixed or determinable; (3) title to the product has transferred; (4) there is an obligation to pay at a specified date without
any additional conditions or actions required by us; and (5) collectability is reasonably assured. Simultaneously with the sale,
we reduce Net sales and Cost of products sold and reserve amounts on the Consolidated Balance Sheet for anticipated returns
based upon an estimated return level in accordance with GAAP. Customers are required to pay for the Sun Care product
purchased during the season under the required terms. Under certain circumstances, we allow customers to return Sun Care
products that have not been sold by the end of the Sun Care season, which is normal practice in the Sun Care industry. The
timing of returns of Sun Care products can vary in different regions, based on climate and other factors. However, the majority
of returns occur in the U.S. from September through January, following the summer Sun Care season. We estimate the level of
Sun Care returns as the Sun Care season progresses, using a variety of inputs including historical experience, consumption
trends during the Sun Care season, obsolescence factors including expiration dates and inventory positions at key retailers. We
monitor shipment activity and inventory levels at key retailers during the season in an effort to more accurately estimate
potential returns. This allows us to manage shipment activity to our customers, especially in the latter stages of the Sun Care
season, to reduce the potential for returned product. The level of returns may fluctuate from our estimates due to several factors,
including weather conditions, customer inventory levels and competitive activity. Based on our fiscal 2021 Sun Care shipments,
each percentage point change in our returns rate would have impacted our reported net sales by $3.4 and our reported operating
income by $3.2. At September 30, 2021 and 2020, our reserve on the Consolidated Balance Sheet for returns was $52.7 and
$44.8, respectively.
37
We offer a variety of programs, primarily to our retail customers, designed to promote sales of our products. Such programs
require periodic payments and allowances based on estimated results of specific programs and are recorded as a reduction to net
sales. We accrue, at the time of sale, the estimated total payments and allowances associated with each transaction.
Additionally, we offer programs directly to consumers to promote the sale of our products. Promotions which reduce the
ultimate consumer sale prices are recorded as a reduction of net sales at the time the promotional offer is made, generally using
estimated redemption and participation levels. Taxes we collect on behalf of governmental authorities, which are generally
included in the price to the customer, are also recorded as a reduction of net sales.
We continually assess the adequacy of accruals for customer and consumer promotional program costs not yet paid. To the
extent total program payments differ from estimates, adjustments may be necessary. Historically, these adjustments have not
been material to annual results.
Pension Plans and Other Postretirement Benefits
The determination of our obligation and expense for pension and other postretirement benefits is dependent on certain
assumptions developed by us and used by actuaries in calculating such amounts. Assumptions include, among others, the
discount rate, the expected long-term rate of return on plan assets, and future salary increases, where applicable. Actual results
that differ from assumptions made are recognized on the balance sheet and subsequently amortized to earnings over future
periods. Significant differences in actual experience or significant changes in macroeconomic conditions resulting in changes to
assumptions may materially affect pension and other postretirement obligations. In determining the discount rate, we use the
yield on high-quality bonds that coincide with the cash flows of our plans’ estimated payouts. For our U.S. plans, which
represent our most significant obligations, we use the Mercer yield curve in determining the discount rates.
We utilize a spot discount rate approach to estimate service and interest components of net periodic benefit cost for our pension
benefits. The spot discount rate approach applies the specific spot rates along the yield curve used in the determination of the
benefit obligation to the relevant projected cash flows and is a more precise application of the yield curve spot rates used in the
traditional single discount rate approach.
Of the assumptions listed above, changes in the expected long-term rate of return on plan assets and changes in the discount rate
used in developing plan obligations will likely have the most significant impact on our annual earnings, prospectively. Based on
plan assets at September 30, 2021, a one percentage point decrease or increase in expected asset returns would increase or
decrease our pension expense by approximately $5.1. In addition, it may increase and accelerate the rate of required pension
contributions in the future. Uncertainty related to economic markets and the availability of credit may produce changes in the
yields on corporate bonds rated as high-quality. As a result, discount rates based on high-quality corporate bonds may increase
or decrease, leading to lower or higher pension obligations, respectively. A one percentage point decrease in the discount rate
would increase pension obligations by approximately $82.5 at September 30, 2021.
As allowed under GAAP, our U.S. qualified pension plan uses market related value, which recognizes market appreciation or
depreciation in the portfolio over five years, thereby reducing the short-term impact of market fluctuations.
We have historically provided defined benefit pension plans to our eligible employees, former employees and retirees. We fund
our pension plans in compliance with the Employee Retirement Income Security Act of 1974 or local funding requirements.
Further detail on our pension and other postretirement benefit plans is included in Note 12 of Notes to Consolidated Financial
Statements.
38
Share-Based Compensation
We award restricted stock equivalents (“RSE”), which generally vest over two to four years. The fair value of each grant is
estimated on the date of grant based on the current market price of our shares of common stock.
We also award performance restricted stock equivalents (“PRSE”) which may provide for the issuance of common stock to
certain managerial staff and executive management if specified performance or market targets are achieved. The recipient of the
PRSE award may earn a total award ranging from 0% to 200% of the target award.
For PRSE awards with performance conditions, the fair value of each grant is estimated on the date of grant based on the
current market price of our shares of common stock. The total amount of compensation expense recognized reflects the initial
assumption that target performance goals will be achieved. Compensation expense may be adjusted during the life of the
performance grant based on management’s assessment of the probability that performance goals will be achieved. If such goals
are not met or it is determined that achievement of performance goals is not probable, compensation expense is adjusted to
reflect the reduced expected payout level. If it is determined that the performance goals will be exceeded, additional
compensation expense is recognized.
For PRSE awards based on market conditions, the fair value is estimated on the grant date using a Monte Carlo simulation. The
payout for PRSE awards with market conditions are assessed by comparing our total shareholder return (“TSR”) during a
certain three year period to the respective TSRs of companies in a selected performance peer group.
Non-qualified stock options (“share options”) are granted at the market price of our common stock on the grant date and
generally vest ratably over three years. We calculate the fair value of total share-based compensation for share options using the
Black-Scholes option pricing model, which utilizes certain assumptions and estimates that have a material impact on the
amount of total compensation cost recognized in our consolidated financial statements, including the expected term, expected
stock price volatility, risk-free interest rate and expected dividends. The original estimate of the grant date fair value is not
subsequently revised unless the awards are modified or there is a change in the number of awards expected to forfeit prior to
vesting.
Further detail on Share-Based Payments is included in Note 13 of Notes to Consolidated Financial Statements.
Valuation of Long-Lived Assets
We periodically evaluate our long-lived assets, including property, plant and equipment, goodwill, and intangible assets, for
potential impairment indicators. Judgments regarding the existence of impairment indicators, including lower than expected
cash flows from acquired businesses, are based on legal factors, market conditions and operational performance. Future events
could cause us to conclude that impairment indicators exist. We estimate fair value using valuation techniques such as
discounted cash flows. This requires management to make assumptions regarding future income, working capital, and discount
rates, which would affect the impairment calculation.
Income Taxes
Our annual effective income tax rate is determined based on our income, statutory tax rates and the tax impacts of items treated
differently for tax purposes than for financial reporting purposes. Tax law requires certain items to be included in the tax return
at different times than the items reflected in the financial statements. Some of these differences are permanent, such as expenses
that are not deductible in our tax return, and some differences are temporary, reversing over time, such as depreciation expense.
These temporary differences create deferred tax assets and liabilities.
Deferred tax assets generally represent the tax effect of items that can be used as a tax deduction or credit in future years for
which we have already recorded the tax benefit in our income statement. Deferred tax liabilities generally represent tax expense
recognized in our financial statements for which payment has been deferred, the tax effect of expenditures for which a
deduction has already been taken in our tax return but has not yet been recognized in our financial statements, or assets
recorded at estimated fair value in business combinations for which there was no corresponding tax basis adjustment.
We estimate income taxes and the effective income tax rate in each jurisdiction that we operate. This involves estimating
taxable earnings, specific taxable and deductible items, the likelihood of generating sufficient future taxable income to utilize
deferred tax assets, the portion of the income of foreign subsidiaries that is expected to be remitted to the U.S. and be taxable
and possible exposures related to future tax audits. Deferred tax assets are evaluated on a subsidiary by subsidiary basis to
ensure that the asset will be realized. Valuation allowances are established when the realization is not deemed to be more likely
than not. Future performance is monitored, and when objectively measurable operating trends change, adjustments are made to
the valuation allowances accordingly. To the extent the estimates described above change, adjustments to income taxes are
made in the period in which the estimate is changed.
39
We operate in multiple jurisdictions with complex tax and regulatory environments, which are subject to differing
interpretations by the taxpayer and the taxing authorities. At times, we may take positions that management believes are
supportable, but are potentially subject to successful challenges by the appropriate taxing authority. We evaluate our tax
positions and establish liabilities in accordance with guidance governing accounting for uncertainty in income taxes. We review
these tax uncertainties in light of the changing facts and circumstances, such as the progress of tax audits, and adjust them
accordingly.
Further detail on Income Taxes is included in Note 5 of Notes to Consolidated Financial Statements.
Acquisitions, Goodwill and Intangible Assets
We allocate the cost of an acquired business to the assets acquired and liabilities assumed based on their estimated fair values at
the date of acquisition. The excess value of the cost of an acquired business over the estimated fair value of the assets acquired
and liabilities assumed is recognized as goodwill. The valuation of the acquired assets and liabilities will impact the
determination of future operating results. We use a variety of information sources to determine the value of acquired assets and
liabilities, including: third-party appraisers for the values and lives of property, identifiable intangibles and inventories;
actuaries for defined benefit retirement plans; and legal counsel or other experts to assess the obligations associated with legal,
environmental or other claims.
During fiscal 2020, the Company used variations of the income approach in determining the fair value of intangible assets
acquired in the acquisition of Cremo Holding Company, LLC. Specifically, we utilized the multi-period excess earnings
method to determine the fair value of the definite lived customer relationships acquired and the relief from royalty method to
determine the fair value of the definite lived trade name and proprietary technology that we acquired.
Our determination of the fair value of customer relationships acquired involved significant estimates and assumptions related to
revenue growth rates, discount rates, and customer attrition rates. The determination of the fair value of trade names and
proprietary technology acquired involved the use of significant estimates and assumptions related to revenue growth rates,
royalty rates and discount rates. We believe that the fair value assigned to the assets acquired and liabilities assumed are based
on reasonable assumptions and estimates that marketplace participants would use.
The recorded value of goodwill and intangible assets from recently acquired businesses are derived from more recent business
operating plans and macroeconomic environmental conditions and, therefore, are likely more susceptible to an adverse change
that could require an impairment charge. As such, significant judgment is required in estimating the fair value of goodwill and
intangible assets. Additionally, significant judgment is needed when assigning a useful life to intangible assets. Certain
intangible assets are expected to have determinable useful lives. Our assessment of intangible assets that have a determinable
life is based on a number of factors including the competitive environment, market share, brand history, underlying product life
cycles, operating plans and the macroeconomic environment. The costs of determinable-lived intangible assets are amortized to
expense over the estimated useful life. The value of residual goodwill is not amortized, but is tested at least annually for
impairment. See Note 7 of Notes to Consolidated Financial Statements.
However, future changes in the judgments, assumptions and estimates that are used in our acquisition valuations and intangible
asset and goodwill impairment testing, including discount rates or future operating results and related cash flow projections,
could result in significantly different estimates of the fair values in the future. An increase in discount rates, a reduction in
projected cash flows or a combination of the two could lead to a reduction in the estimated fair values, which may result in
impairment charges that could materially affect our financial statements in any given year.
During the fourth quarter of fiscal 2021, we performed an annual test for impairment of goodwill on each of our reporting units.
We elected to perform a qualitative test of goodwill impairment for the Feminine Care reporting unit. Taking into account the
excess fair value over carrying value in the prior valuation, as well as macroeconomic factors, industry conditions and actual
results relative to the amounts projected in the prior quantitative test, we determined it was not more likely than not that the fair
value of the reporting unit is less than the carrying amount. For the Wet Shave, Sun Care, and Skin Care reporting units, we
elected to perform a quantitative impairment test in fiscal 2021. As part of the quantitative goodwill impairment test, we
estimated the fair value of each reporting unit using both market and income approaches of valuation. The income approach
utilizes the discounted cash flow method and incorporates significant estimates and assumptions, including long-term
projections of future cash flows, market conditions, and discount rates reflecting the risk inherent in future cash flows. The
projections for future cash flows are generated using our company’s strategic plan to determine a five-year period of forecasted
cash flows and operating data. The market approach uses the guideline public company method to calculate the value of each
reporting unit based on the operating data of similar assets from competing publicly traded companies. Multiples derived from
guideline companies provide an indication of how much a knowledgeable investor in the marketplace would be willing to pay
for a company. The multiples are adjusted given the specific characteristics of the reporting unit including its position in the
market relative to the guideline companies and applied to the reporting unit’s operating data to arrive at an indication of value.
40
The income and market approaches are weighted based on circumstances specific to each reporting unit and combined are used
to calculate fair value.
Determining the fair value of a reporting unit requires the use of significant judgment, estimates and assumptions. While we
believe that the estimates and assumptions underlying the valuation methodology are reasonable, these estimates and
assumptions could have a significant impact on whether an impairment charge is recognized, and also on the magnitude of any
such charge. The results of an impairment analysis are as of a point in time. There is no assurance that actual future earnings or
cash flows of the reporting units will not decline significantly from these projections. We will monitor any changes to these
assumptions and will evaluate goodwill as deemed warranted during future periods.
The key assumptions for the market and income approaches used to determine fair value of the reporting units are updated at
least annually. Those assumptions and estimates include market data and market multiples, discount rates and terminal growth
rates, as well as future levels of revenue growth and operating margins based upon our strategic plan. The assumptions used for
the annual goodwill impairment test for fiscal year 2021 include terminal growth rates ranging from 0.25% to 2.50% and a
weighted-average cost of capital of 9.0%.
Our annual impairment testing date was July 1, 2021, and the valuation indicated there was no impairment of the goodwill of
the tested reporting units. The results of the valuation indicated that all reporting units had a fair value that exceeded its carrying
value by more than 30%.
We evaluate the fair value of indefinite-lived intangible assets annually in conjunction with the goodwill impairment test. Our
assessment of intangible assets that have an indefinite life is based on a number of factors including the competitive
environment, market share, brand history, underlying product life cycles, operating plans and the macroeconomic environment.
During the fourth quarter of fiscal 2021, we elected to complete a qualitative assessment for impairment of indefinite lived trade
names, except for the Banana Boat trade name, for which we completed a quantitative assessment. There were no significant
events nor adverse trends that indicated any of the indefinite lived intangible assets were impaired during the fourth quarter of
fiscal 2021.
We tested the Banana Boat trade name for impairment by performing a quantitative assessment to estimate the fair value. The
estimated fair value was determined using the multi-period excess earnings method, which requires significant assumptions,
including estimates regarding future revenue and operating margin growth, and discount rates. Revenue and operating margin
growth assumptions are based on historical trends and management’s expectations for future growth by brand. The discount
rates were based on a weighted-average cost of capital utilizing industry market data of similar companies, in addition to
estimated returns on the assets utilized in the operations of the applicable reporting unit, including net working capital, fixed
assets and intangible assets.
The valuation of the Banana Boat trade name had no indication of impairment as of the annual testing date on July 1, 2021. The
impairment analysis performed in fiscal 2021 indicated that the Banana Boat trade name had a fair value that exceeded its
carrying value by greater than 40%.
Future changes in the judgment, assumptions and estimates that are used in our impairment testing could result in significantly
different estimates of the fair values in the future. An increase in discount rates, a reduction in projected cash flows or a
combination of the two could lead to a reduction in the estimated fair values, which may result in impairment charges that could
materially affect our financial statements in any given year. The assumptions used for the annual valuation for indefinite-lived
intangible assets for fiscal year 2021 include a terminal growth rate of 2.50% and a weighted-average cost of capital of 9.5%.
The annual impairment analysis performed in fiscal 2021 did not indicate that impairment existed in the reporting units or
indefinite lived trade names.
Recently Issued Accounting Standards
Refer to Note 2 of Notes to Consolidated Financial Statements for a discussion regarding recently issued accounting standards
and their estimated impact on our financial statements.
41
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
($ in millions)
The market risk inherent in our financial instruments and positions represents the potential loss arising from adverse changes in
currency rates, commodity prices, interest rates, and our stock price. The following risk management discussion and the
estimated amounts generated from the sensitivity analysis are forward-looking statements of market risk, assuming certain
adverse market conditions occur. Company policy allows derivatives to be used only for identifiable exposures and, therefore,
we do not enter into hedges for trading purposes where the sole objective is to generate profits.
Currency Rate Exposure
A significant share of our sales is tied to currencies other than the U.S. dollar, our reporting currency. As such, a weakening of
currencies relative to the U.S. dollar can have a negative impact to reported earnings. Conversely, strengthening of currencies
relative to the U.S. dollar can improve reported results. The primary currencies to which we are exposed include the euro, the
Japanese yen, the British pound, the Canadian dollar and the Australian dollar.
We do business in certain developing markets, which may be susceptible to greater volatility of inflation and currency exchange
rates, as well as government pricing and import controls. While the activity is not considered material in relation to the
consolidated company as a whole, there could be negative impacts to operating results in certain markets if inflationary
pressures, exchange volatility and government controls negatively impact our ability to operate effectively and profitably.
Derivatives Designated as Cash Flow Hedging Relationships
At September 30, 2021, we maintained a cash flow hedging program related to foreign currency risk. These derivative
instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective by the
Company for accounting purposes in offsetting the associated risk.
We enter into forward currency contracts to hedge the cash flow uncertainty associated with currency fluctuations. These
transactions are accounted for as cash flow hedges. We had an unrealized pre-tax gain of $3.3 and an unrealized pre-tax loss of
$3.0 at September 30, 2021 and 2020, respectively, on these forward currency contracts accounted for as cash flow hedges
included in Accumulated other comprehensive loss (“AOCI”). Assuming foreign exchange rates versus the U.S. dollar remain
at September 30, 2021 levels over the next 12 months, the majority of the pre-tax gain included in AOCI at September 30, 2021
is expected to be included in Other (income) expense, net. Contract maturities for these hedges extend into fiscal year 2023.
There were 64 open foreign currency contracts at September 30, 2021 with a notional value of approximately $129.2.
For further information on our derivatives designated as cash flow hedging relationships, see Note 16 of Notes to Consolidated
Financial Statements.
Derivatives Not Designated as Cash Flow Hedging Relationships
Our foreign subsidiaries enter into internal and external transactions in the ordinary course of business that create non-
functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of
intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign
subsidiary’s local currency at the end of each period. Changes in the value of the non-functional currency balance sheet
positions in relation to the foreign subsidiary’s local currency result in an exchange gain or loss recorded in Other (income)
expense, net. The primary currency to which our foreign subsidiaries are exposed is the U.S. dollar.
To mitigate these balance sheet exposures we enter into foreign currency derivative contracts, which are not designated as cash
flow hedges for accounting purposes. Any gains or losses on these contracts are expected to be offset by exchange gains or
losses on the underlying exposure; thus, they are not subject to significant market risk. The change in the estimated fair value of
the foreign currency contracts resulted in a gain of $2.3 and a loss of $0.5 for fiscal 2021 and 2020, respectively, which were
recorded in Other (income) expense, net. There were five open foreign currency derivative contracts which were not designated
as cash flow hedges at September 30, 2021, with a notional value of approximately $42.0.
For further information on our derivatives not designated as cash flow hedging relationships, see Note 16 of Notes to
Consolidated Financial Statements.
42
Commodity Price Exposure
We use raw materials that are subject to price volatility. At times, we have used, and may in the future, use hedging instruments
to reduce exposure to variability in cash flows associated with future purchases of certain materials and commodities. At
September 30, 2021, there were no open derivative or hedging instruments for future purchases of raw materials or
commodities.
Interest Rate Exposure
Our exposure to interest rate risk relates primarily to our variable-rate debt instruments, which currently bear interest based on
LIBOR plus margin. As of September 30, 2021, our outstanding debt included $26.5 related to our international, variable-rate
note payable. Assuming a one percent increase in the applicable interest rates, annual interest expense would increase by
approximately $0.3.
The remaining outstanding debt as of September 30, 2021 is fixed-rate debt. Changes in market interest rates generally affect
the fair value of fixed-rate debt, but do not impact earnings or cash flows.
Item 8. Financial Statements and Supplementary Data.
Consolidated Financial Statements
Responsibility for Financial Statements
INDEX TO FINANCIAL STATEMENTS
Report of Independent Registered Public Accounting Firm
Consolidated Statements of Earnings and Comprehensive Income (Loss) for the fiscal years ended September
30, 2021, 2020 and 2019.
Consolidated Balance Sheets as of September 30, 2021 and 2020.
Consolidated Statements of Cash Flows for the fiscal years ended September 30, 2021, 2020 and 2019.
Consolidated Statements of Changes in Shareholders’ Equity for the period from October 1, 2018 to
September 30, 2021.
Notes to Consolidated Financial Statements.
44
45
47
48
49
51
52
43
Responsibility for Financial Statements
The preparation and integrity of the financial statements of Edgewell Personal Care Company (the “Company”) are the
responsibility of its management. These statements have been prepared in conformance with generally accepted accounting
principles(“GAAP”) in the United States of America, and in the opinion of management, fairly present the Company’s financial
position, results of operations and cash flows.
The Company maintains accounting and internal control systems, which it believes are adequate to provide reasonable
assurance that assets are safeguarded against loss from unauthorized use or disposition and that financial records are reliable for
preparing financial statements. The selection and training of qualified personnel, the establishment and communication of
accounting and administrative policies and procedures, and a program of internal audits are important elements of these control
systems.
The Board of Directors, through its Audit Committee consisting solely of non-management directors, meets periodically with
management, internal audit and the independent auditors to discuss audit and financial reporting matters. To ensure
independence, our auditor, PricewaterhouseCoopers LLP, has direct access to the Audit Committee.
44
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of Edgewell Personal Care Company
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of Edgewell Personal Care Company and its subsidiaries (the
“Company”) as of September 30, 2021 and 2020, and the related consolidated statements of earnings and comprehensive
income (loss), of changes in shareholders’ equity and of cash flows for each of the three years in the period ended September
30, 2021, including the related notes and schedule of valuation and qualifying accounts for each of the three years in the period
ended September 30, 2021 appearing under Item 15(2) (collectively referred to as the “consolidated financial statements”). We
also have audited the Company's internal control over financial reporting as of September 30, 2021, based on criteria
established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the
Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial
position of the Company as of September 30, 2021 and 2020, and the results of its operations and its cash flows for each of the
three years in the period ended September 30, 2021 in conformity with accounting principles generally accepted in the United
States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over
financial reporting as of September 30, 2021, based on criteria established in Internal Control - Integrated Framework (2013)
issued by the COSO.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal
control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included
in Management's Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express
opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting
based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement,
whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material
respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement
of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks.
Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated
financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by
management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal
control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the
risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based
on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the
circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures
that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with authorizations of management and directors of the
45
company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or
disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial
statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or
disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or
complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated
financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate
opinions on the critical audit matter or on the accounts or disclosures to which it relates.
Goodwill Impairment Assessment – Skin Care Reporting Unit
As described in Notes 2 and 7 to the consolidated financial statements, the Company’s consolidated goodwill, net balance as of
September 30, 2021 was $1,162.8 million, which includes $232.1 million related to the Skin Care reporting unit. Management
evaluates goodwill annually for impairment in the fourth fiscal quarter, or when indicators of a potential impairment are
present. The impairment assessment compares the carrying value of the reporting unit to the estimated fair value. In
determining the estimated fair value of the reporting unit when performing a quantitative analysis, both the market approach
and the income approach are considered in the valuation, and where appropriate, both methods will be used and weighted,
unless appropriate market comparables are not available for a reporting unit. The key assumptions and estimates for the market
and income approaches used to determine fair value of the reporting unit included market data and market multiples, the
discount rate and terminal growth rate, as well as future levels of revenue growth and operating margins, which are based upon
the Company’s strategic plan.
The principal considerations for our determination that performing procedures relating to the goodwill impairment assessment
for the Skin Care reporting unit is a critical audit matter are the significant judgment by management when developing the fair
value measurement of the reporting unit; this in turn led to a high degree of auditor judgment, subjectivity and effort in
performing procedures and evaluating audit evidence relating to management’s significant assumptions of future operating
margin and the discount rate. In addition, the audit effort involved the use of professionals with specialized skill and
knowledge.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall
opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to
management’s goodwill impairment assessment, including controls over the determination of the fair value of the Company’s
Skin Care reporting unit. These procedures also included, among others, (i) testing management’s process for developing the
fair value estimate of the Skin Care reporting unit, (ii) evaluating the appropriateness of the income and market approaches, (iii)
testing the completeness and accuracy of underlying data used in the income and market approaches, and (iv) evaluating the
reasonableness of significant assumptions used by management related to operating margins and discount rates. Evaluating
management’s assumptions related to the future operating margins and discount rate involved evaluating whether the
assumptions used by management were reasonable considering (i) current and past performance of the reporting unit, (ii)
relevant industry forecasts and macroeconomic conditions, (iii) management’s historical forecasting accuracy, (iv) consistency
with evidence obtained in other areas of the audit, and (v) management’s objectives and strategies. Professionals with
specialized skill and knowledge were used to assist in evaluating the appropriateness of management’s income and market
approaches and the discount rate assumptions.
/s/ PricewaterhouseCoopers LLP
St. Louis, Missouri
November 19, 2021
We have served as the Company’s auditor since 1999.
46
CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME (LOSS)
EDGEWELL PERSONAL CARE COMPANY
(in millions, except per share data)
Fiscal Year
2021
2020
2019
Net sales
Cost of products sold
Gross profit
Selling, general and administrative expense
Advertising and sales promotion expense
Research and development expense
Restructuring charges
Operating income
Impairment charges
Gain on sale of Infant and Pet Care business
Cost of early retirement of long-term debt
Interest expense associated with debt
Other (income) expense, net
Earnings (loss) before income taxes
Income tax provision (benefit)
Net earnings (loss)
Earnings (loss) per share (Note 6):
Basic net earnings (loss) per share
Diluted net earnings (loss) per share
Statements of Comprehensive Income (Loss):
Net earnings (loss)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments
Pension and postretirement activity, net of tax of $17.1 in 2021, $6.3 in 2020, and
($19.4) in 2019
Deferred gain (loss) on hedging activity, net of tax of $2.0 in 2021, ($1.5) in 2020, and
($0.7) in 2019
Total other comprehensive income (loss), net of tax
$
2,087.3
$
1,949.7
$
1,137.2
950.1
1,068.8
880.9
391.2
241.5
57.8
20.8
238.8
—
—
26.1
67.9
(1.2)
146.0
29.0
117.0
2.15
2.12
408.8
216.2
55.3
24.6
176.0
—
(4.1)
26.2
61.2
5.4
87.3
19.7
67.6
1.25
1.24
2,141.0
1,174.4
966.6
372.0
250.9
53.5
46.4
243.8
570.0
—
—
62.6
1.5
(390.3)
(18.1)
(372.2)
(6.88)
(6.88)
$
117.0
$
67.6
$
(372.2)
5.6
44.8
4.3
54.7
29.9
17.7
(3.3)
44.3
(36.7)
(49.5)
(1.4)
(87.6)
Total comprehensive income (loss)
$
171.7
$
111.9
$
(459.8)
See accompanying Notes to Consolidated Financial Statements.
47
EDGEWELL PERSONAL CARE COMPANY
CONSOLIDATED BALANCE SHEETS
(in millions, except share data)
Assets
Current assets
Cash and cash equivalents
Trade receivables, less allowance for doubtful accounts of $6.9 and $8.2
Inventories
Other current assets
Total current assets
Property, plant and equipment, net
Goodwill
Other intangible assets, net
Other assets
Total assets
Liabilities and Shareholders’ Equity
Current liabilities
Current maturities of long-term debt
Notes payable
Accounts payable
Other current liabilities
Total current liabilities
Long-term debt
Deferred income tax liabilities
Other liabilities
Total liabilities
Commitments and contingencies (Note 17)
Shareholders’ equity
Preferred shares, $0.01 par value, 10,000,000 authorized; none issued or outstanding
Common shares, $0.01 par value, 300,000,000 authorized; 65,251,989 and 65,251,989 issued;
54,369,714 and 54,355,183 outstanding
Additional paid-in capital
Retained earnings
Common shares in treasury at cost, 10,882,275 and 10,896,806
Accumulated other comprehensive loss
Total shareholders’ equity
Total liabilities and shareholders’ equity
See accompanying Notes to Consolidated Financial Statements.
48
September 30,
2021
September 30,
2020
$
479.2
$
150.7
345.7
160.1
1,135.7
362.6
1,162.8
906.4
107.1
364.7
158.8
314.1
146.0
983.6
370.9
1,159.7
928.1
98.6
$
3,674.6
$
3,540.9
$
—
$
26.5
209.5
300.8
536.8
1,234.2
129.0
190.3
2,090.3
—
0.7
1,631.1
865.7
(776.3)
(136.9)
1,584.3
$
3,674.6
$
—
21.1
181.9
307.5
510.5
1,237.9
102.5
257.1
2,108.0
—
0.7
1,631.8
782.4
(790.4)
(191.6)
1,432.9
3,540.9
EDGEWELL PERSONAL CARE COMPANY
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
Cash Flow from Operating Activities
Net earnings (loss)
Adjustments to reconcile net earnings (loss) to net cash flow from operations:
Fiscal Year
2021
2020
2019
$
117.0
$
67.6
$
(372.2)
Depreciation and amortization
Share-based compensation expense
Deferred income taxes
Deferred compensation payments
Loss on sale of assets
Gain on sale of Infant and Pet Care business
Cost of early retirement of long-term debt
Impairment charge
Other, net
Changes in current assets and liabilities from operations, net of effects of acquisitions:
Accounts receivable, net
Inventories
Other current assets
Accounts payable
Other current liabilities
Net cash from operating activities
Cash Flow from Investing Activities
Capital expenditures
Acquisitions, net of cash acquired
Proceeds from sale of Infant Care business
Investment in equity securities
Proceeds from sale of other assets
Collection of deferred purchase price from accounts receivable sold
Other, net
Net cash used by investing activities
87.1
27.3
9.6
(9.3)
0.9
—
26.1
—
(2.8)
3.7
(28.8)
(13.8)
25.4
(13.4)
229.0
(56.8)
(0.3)
7.5
—
—
2.6
(1.7)
(48.7)
88.8
19.2
(2.9)
(8.7)
2.3
(4.1)
26.2
—
1.0
66.3
37.1
3.0
(42.9)
(20.3)
232.6
(47.7)
(233.6)
95.8
(13.8)
—
4.3
(1.4)
(196.4)
93.8
17.8
(59.6)
(7.5)
1.5
—
—
570.0
(5.7)
(1.9)
(35.0)
(14.7)
(15.1)
19.2
190.6
(58.0)
—
—
—
4.1
9.7
(1.3)
(45.5)
49
EDGEWELL PERSONAL CARE COMPANY
CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
(in millions)
Cash Flow from Financing Activities
Cash proceeds from the issuance of Senior Notes due 2029
Cash payments on Senior Notes due 2022
Cash proceeds from the issuance of Senior Notes due 2028
Cash payments on Senior Notes due 2021
Cash proceeds from debt with original maturities greater than 90 days
Cash payments on debt with original maturities greater than 90 days
Term Loan repayment
Net increase in debt with original maturities of 90 days or less
Debt issuance costs for the Revolving Credit Facility
Debt issuance costs for Senior Notes due 2029
Debt issuance costs for Senior Notes due 2028
Cost of early retirement of long-term debt
Dividends paid
Repurchase of shares
Employee shares withheld for taxes
Net financing inflow (outflow) from the Accounts Receivable Facility
Other, net
Net cash used by financing activities
Fiscal Year
2021
2020
2019
500.0
(500.0)
—
—
—
—
—
4.2
—
(6.5)
—
(26.1)
(25.6)
(9.2)
(4.2)
2.4
(0.4)
(65.4)
—
—
750.0
(600.0)
50.0
(167.0)
—
3.0
(3.6)
—
(11.7)
(26.2)
—
—
(2.0)
(11.2)
—
(18.7)
—
—
—
—
434.0
(324.0)
(185.0)
5.8
—
—
—
—
—
—
(3.0)
8.4
—
(63.8)
Effect of exchange rate changes on cash
(0.4)
5.6
(6.1)
Net increase in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest, net
Cash paid for income taxes, net
114.5
364.7
23.1
341.6
$
479.2
$
364.7
$
$
61.0
$
56.1
$
25.4
24.6
75.2
266.4
341.6
60.6
58.0
See accompanying Notes to Consolidated Financial Statements.
50
EDGEWELL PERSONAL CARE COMPANY
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(in millions)
Common Shares
Treasury Shares
Number
Par
Value
Number Amount
Additional
Paid-In
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Total
Shareholders’
Equity
Balance at October 1, 2018
65.2 $
0.7
(11.2) $ (819.2) $ 1,628.3 $ 1,083.1 $
(148.3) $
1,744.6
Net loss
Foreign currency translation
adjustments
—
—
—
—
—
—
—
—
Pension and postretirement activity
—
—
—
—
Deferred loss on hedging activity
Impact of ASU 2016-16 (1)
—
—
—
—
—
—
—
—
—
—
—
—
—
Activity under share plans
—
—
0.2
15.4
(0.6)
(372.2)
—
(372.2)
—
—
—
3.9
—
(36.7)
(49.5)
(1.4)
—
—
(36.7)
(49.5)
(1.4)
3.9
14.8
Balance at September 30, 2019
65.2 $
0.7
(11.0) $ (803.8) $ 1,627.7 $ 714.8 $
(235.9) $
1,303.5
Net earnings
Foreign currency translation
adjustments
—
—
—
—
—
—
—
—
Pension and postretirement activity
—
—
—
—
Deferred loss on hedging activity
—
—
—
—
Activity under share plans
—
—
0.1
13.4
—
—
—
—
4.1
67.6
—
—
—
—
—
29.9
17.7
(3.3)
—
67.6
29.9
17.7
(3.3)
17.5
Balance at September 30, 2020
65.2 $
0.7
(10.9) $ (790.4) $ 1,631.8 $ 782.4 $
(191.6) $
1,432.9
Net earnings
Dividends declared to common
shareholders
Foreign currency translation
adjustments
—
—
—
—
—
—
—
—
—
—
—
—
Pension and postretirement activity
—
—
—
—
Deferred gain on hedging activity
—
—
—
—
Repurchase of shares
—
—
Activity under share plans
—
—
(0.3)
0.3
(9.2)
23.3
—
—
—
—
—
—
(0.7)
117.0
(33.7)
—
—
—
—
—
—
—
5.6
44.8
4.3
—
—
117.0
(33.7)
5.6
44.8
4.3
(9.2)
22.6
Balance at September 30, 2021
65.2 $
0.7
(10.9) $ (776.3) $ 1,631.1 $ 865.7 $
(136.9) $
1,584.3
(1) Cumulative retained earnings adjustment for the adoption of ASU 2016-06, “Income Taxes - Intra-Entity Transfers of Assets Other than Inventory”.
See accompanying Notes to Consolidated Financial Statements.
51
EDGEWELL PERSONAL CARE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in millions, except per share data)
Note 1 - Background and Basis of Presentation
Background
Edgewell Personal Care Company and its subsidiaries (collectively, “Edgewell” or the “Company”), is one of the world’s
largest manufacturers and marketers of personal care products in the wet shave, sun and skin care and feminine care categories.
Edgewell operates in more than 20 countries and has a global footprint in more than 50 countries.
The Company conducts its business in the following three segments:
• Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge, Skintimate®, Shave Guard and
Personna® brands, as well as non-branded products. The Company’s wet shave products include razor handles and
refillable blades, disposable shave products and shaving gels and creams.
•
•
Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Jack Black®, Bulldog® and
Cremo® men’s grooming products, and Wet Ones® products.
Feminine Care includes tampons, pads and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®,
Carefree® and o.b.® brands.
Through December 2019, the Company also conducted business in its All Other segment which included infant care products,
such as bottles, cups and pacifiers, sold under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper
Genie® and Litter Genie® disposal systems. The Company completed the sale of the Infant and Pet Care business in December
2019.
Basis of Presentation
The accompanying Consolidated Financial Statements include the accounts of the Company and its controlled subsidiaries and
have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”), under the
rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of the Consolidated
Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and
expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been
eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair
presentation have been included.
Acquisition of Cremo. On September 2, 2020, the Company completed the acquisition of Cremo Holding Company, LLC
(“Cremo”), a men’s skincare products company based in the U.S. The results of Cremo for the post-acquisition period are
included within the Company’s results since the acquisition date for the fiscal year ended September 30, 2021 and 2020. For
more information on the acquisition, see Note 3 of Notes to Consolidated Financial Statements.
Sale of Infant and Pet Care assets. On December 17, 2019, the Company completed the sale of its Infant and Pet Care business
which was included in the All Other segment through the date of the sale. The All Other segment will have no further operating
results after the first quarter of fiscal 2020. Operations for the Company’s manicure kits were reclassified to the Sun and Skin
Care segment for all periods presented as these products were not part of the divestiture. The impact of recasting the prior
period segment information was not material. For more information on the sale of the Infant and Pet Care business, see Note 3
of Notes to Consolidated Financial Statements.
52
Note 2 - Summary of Significant Accounting Policies
Foreign Currency Translation
Financial statements of foreign operations where the local currency is the functional currency are translated using end-of-period
exchange rates for assets and liabilities, and average exchange rates during the period for results of operations. Related
translation adjustments are reported as a component within accumulated other comprehensive income in the shareholders’
equity section of the Consolidated Balance Sheets, except as noted below.
Gains and losses resulting from foreign currency transactions are included in Net earnings (loss). Foreign currency losses of
$0.5, $10.5 and $3.9 during fiscal 2021, 2020 and 2019, respectively, were included within Other (income) expense, net. The
Company uses foreign exchange (“FX”) instruments to reduce the risk of FX transactions as described below and in Note 16 of
Notes to Consolidated Financial Statements.
Financial Instruments and Derivative Securities
The Company uses financial instruments, from time to time, in the management of foreign currency, interest rate, and other
risks that are inherent to its business operations. Such instruments are not held or issued for trading purposes.
FX instruments, including forward currency contracts, are used primarily to reduce cash transaction exposures and, to a lesser
extent, to manage other translation exposures. FX instruments are selected based on their risk reduction attributes, costs, and
related market conditions. The Company has designated certain foreign currency contracts as cash flow hedges for accounting
purposes as of September 30, 2021.
At September 30, 2021, the Company had $26.5 of variable rate debt outstanding. In the past the Company has used interest
rate swaps to hedge the risk of variable rate debt. As of September 30, 2021, the Company did not have any outstanding interest
rate swap agreements.
For further discussion, see Note 11 and Note 16 of Notes to Consolidated Financial Statements.
Cash Equivalents
Cash equivalents are considered to be highly liquid investments with a maturity of three months or less when purchased. At
September 30, 2021, the Company had $479.2 in available cash and cash equivalents, a portion of which was outside of the
U.S. The Company has extensive operations outside of the U.S., including a significant manufacturing footprint. The Company
manages its worldwide cash requirements by reviewing available funds among the many subsidiaries through which it conducts
its business and the cost effectiveness with which those funds can be accessed. The repatriation of cash balances from certain of
the Company’s subsidiaries could have adverse tax consequences or be subject to regulatory capital requirements; however,
those balances are generally available without legal restrictions to fund ordinary business operations.
Cash Flow Presentation
The Consolidated Statements of Cash Flows are prepared using the indirect method, which reconciles Net earnings (loss) to Net
cash from operating activities. The reconciliation adjustments include the removal of timing differences between the occurrence
of operating receipts and payments and their recognition in Net earnings (loss). The adjustments also remove cash flows arising
from investing and financing activities, which are presented separately from operating activities. Cash flows from foreign
currency transactions and operations are translated at an average exchange rate for the period. Cash flows from hedging
activities are included in the same category as the items being hedged, which is primarily operating activities. Cash payments
related to income taxes are classified as operating activities.
Trade Receivables
Trade receivables are stated at their net realizable value. The allowance for doubtful accounts reflects the Company’s best
estimate of probable losses inherent in the trade receivables portfolio determined on the basis of historical experience, specific
allowances for known troubled accounts and other currently available information. Bad debt expense is included in Selling,
general and administrative expense (“SG&A”). The Company began an accounts receivable factoring program in September
2017. For further discussion, see Note 10 of Notes to Consolidated Financial Statements.
53
Inventories
Inventories are valued at the lower of cost or net realizable value, with cost generally determined using average cost or the first-
in, first-out (“FIFO”) method.
Capitalized Software Costs
Capitalized software costs are included in Property, plant and equipment, net. These costs are amortized using the straight-line
method over periods of related benefit ranging from three to seven years. Expenditures related to capitalized software are
included within Capital expenditures in the Consolidated Statements of Cash Flows. Amortization expense associated with
capitalized software was $4.5, $5.2, and $4.3 in fiscal 2021, 2020 and 2019, respectively.
Property, Plant and Equipment, net
Property, plant and equipment, net (“PP&E”) is stated at historical cost. PP&E acquired as part of a business combination is
recorded at estimated fair value. Expenditures for new facilities and expenditures that substantially increase the useful life of
property, including interest during construction, are capitalized and reported as Capital expenditures in the accompanying
Consolidated Statements of Cash Flows. Maintenance, repairs and minor renewals are expensed as incurred. When property is
retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts and gains or
losses on the disposition are reflected in Net earnings (loss). Depreciation is generally provided on the straight-line basis by
charges to earnings at rates based on estimated useful lives. Estimated useful lives range from two to 10 years for machinery
and equipment and three to 30 years for buildings and building improvements. Depreciation expense was $60.6, $66.3 and
$69.9 in fiscal 2021, 2020 and 2019, respectively. Fiscal 2019 depreciation expense includes accelerated depreciation charges
of $1.9 related to restructuring activities. See Note 4 of Notes to Consolidated Financial Statements for further information on
restructuring charges.
Estimated useful lives are periodically reviewed and, when appropriate, changes are made and accounted for prospectively.
When certain events or changes in operating conditions occur, asset lives may be adjusted and an impairment assessment may
be performed on the recoverability of the carrying amounts.
Goodwill and Other Intangible Assets
Goodwill and indefinite-lived intangibles are not amortized but are instead evaluated annually for impairment as part of the
Company’s annual business planning cycle in the fourth fiscal quarter, or when indicators of a potential impairment are present.
The annual test for impairment performed for goodwill can be qualitative or quantitative, taking into consideration certain
factors surrounding the fair value of the goodwill including, level by which fair value exceeded carrying value in the prior
valuation, as well as macroeconomic factors, industry conditions and actual results at the test date. The quantitative analysis to
test for impairment will estimate the fair value of each reporting unit (Wet Shave, Sun Care, Skin Care and Feminine Care)
using valuation models that incorporate assumptions and projections of expected future cash flows and operating plans. In
determining the estimated fair value of the reporting units when performing a quantitative analysis, both the market approach
and the income approach are considered in the valuation, and where appropriate, both methods will be used and weighted,
unless appropriate market comparables are not available for a reporting unit.
Determining the fair value of a reporting unit requires the use of significant judgment, estimates, and assumptions. While the
Company believes that the estimates and assumptions underlying the valuation methodology are reasonable, these estimates and
assumptions could have a significant impact on whether an impairment charge is recognized and the magnitude of any such
charge. The results of an impairment analysis are as of a point in time. There is no assurance that actual future earnings or cash
flows of the reporting units will not vary significantly from these projections. The Company will monitor any changes to these
assumptions and will evaluate the carrying value of goodwill as warranted during future periods.
The key assumptions and estimates for the market and income approaches used to determine fair value of the reporting units
included market data and market multiples, discount rates and terminal growth rates, as well as future levels of revenue growth,
and operating margins, based upon the Company’s strategic plan.
54
The Company evaluates indefinite-lived intangible assets, which consist of trademarks and brand names used across the
Company’s segments for impairment on an annual basis. Similar to goodwill, the impairment test can be qualitative or
quantitative, taking into consideration certain factors surrounding the fair value of the brand names including, level by which
fair value exceeded carrying value in the prior valuation, as well as macroeconomic factors, industry conditions and actual
results at the test date. The quantitative test will determine the fair value using one of two income approaches: (i) the multi-
period excess earnings method and (ii) the relief-from-royalty method, both of which require significant assumptions, including
estimates regarding future revenue and operating margin growth, discount rates, and appropriate royalty rates. Revenue and
operating margin growth assumptions are based on historical trends and management’s expectations for future growth by brand.
The discount rates were based on a weighted-average cost of capital utilizing industry market data of similar companies and
estimated returns on the assets utilized in the operations of the applicable reporting unit, including net working capital, fixed
assets and intangible assets. The Company estimated royalty rates based on operating profits of the brand.
Intangible assets with finite lives, and a remaining weighted-average life of approximately seven years, are amortized on a
straight-line basis over expected lives of five to 20 years. Such intangibles are also evaluated for impairment including ongoing
monitoring of potential impairment indicators.
Refer to Note 7 of Notes to Consolidated Financial Statements for further discussion on goodwill and other intangible assets.
Impairment of Long-Lived Assets
The Company reviews long-lived assets, other than goodwill and other intangible assets, for impairment when events or
changes in business circumstances indicate that the remaining useful life may warrant revision or that the carrying amount of
the long-lived asset may not be fully recoverable. The Company performs an undiscounted cash flow analysis to determine if
impairment exists for an asset or asset group. If impairment is determined to exist, any related impairment loss is calculated
based on estimated fair value. Impairment losses on assets to be disposed of, if any, are based on the estimated proceeds to be
received, less cost of disposal.
Revenue Recognition
Principal Revenue Streams and Significant Judgments
Our principal revenue streams can be divided into: (i) sale of personal care products primarily through retailers in North
America; (ii) sale of personal care products through a combination of retailers and distributors internationally; and (iii)
production and sale of private brands products in North America and internationally that are made to customer specifications.
Performance Obligations
The Company’s revenue is generated from the sale of its products. Revenue is recognized when the customer obtains control of
the goods, which occurs when the ability to use and obtain benefits from the goods are passed to the customer, most commonly
upon the delivery of goods to the customer. Discounts are offered to customers for early payment and an estimate of discounts
is recorded as a reduction of Net sales in the same period as the sale. The Company’s standard sales terms are final and returns
or exchanges are not permitted with the exception of end of season returns for Sun Care products. Reserves are established and
recorded in cases where the right of return exists for a particular sale.
The Company assesses the goods promised in its customers’ purchase orders and identifies a performance obligation to transfer
goods (or a bundle of goods) that is distinct. To identify the performance obligations, the Company considers all the goods
promised, whether explicitly stated or implied based on customary business practices. The Company’s purchase orders are short
term in nature, lasting less than one year and contain a single delivery element. For a purchase order that has more than one
performance obligation, the Company allocates the total consideration to each distinct performance obligation on a relative
stand-alone selling price basis. The Company does not exclude variable consideration in determining the remaining value of
performance obligations.
Significant Judgments
The Company records sales at the time that control of goods pass to the customer. The terms of these sales vary but the
following conditions are applicable to all sales: (i) the sales arrangement is evidenced by purchase orders submitted by
customers; (ii) the selling price is fixed or determinable; (iii) title to the product has transferred; (iv) there is an obligation to
pay at a specified date without any additional conditions or actions required by the Company; and (v) collectability is
reasonably assured. Simultaneously with the sale, the Company reduces Net sales and Cost of products sold and reserves
amounts on its Consolidated Balance Sheet for anticipated returns based upon an estimated return level in accordance with
GAAP. The Company also allows for returns of other products under limited circumstances. Customers are required to pay for
55
the Sun Care product purchased during the season under the required terms. Under certain circumstances, the Company allows
customers to return Sun Care products that have not been sold by the end of the Sun Care season, which is normal practice in
the Sun Care industry. The timing of returns of Sun Care products can vary in different regions based on climate and other
factors. However, the majority of returns occur in the U.S. from September through January following the summer Sun Care
season. The Company estimates the level of Sun Care returns as the Sun Care season progresses using a variety of inputs
including historical experience, consumption trends during the Sun Care season, obsolescence factors including expiration dates
and inventory positions at key retailers. The Company monitors shipment activity and inventory levels at key retailers during
the season in an effort to more accurately estimate potential returns. This allows the Company to manage shipment activity to
its customers, especially in the latter stages of the Sun Care season, to reduce the potential for returned product. The Company
also allows for returns of other products under limited circumstances. Non-Sun Care returns are evaluated each period based on
communications with customers and other issues known as of period end. The Company had a reserve for returns of $52.7
and $44.8 at September 30, 2021 and September 30, 2020, respectively. The adoption of ASU 2014-09, which updated the
guidance related to accounting for revenue from contracts with customers, required changes in the presentation of returns on the
Consolidated Balance Sheet, namely that a return asset should be recognized for returns expected to be resold, measured at the
carrying amount of goods at the time of sale, less the expected costs to recover the goods and any expected reduction in value.
In addition, the Company offers a variety of programs, such as consumer coupons and rebate programs, primarily to its retail
customers, designed to promote sales of its products. Such programs require periodic payments and allowances based on
estimated results of specific programs and are recorded as a reduction to Net sales. The Company accrues, at the time of sale,
the estimated total payments and allowances associated with each transaction. Additionally, the Company offers programs
directly to consumers to promote the sale of its products. Promotions which reduce the ultimate consumer sale price are
recorded as a reduction of Net sales at the time the promotional offer is made using estimated redemption and participation
levels. Taxes the Company collects on behalf of governmental authorities, which are generally included in the price to the
customer, are also recorded as a reduction of Net sales. The Company continually assesses the adequacy of accruals for
customer and consumer promotional program costs not yet paid. To the extent total program payments differ from estimates,
adjustments may be necessary. Historically, these adjustments have not been material.
Contract Balances
The timing of revenue recognition is based on completion of performance obligations through the transfer of goods. Standard
payment terms with customers require payment after goods have been delivered and risk of ownership has transferred to the
customer. The Company has contract liabilities as a result of advanced payments received from certain customers before goods
have been delivered and all performance obligations have been completed. Contract liabilities were $0.6 and $1.4 at September
30, 2021 and September 30, 2020, respectively, and were classified within Other current liabilities on our Consolidated Balance
Sheets. Substantially all of the amount deferred will be recognized within a year, with the significant majority to be captured
within a quarter following deferral.
Trade receivables are stated at their net realizable value. The allowance for doubtful accounts reflects the Company’s best
estimate of probable losses inherent in its receivables portfolio determined by historical experience, specific allowances for
known troubled accounts, and other currently available information.
Advertising and Sales Promotion Costs
The Company advertises and promotes its products through national and regional media and expenses such activities as
incurred. Advertising and sales promotion expense reported on the Consolidated Statements of Earnings and Comprehensive
Income (Loss) includes advertising costs of $142.3, $121.2 and $137.9 for fiscal 2021, 2020 and 2019, respectively.
Share-Based Payments
The Company grants restricted share equivalents (“RSE”), which generally vest over two to four years. The estimated fair value
of each grant is estimated on the date of grant based on the current market price of the Company’s common shares. The original
estimate of the grant date fair value is not subsequently revised unless the awards are modified. The Company has elected to
recognize forfeiture of awards as they occur. A portion of the RSE awards provide for the issuance of common stock to certain
managerial staff and executive management if the Company achieves specified performance targets. The total amount of
compensation expense recognized reflects the initial assumption that target performance goals will be achieved. Compensation
expense may be adjusted during the life of the performance grant based on management’s assessment of the probability that
performance targets will be achieved. If such targets are not met or it is determined that achievement of performance goals is
not probable, compensation expense is adjusted to reflect the reduced expected payout level in the period the determination is
made. If it is determined that the performance targets will be exceeded, additional compensation expense is recognized.
56
Non-qualified stock options (“Share Options”) are granted at the market price on the grant date and generally vest ratably over
three years. The Company calculates the fair value of total share-based compensation for Share Options using the Black-
Scholes option pricing model, which utilizes certain assumptions and estimates that have a material impact on the amount of
total compensation cost recognized in the Consolidated Financial Statements, including the expected term, expected share price
volatility, risk-free interest rate and expected dividends. The original estimate of the grant date fair value is not subsequently
revised unless the awards are modified. The Company has elected to recognize forfeiture of awards as they occur.
Income Taxes
The Company’s annual effective income tax rate is determined based on its pre-tax income (loss), statutory tax rates and the tax
impacts of items treated differently for tax purposes than for financial reporting purposes. Tax law requires that certain items be
included in its federal tax return at different times than the items are reflected in the financial statements. Some of these
differences are permanent, such as expenses that are not deductible in the Company’s tax return, and some differences are
temporary, reversing over time, such as depreciation expense. These temporary differences create deferred tax assets and
liabilities.
Deferred tax assets generally represent the tax effect of items that can be used as a tax deduction or credit in future years for
which the Company has already recorded the tax benefit in the Consolidated Statement of Earnings. Deferred tax liabilities
generally represent tax expense recognized in the Company’s financial statements for which payment has been deferred, the tax
effect of expenditures for which a deduction has already been taken in its tax return but has not yet been recognized in its
financial statements or assets recorded at estimated fair value in business combinations for which there was no corresponding
tax basis adjustment.
The Company estimates income taxes and the effective income tax rate in each jurisdiction that it operates. This involves
estimating taxable earnings, specific taxable and deductible items, the likelihood of generating sufficient future taxable income
to utilize deferred tax assets, the portion of the income of foreign subsidiaries that is expected to be remitted to the U.S. and be
taxable and possible exposures related to future tax audits. Deferred tax assets are evaluated on a subsidiary by subsidiary basis
to ensure that the asset will be realized. Valuation allowances are established when the realization is not deemed to be more
likely than not. Future performance is monitored, and when objectively measurable operating trends change, adjustments are
made to the valuation allowances accordingly. To the extent the estimates described above change, adjustments to income taxes
are made in the period in which the estimate is changed.
The Company operates in multiple jurisdictions with complex tax and regulatory environments, which are subject to differing
interpretations by the taxpayer and the taxing authorities. At times, the Company may take positions that management believes
are supportable but are potentially subject to successful challenges by the appropriate taxing authority. The Company evaluates
its tax positions and establishes liabilities in accordance with guidance governing accounting for uncertainty in income taxes.
The Company reviews these tax uncertainties in light of changing facts and circumstances, such as the progress of tax audits,
and adjusts them accordingly.
Estimated Fair Values of Financial Instruments
Certain financial instruments are required to be recorded at estimated fair value. Changes in assumptions or estimation methods
could affect the fair value estimates; however, the Company does not believe any such changes would have a material impact
on its financial condition, results of operations or cash flows. Other financial instruments including cash and cash equivalents
and short-term borrowings, including notes payable, are recorded at cost, which approximates estimated fair value. The
estimated fair values of long-term debt and financial instruments are disclosed in Note 16 of Notes to Consolidated Financial
Statements.
Recently Adopted Accounting Pronouncements
In June 2016, the Financial Accounting Standards Board (the “FASB”) issued ASU 2016-13 intended to improve financial
reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions
and other organizations. The new guidance applies to all financial instruments, including trade receivables, and requires the
measurement of all expected credit losses for financial assets held at a reporting date to be based on historical experience,
current conditions and reasonable and supportable forecasts. Previous guidance did not include forward-looking information.
The Company adopted the standard effective as of October 1, 2020. The Company evaluates the creditworthiness of customers
when negotiating contracts and, as trade receivables are short term in nature, the timing between recognition of a credit loss
under existing guidance and the new guidance was not materially different for the Company.
57
In August 2018, the FASB issued ASU 2018-13, which adjusts disclosure requirements for fair value measurements. The
guidance updates the disclosure requirements regarding leveling of fair value assets and the valuation of Level 3 fair value
measurements. The update was effective for the Company beginning October 1, 2020 and early adoption was permitted. The
Company believes that the standard did not result in material changes to its required disclosures.
In August 2018, the FASB issued ASU 2018-14, which modifies disclosure requirements for defined benefit pension plans and
other post retirement plans. The guidance removes disclosures that are no longer considered cost beneficial, clarifies the
specific requirements of disclosures, and adds disclosure requirements identified as relevant. The new standard was effective
for the Company beginning October 1, 2020 and early adoption was permitted. The Company believes that the standard did not
result in material changes to its required disclosures.
In August 2018, the FASB issued ASU 2018-15, which aligns the requirements for capitalizing implementation costs incurred
in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to
develop or obtain internal-use software. The amendments in this standard require an entity that is the customer in a hosting
arrangement to follow the guidance on internal-use software to determine which implementation costs to capitalize and which
costs to expense. The standard also requires a customer to expense the capitalized implementation costs of a hosting
arrangement over the term of the hosting arrangement. The new guidance requires an entity to present the expense related to the
capitalized implementation costs in the same line item in the statement of income as the fees associated with the hosting
element of the arrangement and classify payments for capitalized implementation costs in the statement of cash flows in the
same manner as payments made for fees associated with the hosting element. The entity is also required to present the
capitalized implementation costs in the statement of financial position in the same line item that a prepayment for the fees of the
associated hosting arrangement would be presented. The Company adopted the standard effective as of October 1, 2020 on a
prospective basis. The Company notes the guidance has not had a material impact on its financial statements through fiscal
2021.
Recently Issued Accounting Pronouncements
In December 2019, the FASB issued ASU 2019-12, which eliminates certain exceptions related to the approach for intra-period
tax allocation, the methodology for calculating income taxes in an interim period when interim loss exceeds anticipated loss for
the year, and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity
method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for franchise taxes and enacted
changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The
Company adopted this standard as of October 1, 2021. There was no cumulative effect adjustment recorded to retained earnings
as the amount was not material. The effects of this standard on our financial position, results of operations and cash flows were
not material.
58
Note 3 - Business Combinations and Divestitures
Cremo Holding Company, LLC
On September 2, 2020, the Company completed the acquisition (“Acquisition”) of Cremo Holding Company, LLC (“Cremo”).
The Company accounted for the Acquisition utilizing the acquisition method of accounting, which requires assets and liabilities
to be recognized based on estimates of their acquisition date fair values. The determination of the values of the acquired assets
and assumed liabilities, including goodwill and other intangible assets, requires significant judgment. We have calculated fair
values of the assets and liabilities acquired from Cremo including goodwill and intangible assets and working capital. The
Company completed the final fair value determination of the Acquisition in the first quarter of fiscal year 2021.
The Company used variations of the income approach in determining the fair value of intangible assets acquired in the
Acquisition. Specifically, we utilized the multi-period excess earnings method to determine the fair value of the definite lived
customer relationships acquired and the relief from royalty method to determine the fair value of the definite lived trade name
and proprietary technology acquired. Our determination of the fair value of the intangible assets acquired involved the use of
significant estimates and assumptions related to revenue growth rates, discount rates, customer attrition rates, and royalty rates.
The Company believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable
assumptions and estimates that marketplace participants would use.
The Company’s purchase price allocation included net assets of $234.6 and consisted of working capital and other net assets of
$11.5 (including cash of $0.7), other intangible assets of $95.1, and goodwill of $128.0, representing the value of expansion
into new markets and channels of trade. The acquired goodwill is deductible for tax purposes. The intangible assets acquired
consisted primarily of the Cremo trade name, customer relationships, and product formulations with a weighted-average useful
life of 17 years. All assets are included in the Company’s Sun and Skin Care segment.
The Company noted that the net sales and net earnings of Cremo from the beginning of fiscal 2020 through the date of the
closing of the Acquisition were not material relative to the total net sales and net earnings of the Company during fiscal 2020,
and thus pro-forma results for Cremo were not disclosed in accordance with Accounting Standards Codification 805.
Acquisition and integration costs related to Cremo totaling $7.1 and $7.0 for the year ended September 30, 2021 and 2020,
respectively, were included in SG&A on the Consolidated Statement of Earnings and Comprehensive Income. Additionally,
acquisition costs of $1.3 and $0.6 were included in Cost of products sold for the year ended September 30, 2021 and 2020,
respectively.
Sale of Infant and Pet Care Business
On December 17, 2019, the Company completed the sale of its Infant and Pet Care business included in the All Other segment
for $122.5, which included consideration for providing services to the purchaser for up to one year under a transition services
agreement. The Company received proceeds of $115.0, which includes consideration for providing support under the transition
services agreement, with the remaining sales price receivable of $5.0 reported in current assets as of September 30, 2021. Total
assets included in the sale were comprised of $18.8 of inventory, $3.6 of property, plant and equipment, and $77.8 of goodwill
and intangible assets. The sale of the Infant and Pet Care business resulted in a gain of $4.1 in the Company’s 2020
Consolidated Statement of Earnings. The gain on the sale was net of expenses incurred to facilitate the closing of the transaction
and in support of the transition services agreement.
Note 4 - Restructuring Charges
Project Fuel
The Company does not include Project Fuel restructuring costs in the results of its reportable segments. However, the estimated
impact of allocating such charges to segment results for fiscal 2021, 2020, and 2019 would have been as follows:
Wet
Shave
Sun and
Skin Care
Feminine
Care
All Other
Corporate
Total
Fiscal 2021
Project Fuel
Severance and related benefit costs
Asset impairment and accelerated
depreciation
Consulting, project implementation and
management and other exit costs
Total Restructuring
$
$
1.5
$
0.1
$
—
$
—
$
7.8
$
1.1
2.7
5.3
$
—
0.2
0.3
$
—
0.3
0.3
$
—
—
—
—
$
16.4
$
24.2
$
59
9.4
1.1
19.6
30.1
Project Fuel
Severance and related benefit costs
Asset impairment and accelerated
depreciation
Consulting, project implementation and
management and other exit costs
Total Restructuring
$
11.4
$
Project Fuel
Severance and related benefit costs
Asset impairment and accelerated
depreciation
Consulting, project implementation and
management and other exit costs
Wet
Shave
Sun and
Skin Care
Feminine
Care
All Other
Corporate
Total
Fiscal 2020
$
0.2
$
0.3
$
—
$
—
$
7.6
$
1.7
9.5
—
0.8
1.1
$
—
0.4
0.4
$
Fiscal 2019
—
—
—
—
$
17.6
$
25.2
$
Wet
Shave
Sun and
Skin Care
Feminine
Care
All Other
Corporate
Total
$
12.3
$
2.2
$
1.2
$
0.5
$
7.3
$
23.5
3.1
4.8
—
—
—
—
—
—
1.1
$
23.1
8.1
1.7
28.3
38.1
4.2
27.9
55.6
Total Restructuring
$
20.2
$
2.2
$
1.2
$
0.5
$
31.5
$
Consulting, project implementation and management and other exit costs include pre-tax SG&A associated with certain
information technology enablement expenses and compensation expenses related to Project Fuel of $8.7, $13.3, and $8.6 for
fiscal 2021, 2020, and 2019, respectively. Asset impairment and accelerated depreciation includes pre-tax Cost of products sold
associated with inventory obsolescence related to Project Fuel of $0.6 and $0.2 for fiscal 2021 and 2020, respectively. Project-
to-date restructuring costs inclusive of information technology enablement charges and inventory obsolescence totaled $163.7.
Restructuring Reserves
The following table summarizes Project Fuel activities and related accruals:
Restructuring
Severance and termination related costs
Asset impairment and accelerated
depreciation
Other related costs
Total Restructuring
October 1,
2020
Charge to
Income
Other (1)
Cash
Non-Cash
September 30,
2021
Utilized
$
4.3
$
9.4
$
—
$
(11.8) $
—
$
—
1.1
5.4
$
1.1
19.6
$
30.1
$
—
—
—
—
(17.1)
(1.1)
—
$
(28.9) $
(1.1) $
1.9
—
3.6
5.5
October 1,
2019
Charge to
Income
Other (1)
Cash
Non-Cash
September 30,
2020
Utilized
Restructuring
Severance and termination related costs
Asset impairment and accelerated
depreciation
Other related costs
Total Restructuring
$
8.2
$
8.1
$
0.1
$
(12.1) $
—
$
—
1.3
9.5
$
1.7
28.3
—
—
—
(28.5)
(1.7)
—
$
38.1
$
0.1
$
(40.6) $
(1.7) $
4.3
—
1.1
5.4
(1)
Includes the impact of currency translation.
60
On September 29, 2021 the Company announced changes within the commercial organization to position itself to better enable
growth, increase agility and innovation, execute a more consumer-centric strategy, and improve manufacturing and supply
chain efficiency. For fiscal 2022, the Company expects to incur one-time charges of approximately $17 associated with these
initiatives.
Note 5 - Income Taxes
The provisions for income taxes from continuing operations consisted of the following:
Fiscal Year
2021
2020
2019
Currently payable:
United States - Federal
State
Foreign
Total current
Deferred:
United States - Federal
State
Foreign
Total deferred
$
(3.1) $
(0.1)
22.6
19.4
7.9
0.3
1.4
9.6
$
1.2
2.3
19.1
22.6
(2.8)
0.5
(0.6)
(2.9)
Income tax provision (benefit)
$
29.0
$
19.7
$
16.1
4.1
21.7
41.9
(52.4)
(7.0)
(0.6)
(60.0)
(18.1)
The source of pre-tax earnings (loss) was:
United States
Foreign
Pre-tax earnings (loss)
Fiscal Year
2021
2020
2019
$
$
(11.5) $
(27.4) $
(415.6)
157.5
114.7
25.3
146.0
$
87.3
$
(390.3)
A reconciliation of income taxes with the amounts computed at the statutory federal income tax rate follows:
Computed tax at federal statutory rate
$
State income taxes, net of federal tax benefit
Foreign tax less than the federal rate
Adjustments to prior years’ tax accruals
Other taxes including repatriation of foreign
earnings
Impairment
Sale of Infant and Pet Care business
2021
30.7
0.8
(9.0)
(4.3)
8.9
—
—
Fiscal Year
2020
21.0 % $
0.6
(6.2)
(2.9)
6.1
—
—
18.3
1.0
(5.6)
(0.5)
8.2
—
1.6
21.0 % $
1.1
(6.4)
(0.5)
9.4
—
1.8
Uncertain tax positions
(0.8)
(0.6)
(4.4)
(5.1)
2019
(81.9)
(13.5)
15.8
(1.5)
7.9
46.8
—
(0.5)
3.6
5.2
21.0 %
3.5
(4.1)
0.4
(2.0)
(12.0)
—
0.1
(1.0)
(1.3)
Tax reform
Other, net
Total
—
2.7
—
1.8
—
1.1
—
1.3
$
29.0
19.8 % $
19.7
22.6 % $
(18.1)
4.6 %
61
The deferred tax assets and deferred tax liabilities recorded on the balance sheet were as follows, and include current and
noncurrent amounts:
Deferred tax liabilities:
Depreciation and property differences
Intangible assets
Lease liabilities
Other tax liabilities
Gross deferred tax liabilities
Deferred tax assets:
Accrued liabilities
Deferred and share-based compensation
Tax loss carryforwards and tax credits
Postretirement benefits other than pensions
Pension plans
Inventory differences
Lease right of use assets
Other tax assets
Gross deferred tax assets
Valuation allowance
Net deferred tax liabilities
September 30,
2021
2020
$
(26.6) $
(192.5)
(14.9)
(9.4)
(243.4)
52.8
15.4
8.2
1.5
40.2
3.2
15.0
8.5
144.8
(9.4)
$
(108.0) $
(28.4)
(180.1)
(11.4)
(8.6)
(228.5)
47.2
16.1
11.6
1.6
53.1
5.0
11.4
11.7
157.7
(8.5)
(79.3)
There were no material tax loss carryforwards that expired in fiscal 2021. Future expirations of tax loss carryforwards and tax
credits, if not utilized, are not expected to be material from 2022 through 2024. The valuation allowance is primarily
attributable to tax loss carryforwards and certain deferred tax assets impacted by the deconsolidation of the Company’s
Venezuelan subsidiaries.
The Company generally repatriates a portion of current year earnings from select non-US subsidiaries only if the economic cost
of the repatriation is not considered material. No provision is made for additional taxes on undistributed earnings of foreign
affiliates that are intended and planned to be indefinitely invested in the affiliate. The Company intends to, and has plans to,
reinvest these earnings indefinitely in its foreign subsidiaries to, amongst other things, fund local operations, fund pension and
other post-retirement obligations, fund capital projects and to support foreign growth initiatives including potential acquisitions.
As of September 30, 2021, approximately $840.3 of foreign subsidiary earnings were considered indefinitely invested in those
businesses. If the Company repatriated any of the earnings it could be subject to withholding tax and the impact of foreign
currency movements. Accordingly, it is not practical to calculate a specific potential tax exposure. Applicable income and
withholding taxes will be provided on these earnings in the periods in which they are no longer considered reinvested.
Unrecognized tax benefits activity is summarized below:
Unrecognized tax benefits, beginning of year
Additions based on current year tax positions and acquisitions
Reductions for prior year tax positions and dispositions
Settlements with taxing authorities and statute expirations
2021
2020
2019
$
21.8
$
25.5
$
1.7
—
(2.5)
1.8
(1.7)
(3.8)
Unrecognized tax benefits, end of year
$
21.0
$
21.8
$
20.7
9.4
(0.4)
(4.2)
25.5
Included in the unrecognized tax benefits noted above was $19.7 of uncertain tax positions that would affect the Company’s
effective tax rate, if recognized. The Company does not expect any significant increases or decreases to its unrecognized tax
benefits within 12 months of this reporting date. In the Consolidated Balance Sheets, unrecognized tax benefits are classified as
Other liabilities (non-current) to the extent that payments are not anticipated within one year.
The Company classifies accrued interest and penalties related to unrecognized tax benefits in the income tax provision. The
accrued interest and penalties are not included in the table above. The Company accrued approximately $4.3 of interest, (net of
62
the deferred tax asset of $0.7) at September 30, 2021, and $4.1 of interest, (net of the deferred tax asset of $0.6) at
September 30, 2020. Interest was computed on the difference between the tax position recognized in accordance with GAAP
and the amount previously taken or expected to be taken in the Company’s tax returns.
The Company files income tax returns in the U.S. federal jurisdiction, various cities and states, and more than 30 foreign
jurisdictions where the Company has operations. U.S. federal income tax returns for tax years ended September 30, 2018 and
after remain subject to examination by the Internal Revenue Service (the “IRS”). With few exceptions, the Company is no
longer subject to state and local income tax examinations for years before September 30, 2012. The status of international
income tax examinations varies by jurisdiction. At this time, the Company does not anticipate any material adjustments to its
financial statements resulting from tax examinations currently in progress.
U.S. Tax Reform
On December 22, 2017, the U.S. government enacted the Tax Act. This new comprehensive tax legislation reduces the U.S.
federal corporate tax rate from 35% to 21% but also limits and/or eliminates certain deductions while creating new taxes on
certain foreign sourced earnings. For fiscal 2019, the discrete tax adjustment for the one-time transition tax on foreign earnings
was $3.6.
The significant provisions of the Tax Act which impacted the Company beginning in fiscal 2019 include the full U.S. federal
statutory rate reduction to 21%, the repeal of the domestic production activities deduction, tax on global intangible low-taxed
income (“GILTI”), base erosion and anti-avoidance tax (“BEAT”), limitation of deductibility of certain executive
compensation, limitation on business interest, and a deduction for foreign derived intangible income (“FDII”). The Company
recorded tax liabilities/(benefits) for the various provisions during fiscal 2019.
The Tax Act subjects a U.S. corporation to tax on its GILTI. U.S. GAAP allows companies to make an accounting policy
election of either (i) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense
when incurred (the “period cost method”) or (ii) factoring such amounts into the Company’s measurement of deferred taxes (the
“deferred method”). The Company has made an accounting policy election to treat GILTI taxes as a current period expense.
Note 6 - Earnings (Loss) per Share
Basic earnings (loss) per share is based on the average number of common shares outstanding during the period. Diluted
earnings (loss) per share is based on the average number of shares used for the basic earnings per share calculation, adjusted for
the dilutive effect of share options and RSE awards.
The following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings (loss)
per share calculation:
Basic weighted-average shares outstanding
Effect of dilutive securities:
RSE awards
Total dilutive securities
Diluted weighted-average shares outstanding
Fiscal Year
2021
2020
2019
54.4
0.8
0.8
55.2
54.3
0.3
0.3
54.6
54.1
—
—
54.1
For fiscal 2021, 2020 and 2019, the calculation of diluted weighted-average shares outstanding excludes 0.9, 0.7 and 0.5,
respectively, of share options because the effect of including these awards was anti-dilutive. For fiscal 2020, the calculation of
diluted weighted-average shares outstanding excludes 0.1 of RSE awards because the effect of including these awards was anti-
dilutive. For fiscal 2019, the calculation of diluted weighted-average shares outstanding excludes 0.1 of RSE awards that would
have otherwise been dilutive, because the Company reported a net loss.
63
Note 7 - Goodwill and Intangible Assets
The following table sets forth goodwill by segment:
Gross balance at October 1, 2020
Accumulated goodwill impairment
Net balance at October 1, 2020
Changes in the twelve months ended September 30, 2021
Cremo acquisition measurement period adjustment
Cumulative translation adjustment
Gross balance at September 30, 2021
Accumulated goodwill impairment
Net balance at September 30, 2021
$
$
$
$
$
Wet
Shave
Sun and Skin
Care
Feminine
Care
Total
967.2
$
356.8
$
206.7
$
1,530.7
(369.0)
(2.0)
—
(371.0)
598.2
$
354.8
$
206.7
$
1,159.7
—
$
0.3
$
0.3
0.5
—
2.0
$
$
0.3
2.8
967.5
$
357.6
$
208.7
$
1,533.8
(369.0)
(2.0)
—
(371.0)
598.5
$
355.6
$
208.7
$
1,162.8
Gross balance at October 1, 2019
Accumulated goodwill impairment
Net balance at October 1, 2019
Changes in the twelve months ended September
30, 2020
Acquisition of Cremo
Infant and Pet Care divestiture
Cumulative translation adjustment
Gross balance at September 30, 2020
Accumulated goodwill impairment
Net balance at September 30, 2020
$
$
$
$
Total amortizable intangible assets were as follows:
Wet
Shave
Sun and Skin
Care
Feminine
Care
All
Other
Total
960.3
$
228.3
$
207.0
$
69.6
$
1,465.2
(369.0)
(2.0)
—
(61.4)
(432.4)
591.3
$
226.3
$
207.0
$
8.2
$
1,032.8
—
—
6.9
127.7
—
0.8
—
—
(0.3)
—
(8.2)
—
127.7
(8.2)
7.4
967.2
$
356.8
$
206.7
$
61.4
$
1,592.1
(369.0)
(2.0)
—
(61.4)
(432.4)
598.2
$
354.8
$
206.7
$
—
$
1,159.7
September 30, 2021
September 30, 2020
Gross
Carrying
Amount
Accumulated
Amortization
Net
Gross
Carrying
Amount
Accumulated
Amortization
Net
Trade names and brands
$
256.2
$
57.7
$
198.5
$
256.2
$
45.4
$
Technology and patents
Customer related and other
79.1
221.2
75.8
117.4
3.3
103.8
79.1
219.9
75.3
107.8
210.8
3.8
112.1
Total amortizable intangible
assets
$
556.5
$
250.9
$
305.6
$
555.2
$
228.5
$
326.7
Amortization expense for intangible assets was $22.0, $17.3 and $17.7 for fiscal 2021, 2020 and 2019, respectively. Estimated
amortization expense for amortizable intangible assets for fiscal 2022, 2023, 2024, 2025 and 2026 is approximately $22.0,
$21.9, $21.8, $21.8 and $21.6, respectively, and $196.5 thereafter.
64
The Company had indefinite-lived trade names and brands of $600.8 ($182.1 in Wet Shave, $388.8 in Sun and Skin Care, and
$29.9 in Feminine Care) at September 30, 2021, a decrease of $0.6 from September 30, 2020, related to foreign currency
fluctuations. The Company had indefinite-lived trade names and brands of $601.4 ($183.1 in Wet Shave, $388.4 in Sun and
Skin Care, and $29.9 in Feminine Care) at September 30, 2020.
Goodwill and intangible assets deemed to have an indefinite life are not amortized but are instead reviewed annually in the
fourth quarter of each fiscal year for impairment of value or when indicators of a potential impairment are present. The
Company continuously monitors changing business conditions, which may indicate that the remaining useful life of goodwill
and other intangible assets may warrant revision or carrying amounts may require adjustment.
Indefinite-lived intangible assets
The Company’s annual indefinite-lived intangible assets impairment testing was conducted on July 1, 2021 using the
Company’s strategic plan. The Company elected to perform a qualitative test of impairment for all indefinite lived intangible
assets with the exception of the Banana Boat trade name. For the qualitative test of indefinite lived intangible assets, there were
no significant events or adverse trends that could negatively impact the fair value of the intangible assets. For the Banana Boat
trade name, the Company elected to perform a quantitative impairment test in fiscal 2021 using the Company’s strategic plan to
calculate a five-year cash flow. The annual impairment assessment of the indefinite-lived intangible assets concluded there was
no indication of impairment of the Company’s indefinite-lived intangible assets. The Company performed an assessment in the
fourth quarter of fiscal 2021 to determine if any significant events or changes in circumstances had occurred that would be
considered a potential triggering event. The Company did not identify a triggering event that would indicate the existence of
any impairment of the indefinite-lived intangible assets.
The Company performed an interim impairment analysis as of the end of the third quarter of fiscal 2019 as a result of a decline
in the price of the Company’s common stock in the third quarter which was considered a triggering event. The interim
impairment analysis was performed as of June 30, 2019 using the strategic plan to calculate a five-year cash flow for all trade
names. The interim impairment analysis indicated that the indefinite-lived trade names for Wet Ones and Diaper Genie had
carrying values that exceeded their fair values, resulting in non-cash impairments of $87.0 and $75.0, respectively, in fiscal
2019.
Goodwill
The Company performed its annual goodwill impairment analysis as of July 1, 2021. The Company elected to perform a
qualitative test of goodwill impairment for the Feminine Care reporting unit and determined there were no significant events or
adverse trends that could negatively impact the fair value of the business. For the Wet Shave, Sun Care, and Skin Care reporting
units, the Company elected to perform a quantitative impairment test in fiscal 2021 using the Company’s strategic plan to
calculate a five-year cash flow. The analysis indicated that the fair value of each of the reporting units was greater than the
respective carrying amounts of the goodwill and thus no impairment was recorded in fiscal 2021.
The Company performed an interim impairment analysis as of the end of the third quarter of fiscal 2019 as a result of a decline
in the price of the Company’s common stock in the third quarter which was considered a triggering event. The interim
impairment analysis was performed as of June 30, 2019, using the strategic plan to calculate a five-year cash flow for all
reporting units. During the third quarter of fiscal 2019, the Company recorded impairment charges on the goodwill of the Wet
Shave, Infant Care and Skin Care reporting units totaling $369.0, $37.0 and $2.0, respectively, in fiscal 2019.
65
Note 8 - Supplemental Balance Sheet Information
Inventories
Raw materials and supplies
Work in process
Finished products
Total inventories
Other Current Assets
Miscellaneous receivables
Inventory returns receivable
Prepaid expenses
Value added tax collectible from customers
Income taxes receivable
Other
Total other current assets
Property, Plant and Equipment
Land
Buildings
Machinery and equipment
Capitalized software costs
Construction in progress
Total gross property, plant and equipment
Accumulated depreciation
Total property, plant and equipment, net
Other Current Liabilities
Accrued advertising, sales promotion and allowances
Accrued trade allowances
Accrued salaries, vacations and incentive compensation
Income taxes payable
Returns reserve
Restructuring reserve
Value added tax payable
Dividends payable
Deferred compensation
Short term lease obligation
Customer advance payments
Other
Total other current liabilities
Other Liabilities
Pensions and other retirement benefits
Deferred compensation
Long term lease obligation
Other non-current liabilities
Total other liabilities
66
September 30,
2021
September 30,
2020
$
$
$
$
$
$
$
$
$
61.3
$
83.4
201.0
345.7
$
30.3
$
0.9
67.3
19.6
29.1
12.9
58.5
71.5
184.1
314.1
23.3
1.0
64.8
20.4
26.3
10.2
160.1
$
146.0
19.2
$
144.5
1,049.0
57.0
44.0
1,313.7
(951.1)
362.6
$
33.8
$
34.0
66.4
9.8
52.7
5.5
4.6
8.2
5.9
11.0
0.6
68.3
300.8
$
19.3
142.2
1,014.2
53.6
32.7
1,262.0
(891.1)
370.9
49.4
30.8
62.6
13.4
44.8
5.4
6.8
—
5.9
9.1
1.4
77.9
307.5
55.4
$
121.0
22.7
46.9
65.3
28.2
34.6
73.3
$
190.3
$
257.1
Note 9 - Leases
A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or
equipment over a contracted period in exchange for payment. The Company evaluates if an arrangement is a lease as of the
effective date of the agreement. For operating leases entered into prior to October 1, 2019, right of use (“ROU”) assets and
operating lease liabilities are recognized on the balance sheet based on the present value of the remaining future minimum
payments over the lease term from the implementation date. Certain leases include an option to either renew or terminate the
lease. For purposes of calculating lease liabilities, these options are included within the lease term when it has become
reasonably certain that the Company will exercise such options. Leases entered into subsequent to October 1, 2019 calculate the
operating lease ROU asset and operating lease liabilities based on the present value of minimum payments over the lease term
at the effective date of the lease.
The Company leases certain offices and manufacturing facilities, warehouses, employee vehicles and certain manufacturing
related equipment. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheet. All
recorded leases are classified as operating leases and lease expense is recognized on a straight-line basis over the lease term.
The Company has elected to utilize the package of practical expedients which allows it to carryforward its historical lease
classification, its assessment on whether a contract was or contains a lease, and its assessment of initial direct costs for any
leases that existed prior to October 1, 2019. Additionally, the Company has elected as an accounting policy not to separate non-
lease components from lease components and, instead, account for these components as a single lease component. The
Company has made an accounting policy election not to recognize ROU assets and lease liabilities for leases that, as of October
1, 2019, are for 12 months or less. For leases that do not provide an implicit rate, the Company uses its secured incremental
borrowing rate, based on the information available for leases, including the lease term and interest rate environment in the
country in which the lease exists, to calculate the present value of the future lease payments.
A summary of the Company's lease information is as follows:
Classification
Other assets
Other current liabilities
Other liabilities
Assets
Right of use assets
Liabilities
Current lease liabilities
Long-term lease liabilities
Total lease liabilities
Other information
Weighted-average remaining lease term (years)
Weighted-average incremental borrowing rate
Statement of Earnings
Lease cost (1)
Other information
Leased assets obtained in exchange for new lease liabilities
Cash paid for amounts included in the measurement of lease liabilities
September 30,
2021
September 30,
2020
$
$
$
57.7
$
43.5
11.0
46.9
57.9
$
$
9.1
34.6
43.7
10
6.3 %
12
7.2 %
Fiscal Year
Ended
September 30,
2021
Fiscal Year
Ended
September 30,
2020
$
$
$
14.4
$
13.9
28.0
14.3
$
$
1.9
13.4
(1) Lease expense is included in Cost of products sold or SG&A expense based on the nature of the lease. Short-term lease expense is excluded from
this amount and is not material.
67
The Company's future lease payments including reasonably assured renewal options under lease agreements are as follows:
Fiscal 2022
2023
2024
2025
2026
2027 and thereafter
Total future minimum lease commitments
Less: Imputed interest
Present value of lease liabilities
Operating Leases
$
$
13.0
11.0
9.0
8.1
6.7
37.1
84.9
(27.0)
57.9
Note 10 - Accounts Receivable Facility
The Company participates in a $150 uncommitted master accounts receivable purchase agreement with The Bank of Tokyo-
Mitsubishi UFJ, Ltd., New York Branch, as the purchaser (the “Accounts Receivable Facility”). Transfers under the Accounts
Receivable Facility are accounted for as sales of receivables, resulting in the receivables being de-recognized from the
Consolidated Balance Sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign,
transfer, or participate any of its rights under the purchased receivables to another bank or financial institution. The purchase
and sale of receivables under the Accounts Receivable Facility is intended to be an absolute and irrevocable transfer without
recourse by the purchaser to the Company for the creditworthiness of any obligor. The Company continues to have collection
and servicing responsibilities for the receivables sold and receives separate compensation for their servicing. The compensation
received is considered acceptable servicing compensation and, as such, the Company does not recognize a servicing asset or
liability.
As of September 30, 2021, the discount rate used to determine the purchase price for the subject receivables is based upon
LIBOR plus a margin applicable to the specified obligor.
Accounts receivable sold under the Accounts Receivable Facility for the year ended September 30, 2021 and 2020 were $929.9
and $869.0, respectively. The trade receivables sold that remained outstanding under the Accounts Receivable Facility as
of September 30, 2021 and 2020 were $91.1 and $77.0, respectively. The net proceeds received were included in Cash provided
by operating activities in the Consolidated Statement of Cash Flows. The difference between the carrying amount of the trade
receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in Other (income) expense, net in
the Consolidated Statement of Earnings. For the year ended September 30, 2021, the loss on sale of trade receivables was $0.9.
For the year ended September 30, 2020, the loss on sale of trade receivables was $1.4.
68
Note 11 - Debt
The detail of long-term debt was as follows:
Senior notes, fixed interest rate of 4.7%, due 2022(1) (2)
Senior notes, fixed interest rate of 5.5%, due 2028(1)
Senior notes, fixed interest rate of 4.1%, due 2029(1)
Revolving credit facility (3)
Total long-term debt, including current maturities
Less current portion
Less unamortized debt issuance costs and discount (1) (2)
Total long-term debt
September 30,
2021
September 30,
2020
—
750.0
500.0
—
500.0
750.0
—
—
1,250.0
1,250.0
—
15.8
—
12.1
$
1,234.2
$
1,237.9
(1) At September 30, 2021, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $9.8 and
$6.0, respectively. At September 30, 2020, the balance for the Senior Notes due 2022 and the Senior Notes due 2028 are reflected net of debt
issuance costs of $0.6 and $11.3, respectively.
(2) At September 30, 2020, the balance for the Senior Notes due 2022 was reflected net of discount of $0.2.
(3) Variable-rate debt based on LIBOR plus applicable margin.
At September 30, 2021 and 2020, the Company also had outstanding short-term notes payable with financial institutions with
original maturities of less than 90 days of $26.5 and $21.1, respectively, with weighted-average interest rates of 3.9% and 4.5%,
respectively. These notes were primarily outstanding international borrowings.
Issuance of Senior Notes
On March 8, 2021, the Company entered into a new unsecured indenture agreement for 4.125% Senior Notes in the amount of
$500 due April 1, 2029 (the “2029 Notes”). The Company used the net proceeds from the issuance of the 2029 Notes, together
with cash on hand, to satisfy and discharge its obligations outstanding under its 4.70% Senior Notes in the amount of $500 due
2022 (the “2022 Notes”) and to pay fees associated therewith. The Company incurred $6.5 in bank, legal, and other fees in
connection with the issuance of the 2029 Notes, which has been deferred and is being amortized to interest expense over the
term of the 2029 Notes. Interest expense on the 2029 Notes is due semiannually on April 1 and October 1, with the first interest
payment scheduled for October 1, 2021.
In connection with the early repayment of the 2022 Notes, the Company recorded expense of $26.1 in fiscal 2021, which is
included in Cost of early retirement of long-term debt in the Consolidated Statements of Earnings and Comprehensive Income
(Loss). This expense included a premium of $25.5 and debt issuance cost write-offs of $0.6.
On May 22, 2020, the Company entered into a new unsecured indenture agreement for 5.50% Senior Notes in the amount of
$750 due June 1, 2028 (the “2028 Notes”). The Company used a portion of the net proceeds of the 2028 Notes to satisfy and
discharge its obligations outstanding under its 4.70% Senior Notes in the amount of $600 due 2021 (the “2021 Notes”). The
remainder of the net proceeds will be used to pay our debt related fees and expenses and for general corporate purposes, which
may include, but are not limited to, the repayment of outstanding indebtedness, working capital, capital expenditures and
acquisitions. The Company incurred $11.7 in bank, legal, and other fees in connection with the issuance of the 2028 Notes,
which was deferred and is being amortized to interest expense over the term of the 2028 Notes. Interest expense on the 2028
Notes is due semiannually on June 1 and December 1.
In connection with the early repayment of the 2021 Notes, the Company recorded expense of $26.2 in fiscal 2020, which is
included in Cost of early retirement of long-term debt in the Consolidated Statements of Earnings and Comprehensive Income
(Loss). This expense included a premium of $25.7 and debt issuance cost write-offs of $0.5.
Replacement of Credit Agreement
On April 3, 2020, the Company closed its new senior secured revolving credit facility in an aggregate principal amount of $425
dated March 28, 2020, by and among, the Company and certain subsidiaries of the Company, and Bank of America, N.A. as
administrative agent and collateral agent, MUFG Bank, Ltd., as syndication agent, TD Securities (USA) LLC, as joint lead
arranger, and the several lenders from time to time party thereto (the “Revolving Credit Facility”).
69
Interest on any borrowings under the Revolving Credit Facility are paid monthly, bi-monthly or quarterly depending on the
interest rate. Any outstanding amounts under the Revolving Credit Facility must be repaid on or before April 3, 2025. Under the
Revolving Credit Facility, certain of the Company’s subsidiaries guarantee the Company’s payment and performance
obligations. The Revolver includes a letter of credit sub-facility of up to $70 and will provide the Company with the ability to
incur certain amounts of additional incremental loans in the future, subject to the satisfaction of certain conditions.
The Revolving Credit Facility, expandable under an accordion feature, provides for a five-year revolving line of credit and
bears interest at a range of 1.50% - 2.25% over LIBOR, depending on the net debt leverage level of the Company.
Effective April 3, 2020, and in connection with the Revolving Credit Facility, the Company terminated its existing senior
unsecured revolving credit agreement dated as of June 1, 2015, among Edgewell Personal Care Company (formerly named
Energizer Holdings, Inc.), as borrower, JPMorgan Chase Bank, N.A., as administrative agent, and the other parties thereto, as
amended, supplemented or modified from time to time. The Company did not have any outstanding borrowings at the
termination date and no early termination penalties were incurred.
Debt Covenants
The Revolving Credit Facility governing our outstanding debt at September 30, 2021 contains certain customary representations
and warranties, financial covenants, covenants restricting the Company’s ability to take certain actions, affirmative covenants
and provisions relating to events of default. Under the terms of the Revolving Credit Facility, the ratio of the Company’s
indebtedness to earnings before interest, taxes, depreciation and amortization (“EBITDA”), as defined in the agreement and
detailed below, cannot be greater than 4.0 to 1. In addition, under the Revolving Credit Facility, the ratio of the Company’s
EBITDA, as defined in the credit agreement, to total interest expense must exceed 3.0 to 1. Under the Revolving Credit Facility,
EBITDA is defined as net earnings, as adjusted to add-back interest expense, income taxes, depreciation and amortization, all of
which are determined in accordance with GAAP. In addition, the credit agreement allows certain non-cash charges such as
stock award amortization and asset write-offs including, but not limited to, impairment and accelerated depreciation, and
operating expense reductions or synergies to be “added-back” in determining EBITDA for purposes of the indebtedness ratio.
Total debt and interest expense are calculated in accordance with GAAP. If the Company fails to comply with these covenants
or with other requirements of the Revolving Credit Facility, the lenders may have the right to accelerate the maturity of the
debt. Acceleration under the Revolving Credit Facility would trigger cross-defaults on its other borrowings.
As of September 30, 2021, the Company was in compliance with the provisions and covenants associated with the Revolving
Credit Facility.
Debt Maturities
Aggregate maturities of long-term debt, including current maturities, at September 30, 2021 were as follows: $750.0 in 2028
and $500.0 in 2029.
Note 12 - Retirement Plans
Pensions and Postretirement Plans
The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other
countries, which are included in the information below. The plans provide retirement benefits based on years of service and
earnings. The Company also sponsors or participates in a number of other non-U.S. pension and postretirement arrangements,
including various retirement and termination benefit plans, some of which are required by local law or coordinated with
government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information
presented below.
The Company funds its pension plans in compliance with the Employee Retirement Income Security Act of 1974 (“ERISA”) or
local funding requirements.
The following tables present the benefit obligation, plan assets, and funded status of the plans:
70
Change in projected benefit obligation
Benefit obligation at beginning of year
$
652.1
$
635.9
$
6.0
$
As of September 30,
Pension
Postretirement
2021
2020
2021
2020
Service cost
Interest cost
Actuarial (gain) loss
Benefits paid, net
Plan settlements
Expenses paid
Foreign currency exchange rate changes
Projected benefit obligation at end of year
Change in plan assets
Estimated fair value of plan assets at beginning of year
Actual return on plan assets
Company contributions
Plan settlements
Benefits paid
Expenses paid
Foreign currency exchange rate changes
Estimated fair value of plan assets at end of year
4.4
9.6
(14.9)
(32.0)
—
—
(0.5)
618.7
538.6
59.7
4.9
—
(32.0)
—
(0.7)
570.5
4.3
13.5
19.0
(30.0)
(2.2)
—
11.6
652.1
495.0
57.2
9.7
(2.2)
(30.0)
—
8.9
538.6
—
0.2
(0.8)
(0.2)
—
—
0.3
5.5
—
—
0.2
—
9.4
—
0.3
(3.3)
(0.3)
—
—
(0.1)
6.0
—
—
0.3
—
(0.2)
(0.3)
—
—
—
—
—
—
Funded status at end of year
$
(48.2) $
(113.5) $
(5.5) $
(6.0)
The following table presents the amounts recognized in the Consolidated Balance Sheets and Consolidated Statements of
Changes in Shareholders’ Equity:
As of September 30,
Pension
Postretirement
2021
2020
2021
2020
0.8
$
0.4
$
—
$
(0.9)
(48.1)
(0.9)
(113.0)
(0.2)
(5.3)
(48.2) $
(113.5) $
(5.5) $
138.6
$
199.8
$
(7.4) $
—
—
—
138.6
$
199.8
$
(7.4) $
—
(0.2)
(5.8)
(6.0)
(6.5)
—
(6.5)
Amounts recognized in the Consolidated Balance Sheets
Noncurrent assets
Current liabilities
Noncurrent liabilities
Net amount recognized
Amounts recognized in Accumulated other comprehensive loss
Net loss (gain)
Prior service credit
Net amount recognized, pre-tax
$
$
$
$
71
Pre-tax changes recognized in Other comprehensive income for fiscal 2021 were as follows:
Changes in plan assets and benefit obligations recognized in Other comprehensive income
Net gain arising during the year
Effect of exchange rates
Amounts recognized as a component of net periodic benefit cost
Amortization or curtailment recognition of prior service cost
Amortization or settlement recognition of net (loss) gain
$
(52.2) $
0.6
—
(9.5)
Total recognized in Other comprehensive income
$
(61.1) $
(0.9)
(0.3)
—
0.3
(0.9)
Pension
Post-
retirement
Due to the election of certain terms of the American Rescue Plan Act, the Company is not required to make any cash
contributions to our pension and postretirement plans in fiscal 2022; however, discretionary contributions may also be made.
The Company’s expected future benefit payments are as follows:
Fiscal 2022
Fiscal 2023
Fiscal 2024
Fiscal 2025
Fiscal 2026
Fiscal 2027 to 2031
Pension
Post-
retirement
$
36.6
$
35.6
35.9
34.0
34.3
156.5
0.2
0.2
0.2
0.2
0.2
1.3
The accumulated benefit obligation for defined benefit pension plans was $603.0 and $634.8 at September 30, 2021 and 2020,
respectively. The following table shows pension plans with an accumulated benefit obligation in excess of plan assets:
Projected benefit obligation
Accumulated benefit obligation
Estimated fair value of plan assets
As of September 30,
2021
2020
$
590.1
$
575.1
541.9
625.0
607.8
511.1
Pension plan assets in the U.S. plan represent approximately 70% of assets in all of the Company’s defined benefit pension
plans. Investment policy for the U.S. plan includes a mandate to diversify assets and invest in a variety of asset classes to
achieve that goal. The U.S. plan’s assets are currently invested in several funds representing most standard equity and debt
security classes. The broad target allocations are: (a) equities, including U.S. and foreign: approximately 41% and (b) debt
securities, including U.S. bonds: approximately 59%. Actual allocations at September 30, 2021 approximated these targets. The
U.S. plan held no shares of Company common stock at September 30, 2021. Investment objectives are similar for non-U.S.
pension arrangements, subject to local regulations.
72
The following table presents pension and post-retirement expense:
Service cost
Interest cost
Expected return on plan assets
Recognized net actuarial loss (gain)
Settlement loss recognized
Net periodic benefit cost (credit)
Fiscal Year
2021
Pension
2020
2019
2021
2020
2019
Postretirement
$
4.4
9.6
(22.4)
9.5
—
1.1
$
4.3
$
2.9
$
—
$
—
$
13.5
(23.1)
9.3
0.8
4.8
18.5
(25.3)
4.3
—
0.4
0.2
—
(0.3)
—
(0.1)
0.3
—
(0.1)
—
0.2
—
0.3
—
(0.2)
—
0.1
The service cost component of the net periodic cost associated with the Company’s retirement plans is recorded to Cost of
products sold and SG&A on the Consolidated Statement of Earnings. The remaining net periodic cost is recorded to Other
(income) expense, net on the Consolidated Statement of Earnings.
The Company utilized the spot discount rate approach, which applies the specific spot rates along the yield curve used in the
determination of the benefit obligations to the relevant cash flows.
The following table presents assumptions, which reflect weighted-averages for the component plans, used in determining the
above information:
Plan obligations:
Discount rate
Compensation increase rate
Net periodic benefit cost:
Discount rate
Expected long-term rate of
return on plan assets
Compensation increase rate
Cash balance interest credit
rate
2021
Pension
2020
Fiscal Year
Postretirement
2019
2021
2020
2019
2.3 %
2.5 %
2.1 %
4.5 %
2.5 %
1.9 %
2.1 %
2.5 %
2.5 %
4.8 %
2.5 %
1.3 %
2.5 %
2.5 %
3.7 %
5.2 %
2.5 %
2.6 %
3.5 %
N/A
2.8 %
N/A
3.0 %
N/A
2.8 %
3.0 %
4.0 %
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
The expected return on plan assets was determined based on historical and expected future returns of the various asset classes,
using the target allocations described above.
73
The following table sets forth the estimated fair value of the Company’s pension assets segregated by level within the estimated
fair value hierarchy. Refer to Note 16 of Notes to Consolidated Financial Statements for further discussion on the estimated fair
value hierarchy and estimated fair value principles.
Total, excluding investments valued at net asset value (“NAV”)
Investments valued at NAV
Total
$
$
259.3
$
236.6
$
259.3
$
236.6
$
Pension assets at estimated fair value
Equity
U.S. equity
International equity
Debt
U.S. government
Other government
Corporate
Cash and cash equivalents
Other
Pension assets at estimated fair value
Equity
U.S. equity
International equity
Debt
U.S. government
Other government
Corporate
Cash and cash equivalents
Other
As of September 30, 2021
Level 1
Level 2
Total
$
84.5
$
76.0
—
—
66.0
14.4
18.4
$
—
—
236.5
—
—
—
0.1
As of September 30, 2020
Level 1
Level 2
Total
$
96.9
$
68.7
—
—
65.3
8.4
1.0
$
—
—
191.7
1.4
2.1
1.6
14.0
84.5
76.0
236.5
—
66.0
14.4
18.5
495.9
74.6
570.5
96.9
68.7
191.7
1.4
67.4
10.0
15.0
451.1
87.5
538.6
Total, excluding investments valued at NAV
Investments valued at NAV
Total
$
$
240.3
$
210.8
$
240.3
$
210.8
$
The following table sets forth the estimated fair value of the Company’s pension assets valued at NAV:
As of September 30,
2021
2020
$
$
18.0
$
56.6
74.6
$
10.2
77.3
87.5
Pension assets valued at NAV estimated at fair value
Equity
U.S. equity
International equity
Total investments valued at NAV
There were no Level 3 pension assets as of September 30, 2021 and 2020.
The Company had no post-retirement plan assets as of September 30, 2021 and 2020.
74
The Company’s investment objective for defined benefit retirement plan assets is to satisfy its current and future pension
benefit obligations. The investment philosophy is to achieve this objective through diversification of the retirement plan assets
with the goal of earning a suitable return with an appropriate level of risk while maintaining adequate liquidity to distribute
benefit payments. The diversified asset allocation includes equity positions as well as fixed income investments. The increased
volatility associated with equities is offset with higher expected returns, while long duration fixed income investments help
dampen the volatility of the overall portfolio. Risk exposure is controlled by re-balancing the retirement plan assets back to
target allocations, as needed. Investment firms managing retirement plan assets carry out investment policy within their stated
guidelines. Investment performance is monitored against benchmark indices, which reflect the policy and target allocation of
the retirement plan assets.
Defined Contribution Plan
The Company sponsors a defined contribution plan, which extends participation eligibility to the vast majority of U.S.
employees. Effective January 1, 2014, the Company matches 100% of participants’ before-tax or Roth contributions up to 6%
of eligible compensation. Amounts charged to expense during fiscal 2021, 2020, and 2019 were $10.4, $9.9, and $9.7,
respectively, and are reflected in SG&A and Cost of products sold.
Note 13 - Share-Based Payments
As of September 30, 2021, the Company had three share-based compensation plans: the Amended and Restated 2018 Stock
Incentive Plan (the “2018 Plan”), the Second Amended and Restated 2009 Incentive Stock Plan (the “2009 Plan”) and the 2000
Incentive Stock Plan (the “2000 Plan”). The 2000 Plan was superseded by the 2009 Plan, which was then superseded by the
2018 Stock Incentive Plan. New awards granted after January 2018 are issued under the 2018 Plan. The 2018 Plan provides for
the award of restricted stock, RSEs, or Share Options to purchase the Company’s common stock to directors, officers and
employees of the Company. The maximum number of shares authorized for issuance under the 2018 Plan is 14.9, of which 3.5
were available for future awards as of September 30, 2021.
Share options are granted at the market price on the grant date and generally vest ratably over three years. These awards
typically have a maximum term of ten years. Restricted stock and RSEs may also be granted. Option shares and prices, and
restricted stock and RSEs, are adjusted in conjunction with stock splits and other recapitalizations, including our 2015
separation from Energizer, so that the holder is in the same economic position before and after these equity transactions.
The Company uses the straight-line method of recognizing compensation cost. Total compensation costs charged against
earnings before income taxes for the Company’s share-based compensation arrangements were $27.3, $19.2 and $17.8 for fiscal
2021, 2020 and 2019, respectively, and were recorded in SG&A. The total income tax benefit recognized for share-based
compensation arrangements was $6.6, $4.6 and $4.3, for fiscal 2021, 2020 and 2019, respectively. Restricted stock issuance and
shares issued for share option exercises under the Company’s share-based compensation programs are generally issued from
treasury shares.
75
Share Options
The following table summarizes Share Option activity during fiscal 2021:
Outstanding as of October 1, 2020
Granted
Canceled
Exercised
Weighted-
Average
Remaining
Contractual
Term
(in years)
Aggregate
Intrinsic
Value
Weighted-
Average
Exercise Price
Shares
$
0.7
0.2
—
—
67.90
37.67
—
—
Outstanding as of September 30, 2021
0.9
$
60.13
6.6
$
Vested and unvested expected to vest as of September 30, 2021
Exercisable as of September 30, 2021
$
0.9
0.5
60.13
77.89
6.6
$
No share options were exercised in fiscal 2021, 2020 or 2019.
—
—
The Company estimates the grant-date fair value of share option awards using the Black-Scholes option pricing model. During
fiscal 2021 and 2020, the Company granted non-qualified share option awards to certain executives and employees of 0.2 in
each period, with a grant-date fair value of $3.1 and $1.9, respectively. The following table presents the Company’s weighted
average fair value per option and the assumptions utilized in the Black-Scholes option pricing model:
Weighted-average fair value per share option
Expected volatility
Risk-free interest rate
Expected share option life (in years)
Dividend yield
2021
2020
$
12.06
$
9.33
36.00 %
0.57 %
6.3
— %
27.00 %
1.66 %
6.0
— %
As of September 30, 2021, there was an estimated $2.7 of total unrecognized compensation costs related to share option
awards, which will be recognized over a weighted-average period of approximately 1.8 years.
Restricted Share Equivalents
The following table summarizes RSE award activity during fiscal 2021:
Non-vested at October 1, 2020
Granted
Vested
Canceled
Non-vested at September 30, 2021
Weighted-
Average
Grant Date
Estimated
Fair
Value
Shares
$
1.0
0.5
(0.4)
(0.1)
1.0
35.12
35.16
38.16
35.42
34.07
The estimated fair value of the award is determined using the closing share price of the Company’s common stock on the date
of grant.
76
As of September 30, 2021, there was an estimated $20.8 of total unrecognized compensation costs related to RSEs, which will
be recognized over a weighted-average period of approximately 2.1 years. The weighted-average estimated fair value per RSE
granted in fiscal 2021, 2020 and 2019 was $35.16, $29.25, and $42.68, respectively. The estimated fair value of RSEs vested in
fiscal 2021, 2020 and 2019 was $13.2, $11.5, and $13.9, respectively.
Performance Restricted Share Equivalents
The following table summarizes Performance Restricted Share Equivalent (“PRSE”) award activity during fiscal 2021:
Non-vested at October 1, 2020
Granted
Vested
Canceled
Non-vested at September 30, 2021
Weighted-
Average
Grant Date
Estimated
Fair
Value
Shares
$
0.9
0.1
—
(0.2)
0.8
38.50
56.53
—
46.72
38.45
As of September 30, 2021, there was an estimated $7.2 of total unrecognized compensation costs related to PRSEs, which will
be recognized over a weighted-average period of approximately 1.5 years. The weighted-average estimated fair value per PRSE
granted in fiscal 2021, 2020 and 2019 was $56.53, $29.25, and $43.07, respectively. The estimated fair value of PRSEs vested
in fiscal 2021 was $1.0.
For PRSE awards grant during fiscal 2020 and 2019, the Company records estimated expense for performance-based grants
based on target achievement of performance metrics for the three-year period for each respective program, unless evidence
exists that achievement above or below target for the applicable performance metric is more likely to occur. The PRSE awards
will vest with a value of 0% to 200% of the targeted award value based upon the achievement of performance metrics. The
estimated fair value of the award is determined using the closing share price of the Company’s common stock on the date of
grant.
For PRSE awards granted during fiscal 2021, awards will vest by comparing the Company’s total shareholder return (“TSR”)
during a certain three year period to the respective TSRs of companies in a selected performance peer group. Based upon the
Company’s ranking in its performance peer group, a recipient of the PRSE award may earn a total award ranging from 0% to
200% of the target award. The fair value of each PRSE was estimated on the grant date using a Monte Carlo simulation. The
assumptions for PRSE awards during the years ended September 30, 2021 are summarized in the following table.
Expected term (in years)
Expected stock price volatility
Risk-free interest rate
Fair value (per award granted)
Note 14 - Shareholders’ Equity
2021
3.0
48.00 %
0.22 %
56.53
At September 30, 2021, there were 300.0 shares of the Company’s common stock authorized, of which 3.5 shares were reserved
for outstanding awards under the 2018, 2009 and 2000 Plans. The Company’s Amended and Restated Articles of Incorporation
authorize it to issue up to 10.0 shares of $0.01 par value preferred stock. As of September 30, 2021, there were no shares of
preferred stock issued or outstanding.
During fiscal 2021, the Company repurchased 0.3 shares of common stock under the share repurchase Board authorization from
January 2018 for $9.2. Future share repurchases, if any, would be made in the open market, privately negotiated transactions, or
otherwise, in such amounts and at such times as we deem appropriate based upon prevailing market conditions, business needs,
and other factors. Additionally, 0.1 shares were purchased related to the surrender of shares of common stock to satisfy tax
withholding obligations in connection with the vesting of RSEs.
77
On August 5, 2021, the Board declared a quarterly cash dividend of $0.15 per common share for the third fiscal quarter. The
dividend is payable October 5, 2021 to stockholders of record as of the close of business on September 9, 2021. Dividends
declared during the year ended September 30, 2021 totaled $33.7. Payments made for dividends during the year ended
September 30, 2021 totaled $25.6.
On November 4, 2021, the Board declared a quarterly cash dividend of $0.15 per common stock outstanding for the fourth
fiscal quarter. The dividend is payable January 6, 2022 to stockholders of record as of the close of business on December 3,
2021.
Note 15 - Accumulated Other Comprehensive Loss
The following table presents the changes in accumulated other comprehensive loss (“AOCI”), net of tax, by component:
Foreign
Currency
Translation
Adjustments
Pension and
Post-
retirement
Activity
Hedging
Activity
Total
$
(77.3) $
(159.8) $
1.2
$
(235.9)
29.9
—
(47.4)
5.6
—
10.4
7.3
(142.1)
38.1
6.7
$
(41.8) $
(97.3) $
(1.8)
(1.5)
(2.1)
2.1
2.2
2.2
38.5
5.8
(191.6)
45.8
8.9
$
(136.9)
Balance at October 1, 2019
OCI before reclassifications (1)
Reclassifications to earnings
Balance at September 30, 2020
OCI before reclassifications (1)
Reclassifications to earnings
Balance at September 30, 2021
(1) OCI is defined as other comprehensive income (loss).
The following table presents the reclassifications out of AOCI:
Details of AOCI Components
2021
2020
Affected Line Item in the
Consolidated Statement of
Earnings
Fiscal Year
(Loss) gain on cash flow hedges
Foreign exchange contracts
Amortization of defined benefit pension and postretirement items
Prior service costs
Actuarial losses
Settlements
Total reclassifications for the period
$
$
$
$
$
(3.2) $
2.1 Other expense (income), net
(3.2)
(1.0)
2.1 Total before tax
Income tax provision
(benefit)
0.6
(2.2) $
1.5 Net of tax
—
$
(9.2)
—
(9.2)
(2.5)
—
(1)
(9.3)
(1)
(0.8)
(1)
(10.1) Total before tax
(2.8) Tax expense (benefit)
(6.7) $
(7.3) Net of tax
(8.9) $
(5.8) Net of tax
(1) These AOCI components are included in the computation of net periodic benefit cost. See Note 12 of Notes to Consolidated Financial Statements.
78
Note 16 - Financial Instruments and Risk Management
In the course of ordinary business, the Company enters into contractual arrangements (also referred to as derivatives) to reduce
its exposure to foreign currency. The Company has master netting agreements with all of its counterparties that allow for the
settlement of contracts in an asset position with contracts in a liability position in the event of default. The Company manages
counterparty risk through the utilization of investment grade commercial banks, diversification of counterparties, and its
counterparty netting arrangements. The section below outlines the types of derivatives that existed at September 30, 2021 and
2020, respectively, as well as the Company’s objectives and strategies for holding derivative instruments.
Foreign Currency Risk
A significant share of the Company’s sales are tied to currencies other than the U.S. dollar, the Company’s reporting
currency. As such, a weakening of currencies relative to the U.S. dollar can have a negative impact to reported
earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary
currencies to which the Company is exposed include the euro, the Japanese yen, the British pound, the Canadian dollar and the
Australian dollar.
Additionally, the Company’s foreign subsidiaries enter into internal and external transactions that create non-functional
currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany
purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary’s local
currency at the end of each period. Changes in the value of the non-functional currency balance sheet positions in relation to the
foreign subsidiary’s local currency results in an exchange gain or loss recorded in Other expense (income), net. The primary
currency to which the Company’s foreign subsidiaries are exposed is the U.S. dollar.
Interest Rate Risk
The Company has interest rate risk with respect to interest expense on variable rate debt. At September 30, 2021, the Company
had $26.5 of variable rate debt outstanding, which consisted primarily of outstanding borrowings under the Revolving Credit
Facility in the U.S.
Other Risks
Customer Concentration. Financial instruments that potentially subject the Company to concentrations of credit risk primarily
consist of accounts receivable. The Company generally does not require collateral from customers. The Company’s largest
customer, Walmart Inc. and its affiliates (collectively, “Walmart”), accounted for approximately 21% of Net sales in fiscal
2021. No other customer accounted for more than 10% of the Company’s consolidated Net sales. Purchases by Walmart
included products from all of the Company’s segments. Additionally, in fiscal 2021, Target Corporation represented
approximately 11% of net sales for the Sun and Skin Care segment and 10% of net sales for the Feminine Care segment,
respectively.
Product Concentration. Within the Wet Shave segment, the Company’s razor and blades represented 52%, 52% and 52% of net
sales during fiscal 2021, 2020 and 2019, respectively, and within the Sun and Skin Care segment, sun care products represented
16%,15%, and 15% of net sales during each of fiscal 2021, 2020 and 2019.
Cash Flow Hedges
At September 30, 2021, the Company maintained a cash flow hedging program related to foreign currency risk. These
derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective
by the Company for accounting purposes in offsetting the associated risk.
The Company entered into a series of forward currency contracts to hedge cash flow uncertainty associated with currency
fluctuations. These transactions are accounted for as cash flow hedges. The Company had an unrealized pre-tax gain of $3.3
and an unrealized pre-tax loss of $3.0 at September 30, 2021 and 2020, respectively, on these forward currency contracts, which
are accounted for as cash flow hedges included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at
September 30, 2021 levels over the next 12 months, the majority of the pre-tax gain included in AOCI at September 30, 2021 is
expected to be included in Other (income) expense, net. Contract maturities for these hedges extend into fiscal year 2023. At
September 30, 2021, there were 64 open foreign currency contracts with a total notional value of $129.2.
79
Derivatives not Designated as Hedges
The Company has entered into foreign currency derivative contracts, which are not designated as cash flow hedges for
accounting purposes to hedge balance sheet exposures and, thus, are not subject to significant market risk. The change in
estimated fair value of the foreign currency contracts resulted in gains of $2.3 and losses of $0.5 for fiscal 2021 and 2020,
respectively, which were recorded in Other (income) expense, net in the Consolidated Statements of Earnings and
Comprehensive Income (Loss). At September 30, 2021, there were five open foreign currency derivative contracts which were
not designated as cash flow hedges with a total notional value of $42.0.
The following table provides estimated fair values of derivative instruments:
Derivatives designated as cash flow hedging relationships:
Foreign currency contracts
Derivatives not designated as cash flow hedging relationships:
Foreign currency contracts
Fair Value of (Liability) Asset (1)
September 30,
September 30,
2021
2020
$
$
3.3
$
(3.0)
0.5
$
(0.6)
(1) All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other
liabilities.
The following table provides the amounts of gains and losses on derivative instruments:
Derivatives designated as cash flow hedging relationships:
Foreign currency contracts
Gain (loss) recognized in OCI (1)
(Loss) gain reclassified from AOCI into income (effective portion) (1) (2)
Derivatives not designated as cash flow hedging relationships:
Foreign currency contracts
Gain (loss) recognized in income (2)
Fiscal Year
2021
2020
2019
$
3.1
$
(2.7) $
(3.2)
2.1
2.7
4.8
$
2.3
$
(0.5) $
(1.2)
(1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed
highly effective in offsetting associated risk.
(2) Gain (loss) was recorded in Other (income) expense, net.
The following table provides financial assets and liabilities for balance sheet offsetting:
As of September 30, 2021
Assets (1)
Liabilities (2)
As of September 30, 2020
Assets (1)
Liabilities (2)
Foreign currency contracts
Gross amounts of recognized assets (liabilities)
Gross amounts offset in the balance sheet
Net amounts of assets (liabilities) presented in the balance sheet
$
$
3.9
$
(0.2) $
(0.1)
0.1
3.8
$
(0.1) $
—
—
—
$
$
(3.7)
0.1
(3.6)
(1) All derivative assets are presented in Other current assets or Other assets.
(2) All derivative liabilities are presented in Other current liabilities or Other liabilities.
80
Fair Value Hierarchy
Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities
carried at fair value be classified in one of the following three categories:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs from inactive
markets.
Under the fair value accounting guidance hierarchy, an entity is required to maximize the use of quoted market prices and
minimize the use of unobservable inputs. The following table sets forth the Company’s financial assets and liabilities, which are
carried at fair value, that are measured on a recurring basis during the period, all of which are classified as Level 2 within the
fair value hierarchy:
(Liabilities) Assets at estimated fair value:
Deferred compensation
Derivatives - foreign currency contracts
Net liabilities at estimated fair value
As of September 30,
2021
2020
$
$
(28.4) $
3.7
(24.7) $
(33.9)
(3.6)
(37.5)
At September 30, 2021 and 2020, the Company had no Level 1 or Level 3 financial assets or liabilities, other than pension plan
assets which contained certain assets classified as Level 1. Refer to Note 12 of Notes to Consolidated Financial Statements for
the fair value hierarchy of the pension plan assets.
At September 30, 2021 and 2020, the fair market value of fixed rate long-term debt was $1,300.1 and $1,323.1, respectively,
compared to its carrying value of $1,250.0 in each period. The estimated fair value of the fixed-rate long-term debt is estimated
using yields obtained from independent pricing sources for similar types of borrowing arrangements. There was no variable rate
debt excluding revolving credit facilities as of September 30, 2021. The estimated fair values of long-term debt, excluding the
Revolving Credit Facility and the Company’s previous senior unsecured revolving credit agreement dated as of June 1, 2015
(Collectively, the “Credit Facilities”),have been determined based on Level 2 inputs.
Due to the nature of cash and cash equivalents and short-term borrowings, including notes payable, carrying amounts on the
balance sheets approximate fair value. Additionally, the carrying amounts of the Credit Facilities, which are classified as long-
term debt on the balance sheet, approximate fair value due to the revolving nature of the balances. The estimated fair value of
cash and cash equivalents, short-term borrowings and the Credit Facilities have been determined based on Level 2 inputs.
As of September 30, 2021, the estimated fair value of foreign currency contracts is the amount that the Company would receive
or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of
quoted market prices, factors such as interest rates, currency exchange rates and remaining maturities. The estimated fair value
of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are
offered under the plan.
Note 17 - Commitments and Contingencies
Legal Proceedings
The Company and its affiliates are subject to a number of legal proceedings in various jurisdictions arising out of its operations
during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law
and fact and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be
determined with certainty. The Company reviews its legal proceedings and claims, regulatory reviews and inspections and other
legal proceedings on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure
decisions. The Company establishes accruals for those contingencies when the incurrence of a loss is probable and can be
reasonably estimated and discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount
accrued if such disclosure is necessary for its financial statements to not be misleading. The Company does not record liabilities
when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. Based upon
81
present information, the Company believes that its liability, if any, arising from such pending legal proceedings, asserted legal
claims, and known potential legal claims which are likely to be asserted, is not reasonably likely to be material to its financial
position, results of operations or cash flows, when taking into account established accruals for estimated liabilities.
Government Regulation and Environmental Matters
The operations of the Company are subject to various federal, state, local, and foreign laws and regulations intended to protect
the public health and environment.
Contamination has been identified at certain of the Company’s current and former facilities, as well as third-party waste
disposal sites, and the Company is conducting investigation and remediation activities in relation to such properties. In
connection with certain sites, the Company has received notices from the U.S. Environmental Protection Agency, state agencies
and private parties, that it has been identified as a potentially responsible party (“PRP”) under the Comprehensive
Environmental Response, Compensation and Liability Act of 1980 (“CERCLA”), and may be required to share in the cost of
cleanup with respect to a number of federal “Superfund” sites. The Company may also be required to share in the cost of
cleanup with respect to state-designated sites, and certain international locations, as well as any of its own properties.
The amount of the Company’s ultimate liability in connection with those sites may depend on many factors, including the
volume and toxicity of material contributed to the site, the number of other PRPs and their financial viability, and the
remediation methods and technology to be used. Total environmental capital expenditures and operating expenses are not
expected to have a material effect on the Company’s total capital and operating expenditures, cash flows, earnings or
competitive position. Current environmental spending estimates may be modified as a result of changes in the Company’s plans
or its understanding of the underlying facts, changes in legal requirements, including any requirements related to global climate
change, or other factors.
Many European countries, as well as the European Union, have been very active in adopting and enforcing environmental
regulations. As such, it is possible that new regulations may increase the risk and expense of doing business in such countries.
Certain of the Company’s products are subject to regulation under the U.S. Federal Food, Drug and Cosmetic Act and are
regulated by the U.S. Food and Drug Administration.
Note 18 - Segment and Geographical Data
Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation
costs, impairment charges, costs associated with restructuring initiatives, acquisition and integration costs, cost of early debt
retirement, advisory expenses incurred in connection with the evaluation of the Feminine Care and Infant Care businesses, Sun
Care reformulation costs, investor settlement expenses, the gain on sale of the Infant and Pet Care business and the Playtex
gloves assets, pension settlement expense and the amortization of intangible assets. Financial items, such as interest income and
expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects
management’s view on how it evaluates segment performance.
The Company’s operating model includes some shared business functions across the segments, including product warehousing
and distribution, transaction processing functions and, in most cases, a combined sales force and management teams. The
Company applies a fully allocated cost basis, in which shared business functions are allocated among the segments. Such
allocations are estimates and do not represent the costs of such services if performed on a stand-alone basis.
Segment net sales and profitability are presented below:
82
Net Sales
Wet Shave
Sun and Skin Care
Feminine Care
All Other
Total net sales
Segment Profit
Wet Shave
Sun and Skin Care
Feminine Care
All Other
Total segment profit
General corporate and other expenses
Restructuring and related costs (1)
Cost of early retirement of long-term debt
Acquisition and integration costs (2)
Sun Care reformulation costs (3)
COVID-19 expenses (4)
Gain on sale of Infant and Pet Care business
Feminine and Infant Care evaluation costs (5)
Impairment charges
Investor settlement expense (6)
Amortization of intangibles
Interest and other expense, net
Fiscal Year
2021
2020
2019
$
1,215.9
$
1,162.3
$
1,250.1
585.3
286.1
—
462.0
298.6
26.8
463.1
308.1
119.7
$
2,087.3
$
1,949.7
$
2,141.0
$
221.0
$
206.2
$
246.5
98.7
37.2
—
356.9
(56.5)
(30.1)
(26.1)
(8.4)
(1.1)
—
—
—
—
—
(22.0)
(66.7)
69.1
52.3
3.1
330.7
(54.9)
(38.1)
(26.2)
(39.8)
—
(4.3)
4.1
(0.3)
—
—
(17.3)
(66.6)
80.4
48.3
11.7
386.9
(57.3)
(55.6)
—
(6.7)
(2.8)
—
—
(2.1)
(570.0)
(0.9)
(17.7)
(64.1)
Total earnings (loss) before income taxes
$
146.0
$
87.3
$
(390.3)
Depreciation and amortization
Wet Shave
Sun and Skin Care
Feminine Care
All Other
Total segment depreciation and amortization
Corporate
$
39.9
$
44.8
$
15.6
9.6
—
65.1
22.0
13.8
11.9
1.0
71.5
17.3
Total depreciation and amortization
$
87.1
$
88.8
$
47.3
12.9
11.2
4.7
76.1
17.7
93.8
83
Total Assets
Wet Shave
Sun and Skin Care
Feminine Care
All Other
Total segment assets
Corporate (7)
Goodwill and other intangible assets, net
Total assets
Capital Expenditures
Wet Shave
Sun and Skin Care
Feminine Care
All Other
Total segment capital expenditures
Corporate
Total capital expenditures
2021
Fiscal Year
2020
2019
$
713.7
$
256.3
137.1
—
1,107.1
498.3
2,069.2
$
3,674.6
$
709.8
212.4
146.3
—
1,068.5
384.6
2,087.8
3,540.9
$
36.1
$
34.8
$
37.4
12.2
8.5
—
56.8
—
7.1
5.0
0.8
47.7
—
$
56.8
$
47.7
$
9.9
7.5
3.2
58.0
—
58.0
(1) Restructuring costs associated with Project Fuel includes SG&A of $8.7, $13.3, and $8.6 for fiscal 2021, 2020, and 2019, respectively, primarily
consisting of certain information technology enablement expenses and incentive and retention compensation expenses. Additionally, restructuring
costs associated with Project Fuel includes Cost of products sold of $0.6, $0.2, and $0.6 for fiscal 2021, 2020, and 2019, respectively, related to
inventory obsolescence write-offs.
(2)
(3)
(4)
(5)
Includes SG&A of $7.1, $39.2, and $6.7 for fiscal 2021, 2020, and 2019, respectively, related to integration expenses associated with acquisitions
and Cost of products sold of $1.3 and $0.6 related to the valuation of acquired inventory for fiscal 2021 and 2020, respectively.
Includes Cost of products sold of $1.1 and $2.8 for fiscal 2021 and 2019, respectively, associated with supply chain and formulation changes and
inventory write-offs on select Sun Care products.
Includes pre-tax Cost of products sold of $4.3 for fiscal 2020, which included incremental costs incurred by the Company related to higher benefit
and emergency payments, supplies and freight.
Includes pre-tax SG&A of $0.3 and $2.1 for fiscal 2020 and 2019, respectively, associated with consulting costs incurred in connection with the
evaluation of our Feminine Care and Infant Care segments.
(6)
Includes pre-tax SG&A of $0.9 for fiscal 2019 associated with a settlement with an investor.
(7) Corporate assets include all cash and cash equivalents, financial instruments and deferred tax assets that are managed outside of operating segments.
The following table presents the Company’s net sales and long-lived assets by geographic area:
Net Sales to Customers
United States
International
Total net sales
Long-lived Assets
United States
Germany
Other International
Fiscal Year
2021
2020
2019
$
$
1,183.6
$
1,082.8
$
1,189.2
903.7
866.9
951.8
2,087.3
$
1,949.7
$
2,141.0
$
244.6
$
257.0
51.9
66.1
51.6
62.3
Total long-lived assets excluding goodwill and other intangibles, net, and other
assets
$
362.6
$
370.9
84
The Company’s international net sales are derived from customers in numerous countries, with no sales to any individual
foreign country exceeding 10% of the Company’s total Net sales. For information on customer concentration and product
concentration risk, see Note 16 of Notes to Consolidated Financial Statements.
Supplemental product information is presented below for net sales:
Razors and blades
Sun care products
Tampons, pads and liners
Skin care products
Shaving gels and creams
Infant care and other
Total net sales
Fiscal Year
2021
2020
2019
$
1,084.6
$
1,023.3
$
1,108.4
333.6
286.1
251.7
131.3
—
283.3
298.6
178.7
139.0
26.8
328.7
308.1
134.4
141.7
119.7
$
2,087.3
$
1,949.7
$
2,141.0
85
Note 19 - Quarterly Financial Information (Unaudited)
Net sales
Gross profit (1)(2)
Net earnings (1)(2)(3)(4)
Basic earnings per share (8)
Diluted earnings per share (8)
Net sales
Gross profit (1)(2)(5)
Net earnings (1)(2)(3)(5)(6)(7)
Basic earnings per share (8)
Diluted earnings per share (8)
Fiscal 2021 (by quarter)
Q1
Q2
Q3
Q4
$
451.1
$
519.3
$
573.7
$
193.3
17.7
0.33
0.32
241.7
14.4
0.26
0.26
270.3
40.8
0.75
0.74
Fiscal 2020 (by quarter)
Q1
Q2
Q3
Q4
$
454.0
$
523.0
$
483.9
$
193.1
22.4
0.41
0.41
243.0
19.5
0.36
0.36
222.7
4.7
0.09
0.09
543.2
244.8
44.1
0.81
0.80
488.8
222.1
21.0
0.39
0.38
(1) Restructuring and related costs were $4.4, $5.5, $8.2 and $12.0 for the first, second, third and fourth quarters of fiscal 2021, respectively, and $8.0,
$12.4, $10.4 and $7.3 for the first, second, third and fourth quarters of fiscal 2020, respectively. See Note 4 of Notes to Consolidated Financial
Statements.
(2)
Includes acquisition and integration costs impacting SG&A of $1.7, $0.3, $1.3 and $3.8 for the first, second, third and fourth quarters of fiscal 2021,
respectively, and $6.2, $25.5, $0.3 and $7.2 for the first, second, third and fourth quarters of fiscal 2020, respectively. Additionally, the impact of
acquisition and integration costs to Cost of products sold totaled $1.3 and $0.6 in the first quarter of fiscal 2021 and the fourth quarter of fiscal 2020,
respectively. See Note 3 of Notes to Consolidated Financial Statements.
(3) Cost of early debt retirement was $26.1 and $26.2 in the second quarter of fiscal 2021 and the third quarter of fiscal 2020, related to retirement of the
Senior Notes due 2022 and 2021, respectively.
(4) Sun Care reformulation included charges to Cost of products sold of $1.1 in the fourth quarter of fiscal 2021.
(5)
Includes pre-tax Cost of products sold of $3.9 and $0.4 for the third and fourth quarters of fiscal 2020, which included incremental costs incurred by
the Company related to higher benefit and emergency payments, supplies and freight, net of government credits received.
(6) The sale of the Infant and Pet Care business resulted in a gain of $4.1 in the first quarter of fiscal 2020.
(7) Feminine and Infant Care evaluation costs were $0.3 for the first quarter of fiscal 2020.
(8) Quarterly and annual computations are prepared independently. Therefore, the sum of each quarter may not necessarily total the fiscal period
amounts noted elsewhere within this Annual Report on Form 10-K.
Note 20 - Subsequent Event
Since November 15, 2021, the Company repurchased 0.2 shares of common stock on the open market for $7.4 under the share
repurchase Board authorization from January 2018 which allows the repurchase of up to 10.0 shares. There are 9.6 common
shares remaining available to be purchased.
86
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.
None.
Item 9A. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed
under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported
within the specified time periods, and that such information is accumulated and communicated to management, including our
Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding
required disclosure.
Our management, with the participation of our CEO and CFO, evaluated the effectiveness of our disclosure controls and
procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2020. Based on that
evaluation, our CEO and CFO concluded that, as of that date, our disclosure controls and procedures were effective.
Management’s Report on Internal Control Over Financial Reporting
The management of the Company is responsible for establishing and maintaining adequate internal control over financial
reporting, as defined under Exchange Act Rules 13a-15(f) and 15d-15(f). The Company’s internal control over financial
reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements in accordance with generally accepted accounting principles (“GAAP”) for external
purposes. The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the
maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of
the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with GAAP, and that receipts and expenditures of the Company are being made only in accordance
with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on
the financial statements. Internal control over financial reporting, because of its inherent limitations, may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may
become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may
deteriorate. Management conducted an assessment of the effectiveness of the Company’s internal control over financial
reporting based on the framework set forth in Internal Control - Integrated Framework (2013), issued by the Committee of
Sponsoring Organizations of the Treadway Commission. Based on the Company’s assessment, management has concluded that
internal control over financial reporting as of September 30, 2021 was effective.
The Company’s internal control over financial reporting as of September 30, 2021 has been audited by PricewaterhouseCoopers
LLP, an independent registered public accounting firm, as stated in their report that appears herein.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended September 30, 2021 that have
materially affected, or are likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information.
None.
87
PART III
Item 10. Directors, Executive Officers and Corporate Governance.
Information regarding our directors will be included in our definitive proxy statement for our annual meeting of shareholders,
which will be filed with the United States Securities and Exchange Commission (“SEC”) within 120 days after September 30,
2021.
Information regarding our executive officers is included in Item 1. Business of this Annual Report on Form 10-K.
We have adopted business practices and standards of conduct that are applicable to all employees, including our Chief
Executive Officer, Chief Financial Officer and Chief Accounting Officer. We have also adopted a code of business conduct
applicable to our Board of Directors. The codes have been posted on the Investor section of our website at www.edgewell.com.
In the event that an amendment to, or a waiver from, a provision of one of the codes of ethics occurs and it is determined that
such amendment or waiver is subject to the disclosure provisions of Item 5.05 of Current Report on Form 8-K, we intend to
satisfy such disclosure by posting such information on our website for at least a 12-month period.
Item 11. Executive Compensation.
Information regarding the compensation of our named executive officers and directors will be included in our definitive proxy
statement for our annual meeting of shareholders, which will be filed with the SEC within 120 days after September 30, 2021.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Information regarding individuals or groups that own more than five percent of our common shares, as well as information
regarding the security ownership of our executive officers and directors, information relating to securities authorized for
issuance under equity compensation plans and other shareholder matters will be included in our definitive proxy statement for
our annual meeting of shareholders, which will be filed with the SEC within 120 days after September 30, 2021.
Item 13. Certain Relationships and Related Transactions, and Director Independence.
Information regarding transactions with related parties and director independence will be included in our definitive proxy
statement for our annual meeting of shareholders, which will be filed with the SEC within 120 days after September 30, 2021.
Item 14. Principal Accounting Fees and Services.
Information regarding the services provided by and fees paid to PricewaterhouseCoopers LLP, our independent auditors, will be
included in our definitive proxy statement for our annual meeting of shareholders, which will be filed with the SEC within 120
days after September 30, 2021.
88
PART IV
Item 15. Exhibits, Financial Statement Schedules.
Documents filed as part of this report:
1) Financial Statements. The following are included within Item 8. Financial Statements and Supplementary Data of this
Annual Report on Form 10-K.
◦
◦
◦
◦
◦
◦
Report of Independent Registered Public Accounting Firm.
Consolidated Statements of Earnings and Comprehensive Income (Loss) for the fiscal years ended September 30,
2021, 2020 and 2019.
Consolidated Balance Sheets as of September 30, 2021 and 2020.
Consolidated Statements of Cash Flows for the fiscal years ended September 30, 2021, 2020 and 2019.
Consolidated Statements of Changes in Shareholders’ Equity for the period from October 1, 2018 to September
30, 2021.
Notes to Consolidated Financial Statements.
2) Financial Statement Schedules.
Schedule II - Valuation and Qualifying Accounts
Allowance for Doubtful Accounts
Balance at beginning of year
Provision charged to expense, net of reversals
Write-offs, less recoveries, translation, other
Allowance for acquired receivables
Balance at end of year
Income Tax Valuation Allowance
Balance at beginning of year
Provision charged to expense
Write-offs, less recoveries, translation, other
Balance at end of year
Fiscal Year
2021
2020
2019
8.2
(0.7)
(0.6)
—
$
6.9
$
8.5
1.0
(0.1)
$
5.6
3.7
(1.4)
0.3
8.2
7.2
1.4
(0.1)
$
9.4
$
8.5
$
6.0
0.2
(0.6)
—
5.6
7.0
(0.1)
0.3
7.2
3) Exhibits. The exhibits are included in the Exhibit Index that appears at the end of this Annual Report on Form 10-K.
89
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized.
SIGNATURES
EDGEWELL PERSONAL CARE COMPANY
By:
/s/ Rod R. Little
Rod R. Little
President and Chief Executive Officer
Date: November 19, 2021
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following
persons on behalf of the registrant and in the capacities and as of the date indicated.
Signature
/s/ Rod R. Little
Rod R. Little (principal executive officer)
/s/ Daniel J. Sullivan
Daniel J. Sullivan (principal financial officer)
Title
President and Chief Executive Officer
Chief Financial Officer
/s/ Robert Black
Robert Black
/s/ George Corbin
George Corbin
/s/ Daniel J. Heinrich
Daniel J. Heinrich
/s/ Carla C. Hendra
Carla C. Hendra
/s/ John C. Hunter
John C. Hunter
/s/ James C. Johnson
James C. Johnson
/s/ Joseph D. O’Leary
Joseph D. O’Leary
/s/ Rakesh Sachdev
Rakesh Sachdev
/s/ Swan Sit
Swan Sit
/s/ Gary Waring
Gary Waring
November 19, 2021
Director
Director
Director
Director
Director
Director
Director
Director
Director
Director
90
EXHIBIT INDEX
Exhibit
Number
2.1***
Exhibit
Separation and Distribution Agreement by and between the Company and Energizer Holdings, Inc. dated as of June 25, 2015
(incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed June 29, 2015).
2.2***
Tax Matters Agreement by and between the Company and Energizer Holdings, Inc. dated as of June 26, 2015 (incorporated by
reference to Exhibit 2.2 to the Company's Current Report on Form 8-K filed June 29, 2015).
2.3***
Employee Matters Agreement by and between the Company and Energizer Holdings, Inc. dated as of June 25, 2015
(incorporated by reference to Exhibit 2.3 to the Company's Current Report on Form 8-K filed June 29, 2015).
2.4***
Transition Services Agreement by and between the Company and Energizer Holdings, Inc. dated as of June 25, 2015
(incorporated by reference to Exhibit 2.4 to the Company's Current Report on Form 8-K filed June 29, 2015).
2.5***
Contribution Agreement by and between the Company and Energizer Holdings, Inc. dated June 30, 2015 (incorporated by
reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed July 1, 2015).
2.6
2.7
3.1
3.2
Agreement and Plan of Merger by and among Edgewell Personal Care Company, Callahan Corp., Harry’s Inc. and the Person
party thereto solely in its capacity as the Stockholder Representative, dated as of May 8, 2019 (incorporated by reference to
Exhibit 2.1 to the Company’s Current Report on Form 8-K filed May 13, 2019).
Membership Interest Purchase Agreement by and among Edgewell Personal Care Company, solely for purposes of Section
13.17, Edgewell Personal Care, LLC, Cremo Holding Company, LLC, the sellers named therein, and the Joint Holder
Representatives named therein, dated as of August 1, 2020.
Amended and Restated Articles of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company's
Quarterly Report on Form 10-Q for the quarter ended December 31, 2013).
Articles of Merger effective June 30, 2015 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form
8-K filed July 1, 2015).
3.3*
Amended and Restated Bylaws of the Company effective November 5, 2020.
4.1
4.2
4.3
10.1
10.2
10.3
10.4
10.5
Indenture, dated as of May 19, 2011, by and among the Company, the guarantors named therein, and The Bank of New York
Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 of the Company's Current Report on Form
8-K, filed May 19, 2011).
First Supplemental Indenture, dated as of May 19, 2011, by and among the Company, the guarantors named therein, and The
Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 of the Company's
Current Report on Form 8-K, filed May 19, 2011).
Second Supplemental Indenture (including the Form of Note), dated as of May 24, 2012, by and among the Company, the
guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to
Exhibit 4.2 to the Company's Current Report on Form 8-K filed May 24, 2012).
Credit Agreement, dated June 1, 2015, by and among the Company, as borrower, JPMorgan Chase Bank, N.A., as
administrative agent, and Bank of America, N.A., The Bank of Tokyo-Mitsubishi UFJ, Ltd., and Citibank, N.A., as co-
syndication agents (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed June 1,
2015).
Omnibus Amendment No. 1 dated as of September 25, 2015 to Credit Agreement and Subsidiary Guaranty by and among
Edgewell Personal Care Company, as borrower, Edgewell Personal Care Brands, LLC, as new subsidiary borrower, certain
other subsidiaries of Edgewell, as subsidiary guarantors, JPMorgan Chase Bank, N.A., as administrative agent, Bank of
America, N.A., The Bank of Tokyo-Mitsubishi UFJ, Ltd., and Citibank, N.A., as co-syndication agents, and the various
lenders who are a party thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed
September 29, 2015).
Amendment No. 2 to Credit Agreement by and among Edgewell Personal Care Company, as borrower, Edgewell Personal
Care Brands, LLC, as subsidiary borrower, certain other subsidiaries of Edgewell Personal Care Company, as subsidiary
guarantors, JPMorgan Chase Bank, N.A., as administrative agent, and the various lenders who are a party thereto
(incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed April 29, 2016).
Amendment No. 3 to Credit Agreement dated as of March 13, 2017, by and among Edgewell Personal Care Company, as
borrower, Edgewell Personal Care Brands, LLC, as subsidiary borrower, certain other subsidiaries of Edgewell Personal Care
Company, as subsidiary guarantors, JPMorgan Chase Bank, N.A., as administrative agent, Bank of America, N.A., as
syndication agent, and the various lenders who are a party thereto (incorporated by reference to Exhibit 10.1 to the Company's
Current Report on Form 8-K filed March 14, 2017).
Increasing Lender Supplement dated as of March 13, 2017, by and among The Bank of Tokyo-Mitsubishi UFJ, Ltd., as
increasing lender, Edgewell Personal Care Company, as borrower, and JPMorgan Chase Bank, N.A., as administrative agent
(incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed March 14, 2017).
91
10.6
10.7
10.8
10.9
10.10
10.11
10.12
10.13
Credit Agreement by and among Edgewell Personal Care Netherlands B.V., as borrower, the Company, and The Bank of
Tokyo-Mitsubishi UFJ, Ltd., as Administrative Agent (incorporated by reference to Exhibit 10.1 to the Company's Current
Report on Form 8-K filed June 15, 2015).
Amendment No. 1 dated as of September 25, 2015 to Credit Agreement by and among Edgewell Personal Care Netherlands
B.V., Edgewell Personal Care Company, the institutions listed on the signature pages thereto and the Bank of Tokyo-
Mitsubishi UFJ, Ltd., as the administrative agent for the lenders referred to therein (incorporated by reference to Exhibit 10.2
to the Company's Current Report on Form 8-K filed September 29, 2015).
Master Accounts Receivable Purchase Agreement dated as of September 15, 2017 among Edgewell Personal Care, LLC, as
the Seller, Edgewell Personal Care Company, as Guarantor, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch,
as the Purchaser (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed September 19,
2017).
Credit Agreement, dated as of March 28, 2020, by and among, inter alia, the Company, the subsidiaries of the Company from
time to time parties thereto, the lenders from time to time parties thereto, MUFG, as syndication agent, TD as joint lead
arranger and BofA, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.1 to the Company’s
Current Report on Form 8-K filed April 2, 2020).
Indenture, dated as of May 22, 2020, among Edgewell Personal Care Company, the guarantors party thereto and the Trustee
(incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed May 22, 2020.
Trademark License Agreement by and between the Company and Energizer Brands, LLC dated June 25, 2015 (incorporated
by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed June 29, 2015).
Trademark License Agreement by and between the Company and Wilkinson Sword GmbH, as licensors, and Energizer
Holdings, Inc. dated June 25, 2015 (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K
filed June 29, 2015).
Tax Sharing Agreement (incorporated by reference to Exhibit 2.2 of the Company’s Post-Effective Amendment No. 1 to Form
10, filed April 19, 2000).
10.14**
A Summary of the Company's director compensation program (incorporated by reference to the Company's Definitive Proxy
Statement for the fiscal year ended September 30, 2016).
10.15**
Form of Indemnification Agreement (for directors with existing agreements) (incorporated by reference to Exhibit 10.1 to the
Company's Current Report on Form 8-K filed May 28, 2015).
10.16**
Form of Indemnification Agreement (for new directors) (incorporated by reference to Exhibit 10.2 to the Company's Current
Report on Form 8-K filed May 28, 2015).
10.17**
Second Amended and Restated 2009 Incentive Stock Plan (incorporated by reference to Exhibit 10.1 to the Company's
Quarterly Report on Form 10-Q for the quarter ended December 31, 2013).
10.18**
Form of Restricted Stock Equivalent Award Agreement (incorporated by reference to Exhibit 10.1 to the Company's Current
Report on Form 8-K filed November 14, 2014).
10.19**
Form of Restricted Stock Equivalent Award Agreement (incorporated by reference to Exhibit 10.1 to the Company's Current
Report on Form 8-K filed July 10, 2015).
10.20**
Form of Non-Qualified Stock Option Agreement (incorporated by reference to Exhibit 10.2 to the Company's Current Report
on Form 8-K filed July 10, 2015).
10.21**
Form of Performance Restricted Stock Equivalent Award Agreement (incorporated by reference to Exhibit 10.16 to the
Company's Annual Report on Form 10-K for the year ended September 30, 2016).
10.22**
Form of annual Restricted Stock Equivalent Award Agreement for Directors (incorporated by reference to Exhibit 10.15 to the
Company's Annual Report on Form 10-K for the year ended September 30, 2015).
10.23**
Form of annual Restricted Stock Equivalent Award Agreement for Directors (incorporated by reference to Exhibit 10.21 to the
Company's Annual Report on Form 10-K for the year ended September 30, 2018).
10.24**
Form of appointment Restricted Stock Equivalent Award Agreement for Directors (incorporated by reference to Exhibit 10.16
to the Company's Annual Report on Form 10-K for the year ended September 30, 2015).
10.25**
Form of Change of Control Employment Agreement, as amended December 31, 2008 (incorporated by reference to Exhibit
10.1 of the Company's Current Report on Form 8-K filed January 6, 2009).
10.26**
Form of Change of Control Employment Agreement for use with designated individuals subsequent to January 1, 2012
(incorporated by reference to Exhibit 10.64 to the Company's Annual Report on Form 10-K for the year ended September 30,
2012).
10.27**
Form of Change of Control Agreement with certain Executive Officers (incorporated by reference to Exhibit 10.3 to the
Company's Current Report on Form 8-K filed July 10, 2015).
92
10.28**
Form of Change of Control Agreement with certain Executive Officers (incorporated by reference to Exhibit 10.1 to the
Company's Current Report on Form 8-K filed May 2, 2017).
10.29**
January 1, 2015 Restatement of the Company's Executive Savings Investment Plan (incorporated by reference to Exhibit
10.21 to the Company's Annual Report on Form 10-K for the year ended September 30, 2015).
10.30**
Amendment to the Company's Executive Savings Investment Plan, effective July 1, 2015 (incorporated by reference to
Exhibit 10.12 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2015).
10.31**
2010 Restatement of the Company's Supplemental Executive Retirement Plan dated October 15, 2010 (incorporated by
reference to Exhibit 10.54 of Amendment No. 1 to the Company's Annual Report on Form 10-K/A, filed May 16, 2011).
10.32**
10.33**
10.34**
First Amendment to the 2010 Restatement of the Company's Supplemental Executive Retirement Plan, effective July 1, 2015
(incorporated by reference to Exhibit 10.24 to the Company's Annual Report on Form10-K for the year ended September 30,
2015).
Second Amendment to the 2010 Restatement of the Company's Supplemental Executive Retirement Plan, effective July 1,
2015 (incorporated by reference to Exhibit 10.13 to the Company's Quarterly Report on Form 10-Q for the quarter ended June
30, 2015).
2009 Restatement of the Company's Deferred Compensation Plan, as amended and restated effective as of January 1, 2009
(incorporated by reference to Exhibit 10 of the Company's Annual Report on Form 10-K for the year ended September 30,
2008).
10.35**
First Amendment to the 2009 Restatement of the Company's Deferred Compensation Plan (incorporated by reference to
Exhibit 4.3 to the Company's Registration Statement on Form S-8 filed November 21, 2012).
10.36**
Amendment No. 2 to the 2009 Restatement of the Company's Deferred Compensation Plan (incorporated by reference to
Exhibit 4.4 to the Company's Registration Statement on Form S-8 filed November 21, 2012).
10.37**
Amendment No. 3 to 2009 Restatement of the Company's Deferred Compensation Plan, dated November 7, 2011
(incorporated by reference to Exhibit 10.59 to the Company's Annual Report on Form 10-K for the year ended September 30,
2012).
10.38**
Amendment No. 4 to the 2009 Restatement of the Company's Deferred Compensation Plan (incorporated by reference to
Exhibit 10.60 to the Company's Annual Report on Form 10-K for the year ended September 30, 2012).
10.39**
Amendment to the 2009 Restatement of the Company's Deferred Compensation Plan, effective July 1, 2015 (incorporated by
reference to Exhibit 10.14 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2015).
10.40**
Executive Group Personal Excess Liability Insurance Plan (incorporated by reference to Exhibit 10.9 of the Company's Post-
Effective Amendment No. 1 to Form 10, filed April 19, 2000).
10.41**
Amended and Restated Executive Officer Bonus Plan (incorporated by reference to Exhibit 10.36 to the Company's Annual
Report on Form 10-K for the year ended September 30, 2016).
10.42**
2017 Edgewell Personal Care Company Financial Planning Plan (incorporated by reference to Exhibit 10.39 to the Company's
Annual Report on Form 10-K for the year ended September 30, 2017.
10.43**
10.44**
Edgewell Personal Care Company Executive Severance Plan (incorporated by reference to Exhibit 10.4 to the Company's
Quarterly Report on Form 10-Q for the quarter ended March 31, 2017).
Edgewell Personal Care Company Change in Control Plan (incorporated by reference to Exhibit 10.1 to the Company’s
Current Report on Form 8-K filed May 1, 2019).
21.1*
Subsidiaries of Registrant.
23.1*
31.1*
31.2*
32.1*
32.2*
Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as
amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as
amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
93
101*
The following materials from the Edgewell Personal Care Company Annual Report on Form 10-K formatted in inline
eXtensible Business Reporting Language (iXBRL): (i) the Consolidated Statements of Earnings and Comprehensive Income
for the years ended September 30, 2019, 2020 and 2021, (ii) the Consolidated Balance Sheets at September 30, 2020 and
2021, (iii) the Consolidated Statements of Cash Flows for the years ended September 30, 2019, 2020 and 2021, (iv)
Consolidated Statements of Changes in Shareholders’ Equity for the period from October 1, 2018 to September 30, 2021, and
(v) Notes to Consolidated Financial Statements for the year ended September 30, 2021.
*Filed herewith.
**Denotes a management contract or compensatory plan or arrangement.
***The Company hereby undertakes to furnish supplementally a copy of any omitted schedule or exhibit to such agreement to the Securities
and Exchange Commission upon request.
94